Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,20947,267,1.85 [0.94-3.65],0.0762558886230806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AAMDC,Mth938 domain-containing protein,20347,252,0.85 [0.67-1.08],0.1854722412836255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,24013,293,1.23 [1.03-1.49],0.025805907804895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,20268,261,1.30 [0.93-1.80],0.1196825699142223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABHD14B,Protein ABHD14B,23878,296,0.96 [0.79-1.15],0.6347927170301785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,24013,293,0.98 [0.84-1.15],0.824360056059538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABO,Histo-blood group ABO system transferase,20949,268,0.99 [0.91-1.07],0.739483465953491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,20268,261,0.99 [0.83-1.20],0.9565723351306622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23512,290,1.42 [1.26-1.59],2.689640094488426e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20535,263,0.98 [0.82-1.18],0.8541699912206587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",20929,268,0.98 [0.86-1.12],0.7645986113225263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,23886,294,1.94 [1.35-2.78],0.0003018477342169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,20949,268,2.59 [1.61-4.16],9.186424844838484e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,23674,285,1.99 [1.69-2.33],3.406519737232915e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,20437,253,1.89 [1.39-2.58],5.014254128953649e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,20845,268,1.04 [0.94-1.16],0.4237487183506049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,24107,295,1.04 [0.84-1.28],0.7447799400482142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,20324,257,0.73 [0.55-0.97],0.031702185665274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,24187,297,2.79 [2.10-3.70],1.3504585045544854e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,24307,301,1.18 [1.00-1.39],0.0566177211005508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRBP,Acrosin-binding protein,20831,269,1.00 [0.72-1.38],0.9886144087559148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,20324,257,1.22 [1.10-1.35],0.0002399151926775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,20268,261,1.02 [0.71-1.45],0.9277817783601208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",23674,285,1.37 [1.12-1.66],0.0020710142682945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,20268,261,1.20 [0.99-1.44],0.0594966098355042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,23650,292,0.91 [0.63-1.30],0.6010498170567795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,23926,296,3.08 [2.08-4.55],1.8663402663672657e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,24107,295,1.58 [1.37-1.82],3.5395980698375297e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20268,261,1.46 [1.20-1.78],0.0001491145778859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACYP1,Acylphosphatase-1,20363,253,1.09 [0.91-1.31],0.3587043053508775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,24394,299,1.61 [1.24-2.09],0.0004020112503105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,23946,294,1.60 [1.26-2.02],0.0001234331797699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20324,257,1.51 [1.22-1.87],0.0001820988502881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,23674,285,1.62 [1.15-2.29],0.006132806909942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,23969,296,0.45 [0.33-0.61],1.3647212118274637e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,24394,299,0.74 [0.56-0.98],0.0329150777308762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24313,299,1.43 [1.00-2.04],0.0515206540910644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,20845,268,2.59 [1.86-3.61],2.1714014497766395e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20324,257,1.49 [1.07-2.08],0.0198581938552141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24403,298,0.48 [0.31-0.75],0.0012484666879045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24013,293,1.51 [1.16-1.96],0.0021092514218648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,23674,285,0.87 [0.60-1.24],0.4289923681935853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20324,257,1.22 [0.88-1.69],0.2403187089075387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24166,299,0.75 [0.59-0.94],0.0135241044979463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,20923,268,3.05 [2.27-4.11],2.251827982536888e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,20347,252,0.79 [0.48-1.31],0.3667051290282414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,20929,268,0.88 [0.65-1.19],0.3949667104091228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23512,290,0.93 [0.67-1.29],0.661894398774044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADD1,Alpha-adducin,20437,253,0.98 [0.82-1.17],0.8061868783710587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,23926,296,0.92 [0.67-1.26],0.6010495172127417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,20437,253,2.66 [2.08-3.39],4.3250809285142526e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,20845,268,1.09 [0.87-1.36],0.4372706398074251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,24204,299,1.16 [0.81-1.65],0.4270888412003581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,24267,297,1.16 [0.83-1.62],0.389038859350349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,20929,268,1.61 [1.08-2.41],0.0203929832779557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,24013,293,1.46 [1.27-1.66],2.9682213589610988e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,24107,295,0.58 [0.41-0.83],0.0025360399295753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,20261,268,1.06 [0.89-1.25],0.5184978330087899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,20437,253,1.13 [0.97-1.31],0.1192980738453194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,23674,285,1.18 [1.04-1.32],0.007138958747297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,20947,267,1.06 [0.90-1.24],0.4958391860642324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,24336,301,4.63 [3.14-6.81],8.559320966527361e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,20268,261,0.98 [0.82-1.16],0.7762436639564907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,20437,253,0.79 [0.68-0.92],0.0027701281128313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFM,Afamin,20947,267,1.04 [0.56-1.90],0.9095219007964656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,23893,295,1.18 [1.01-1.38],0.0388500749575722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,20261,268,0.99 [0.86-1.13],0.8631894818009062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,24039,295,0.66 [0.51-0.85],0.0016355313993348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,23369,285,1.26 [1.13-1.40],1.865392002200871e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,23481,289,1.20 [1.01-1.42],0.0433887968841955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,24204,299,1.64 [1.23-2.18],0.0007835274542736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,24394,299,1.04 [0.86-1.27],0.6593375727836136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGT,Angiotensinogen,20949,268,0.92 [0.55-1.56],0.764483762726257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,24107,295,1.35 [1.19-1.53],1.6748160236012649e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHCY,Adenosylhomocysteinase,24107,295,1.03 [0.88-1.20],0.6972018921793457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,20347,252,1.23 [0.86-1.76],0.2627902801956298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,20347,252,1.90 [1.34-2.69],0.0003257141505724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,20831,269,0.94 [0.78-1.14],0.5340985481647779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,20949,268,1.40 [0.90-2.19],0.1367594472625966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,24070,296,1.25 [1.11-1.41],0.0002672795032802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",20341,262,1.08 [0.94-1.25],0.2714860757507229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,23512,290,1.18 [0.96-1.45],0.1095622770345252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,20347,252,0.88 [0.69-1.11],0.2849047389219294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",23967,293,1.16 [1.06-1.28],0.0022759604754337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK1,Adenylate kinase isoenzyme 1,24107,295,1.24 [1.06-1.46],0.0077639735417364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",20872,268,1.04 [0.93-1.16],0.532524298927888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKAP12,A-kinase anchor protein 12,20437,253,0.97 [0.54-1.72],0.9088622605119856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,23512,290,1.02 [0.89-1.18],0.7368870057635575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,20341,262,1.34 [1.13-1.59],0.0006845627140532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,23674,285,1.17 [0.98-1.39],0.0805374374742024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,20324,257,1.21 [1.03-1.42],0.0223300703204386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,23557,291,1.08 [0.92-1.27],0.3323966024991098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,20901,269,0.96 [0.87-1.05],0.3731026954688754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,23387,290,0.83 [0.68-1.00],0.0544257924013236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,24403,298,1.54 [0.94-2.50],0.0858452302439677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,24103,297,1.61 [1.36-1.89],1.4751340057832094e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",20831,269,1.20 [0.95-1.51],0.1321600829600558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24055,293,1.55 [1.39-1.74],1.4694904180466582e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",20901,269,1.43 [1.14-1.79],0.0022902897249525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,20535,263,0.87 [0.64-1.19],0.3934704611571304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,20324,257,1.11 [1.00-1.23],0.0450767109129713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",24013,293,1.24 [1.15-1.34],8.670865621459984e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,23650,292,0.80 [0.53-1.22],0.3049553135203252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,24307,299,2.15 [1.27-3.63],0.0044142981446808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,20923,268,0.85 [0.53-1.36],0.4961327807677763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,23557,291,1.05 [0.90-1.23],0.548288388643308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,20341,262,0.99 [0.78-1.25],0.9318792155602594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,24013,293,1.26 [0.80-2.00],0.3172242207032389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,23650,292,1.03 [0.83-1.29],0.7756795060102539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,20437,253,0.74 [0.56-0.98],0.0326828958282378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOTL2,Angiomotin-like protein 2,20765,268,0.95 [0.72-1.26],0.7390859498184835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMPD3,AMP deaminase 3,20872,268,1.23 [1.04-1.45],0.0160824751614814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19645,253,0.81 [0.63-1.06],0.1225907417034362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,23199,283,0.76 [0.60-0.95],0.0177401077371174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,22465,275,0.72 [0.57-0.91],0.0054099545747361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,24017,294,1.71 [1.29-2.27],0.0001805012673236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,24033,297,0.95 [0.84-1.07],0.3943922213638603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,24336,301,2.22 [1.74-2.84],1.9690646968122123e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,23743,287,1.94 [1.37-2.75],0.0002120615907232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,24128,298,1.58 [1.22-2.04],0.0005152208683432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,24102,295,1.06 [0.80-1.40],0.6971695246347311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,24166,298,1.86 [1.49-2.33],5.3206052643930914e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,24336,301,1.81 [1.42-2.31],1.8527832255658749e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANK2,Ankyrin-2,20268,261,1.05 [0.89-1.24],0.5459671597042535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,20324,257,0.90 [0.77-1.05],0.1735039969093966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,20195,258,0.96 [0.76-1.21],0.7067254682383762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,23512,290,1.28 [1.10-1.50],0.0019057769029818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,20347,252,0.79 [0.55-1.15],0.2212723278549124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,24134,296,2.38 [1.69-3.36],6.898379716027513e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA1,Annexin A1,20315,251,1.26 [1.01-1.57],0.0375292121722105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,23557,291,1.57 [1.40-1.76],5.8299576869434955e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA11,Annexin A11,24045,293,1.00 [0.85-1.18],0.9851864639473904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,20052,248,1.25 [1.07-1.46],0.0042057947033384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,24313,299,1.05 [0.91-1.22],0.5156500571302942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA4,Annexin A4,23982,293,0.95 [0.82-1.10],0.4853644859099095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,23482,288,1.29 [0.89-1.87],0.1728218391609366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],23650,292,0.97 [0.79-1.18],0.762219619090279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,24176,296,1.90 [1.34-2.69],0.0002926584108521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,20831,269,1.05 [0.91-1.22],0.5132740936282341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP2B1,AP-2 complex subunit beta,20341,262,1.12 [0.88-1.41],0.3606787572771133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3B1,AP-3 complex subunit beta-1,20845,268,1.03 [0.88-1.20],0.7450067910468917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,20872,268,0.99 [0.77-1.27],0.9439629376277626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24013,293,1.21 [0.98-1.48],0.0760802868850974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,20775,264,1.79 [1.29-2.49],0.0005204391812917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24270,301,1.36 [1.16-1.61],0.0002210271374227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,24107,295,0.67 [0.54-0.82],0.0001293210230686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,20947,267,0.95 [0.63-1.43],0.8098156343560811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,20949,268,1.25 [0.99-1.59],0.0651514476046379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,20947,267,1.17 [0.86-1.59],0.3149577103556514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOB,Apolipoprotein B-100,20949,268,1.05 [0.61-1.80],0.8674544303187868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOBR,Apolipoprotein B receptor,20347,252,0.87 [0.65-1.16],0.3381995952178239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,20902,267,1.04 [0.78-1.39],0.7917639672860793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,19980,256,1.21 [0.95-1.56],0.1278554421238028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,20947,267,1.07 [0.92-1.24],0.3694223580426309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,20949,268,0.87 [0.59-1.28],0.4782302044738012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOH,Beta-2-glycoprotein 1,24103,297,1.46 [1.10-1.95],0.0098343486997669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOL1,Apolipoprotein L1,20949,268,0.88 [0.72-1.08],0.2172425145500256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,24145,296,1.23 [0.84-1.78],0.2857277353378493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,24060,297,0.94 [0.81-1.10],0.475516959201701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APPL2,DCC-interacting protein 13-beta,20437,253,0.91 [0.82-1.02],0.1123206956844301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APRT,Adenine phosphoribosyltransferase,23941,296,1.14 [0.90-1.42],0.2728553963622226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,20535,263,0.92 [0.76-1.12],0.4057371014302696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,24013,293,1.99 [1.67-2.38],1.8039993102973948e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARF6,ADP-ribosylation factor 6,20845,268,0.98 [0.88-1.10],0.7561292293962893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARFIP1,Arfaptin-1,20901,269,1.02 [0.85-1.21],0.8596915056008094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,24000,297,1.08 [0.88-1.31],0.4657008629079199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG2,"Arginase-2, mitochondrial",20831,269,0.86 [0.63-1.17],0.3389403211636187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,23512,290,0.97 [0.77-1.22],0.8042843927908412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,23512,290,0.98 [0.82-1.16],0.778917839569812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,20535,263,1.05 [0.75-1.48],0.7637300566190458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,20437,253,0.92 [0.79-1.07],0.2758003820674329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,20195,258,1.02 [0.86-1.20],0.8404763504502967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,20872,268,1.06 [0.93-1.21],0.4010122047940357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,20901,269,1.01 [0.89-1.15],0.8325811068715615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,24087,294,0.93 [0.84-1.03],0.1871924774441986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,20261,268,1.14 [0.98-1.33],0.0872245878052245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,20261,268,0.90 [0.65-1.25],0.5360903289275059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,23557,291,1.00 [0.77-1.30],0.9877199145012744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,20268,261,1.12 [0.95-1.33],0.1759075253456631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,20268,261,0.91 [0.67-1.23],0.5267214660958095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,20261,268,1.05 [0.87-1.26],0.6231135796551941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,23650,292,1.08 [0.80-1.45],0.6195005041946249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,20268,261,0.78 [0.60-1.02],0.0687410557373357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,24103,297,1.35 [1.09-1.68],0.0067443565734301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,24013,293,1.21 [1.01-1.46],0.0367239251089064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,24176,296,1.08 [0.82-1.43],0.5912172288288438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,20261,268,0.90 [0.72-1.12],0.3366260551556371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,23650,292,1.29 [1.07-1.56],0.0077301798102053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,20752,267,1.46 [1.17-1.83],0.0008171873165301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,23969,296,0.93 [0.77-1.12],0.4461475714882874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,23969,296,3.27 [2.41-4.46],4.5226497043001716e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,20949,268,2.50 [1.62-3.84],3.1235711061456746e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,20929,268,1.31 [0.87-1.95],0.1914609790788605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,20901,269,1.02 [0.86-1.22],0.8232886853522102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,20347,252,0.96 [0.85-1.08],0.4848435875733504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,20268,261,1.11 [0.97-1.29],0.13420804360421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,23557,291,1.00 [0.86-1.17],0.984224874869754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,20195,258,0.72 [0.49-1.06],0.0949500640426401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,20845,268,1.01 [0.88-1.16],0.8757923283030534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG4A,Cysteine protease ATG4A,23512,290,1.19 [1.00-1.41],0.0524937566300124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,24166,299,1.12 [0.96-1.30],0.1407689722638203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,20268,261,0.91 [0.69-1.19],0.4916112297986819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,20268,261,0.81 [0.53-1.24],0.3329623618617816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,20268,261,1.01 [0.73-1.40],0.9548534656924904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B4,Protein ATP1B4,20195,258,1.07 [0.80-1.42],0.6573703634381949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,20268,261,0.92 [0.74-1.15],0.4646238466206048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",20268,261,0.95 [0.75-1.20],0.6660201730861368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",24204,299,1.01 [0.92-1.12],0.7717156356913295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",23557,291,1.00 [0.77-1.29],0.9852688216968116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,23512,290,0.99 [0.77-1.28],0.95679779908244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,24013,293,1.00 [0.65-1.53],0.9890580402551458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,23512,291,1.04 [0.88-1.22],0.6626345758366429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,20347,252,0.95 [0.80-1.13],0.5682511872656894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,20268,261,0.95 [0.83-1.09],0.460075067785305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,20845,268,1.52 [1.17-1.97],0.0015964804611322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",20947,267,1.65 [0.79-3.45],0.1860980719108611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN10,Ataxin-10,23557,291,0.86 [0.74-1.00],0.0428930753534108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2,Ataxin-2,20261,268,0.88 [0.78-1.01],0.0607573534551301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2L,Ataxin-2-like protein,20901,269,0.86 [0.66-1.12],0.2548712369900529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN3,Ataxin-3,20872,268,1.23 [1.01-1.49],0.0362627896345171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,24087,294,0.95 [0.85-1.07],0.422360558173032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,24176,296,1.23 [0.85-1.80],0.2747887791917395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,20901,269,1.00 [0.81-1.24],0.993193639057384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,23369,286,1.18 [1.05-1.33],0.007036643546448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,20947,267,1.68 [1.32-2.12],1.7393339360430966e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,20268,261,1.41 [0.79-2.54],0.2484862726415503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20347,252,1.87 [1.33-2.64],0.0003063813770188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",24204,299,2.58 [1.80-3.70],2.93850383614158e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",24103,297,0.91 [0.59-1.39],0.6592177262464445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,20324,257,1.19 [0.80-1.77],0.4012916430087015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,24087,294,1.06 [0.92-1.23],0.3951172179554395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,23926,296,0.90 [0.69-1.17],0.42928430623161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,20324,257,1.04 [0.82-1.32],0.7439375484055117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG6,Large proline-rich protein BAG6,23674,285,0.98 [0.74-1.31],0.9109449743420754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23512,290,1.55 [1.34-1.80],3.17465622374633e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,23512,290,1.13 [0.79-1.63],0.5057141393580414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,24087,294,0.96 [0.86-1.06],0.3766856591202231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,20872,268,1.29 [1.12-1.49],0.0004199272145885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,20341,262,1.14 [1.00-1.30],0.0492909374078452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,23515,288,1.05 [0.94-1.19],0.3810361269785001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,24103,297,1.87 [1.23-2.83],0.0032721178532388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,23969,296,0.25 [0.19-0.34],7.352039521421625e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",20929,268,1.69 [1.23-2.32],0.0012842972134221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",20261,268,0.88 [0.69-1.12],0.2894918460961895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,20564,264,1.14 [0.74-1.75],0.5529136682245381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,20845,268,0.99 [0.78-1.26],0.9291208101195476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L1,Bcl-2-like protein 1,20872,268,0.99 [0.88-1.12],0.8494374872416862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24087,294,1.43 [1.10-1.86],0.0071240145919417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,20324,257,1.28 [1.08-1.52],0.004602423355928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,20195,258,1.06 [0.88-1.27],0.5453824051018545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,20831,269,1.04 [0.79-1.38],0.7677070158115052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,24087,294,0.97 [0.86-1.09],0.6038360626006423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,20923,268,0.93 [0.81-1.08],0.3341886243955797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,20347,252,1.00 [0.82-1.23],0.990460559557097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BEX3,Protein BEX3,20195,258,0.84 [0.62-1.15],0.2792892202838782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,20923,268,1.08 [0.95-1.24],0.2370120862562401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,23481,288,0.93 [0.85-1.02],0.1084050454062837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,20261,268,0.95 [0.80-1.14],0.5862209904753631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,20268,261,1.22 [0.74-2.00],0.4386899401474919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,24087,294,1.04 [0.89-1.21],0.6564898310728586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,24103,297,0.90 [0.80-1.02],0.0925649662029095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,23512,290,0.92 [0.77-1.09],0.3480959962398247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,24403,298,1.20 [0.88-1.63],0.2512782954376734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,20324,257,0.92 [0.67-1.27],0.611746586902101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,20261,268,0.93 [0.78-1.11],0.4317503405391499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,20872,268,0.95 [0.71-1.28],0.7271255931416489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLVRB,Flavin reductase,24103,297,1.29 [1.11-1.50],0.0008519698206045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,20437,253,1.46 [0.95-2.24],0.0838829232870934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,23926,296,1.06 [0.85-1.32],0.6219610141532872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,23630,284,1.21 [0.93-1.58],0.1617979190805529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,20437,253,2.67 [1.60-4.47],0.0001833006969767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,20929,268,1.15 [0.82-1.60],0.426419947800465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20324,257,1.42 [1.10-1.83],0.0063384107707054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,23674,285,1.59 [1.02-2.48],0.0403718263950697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,20261,268,1.12 [0.92-1.37],0.2443317671448017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,20347,252,1.08 [0.86-1.36],0.521206070730772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,19628,247,0.91 [0.81-1.03],0.134789494461461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,24055,294,1.35 [1.14-1.59],0.0003614877103553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB2,BPI fold-containing family B member 2,20892,268,0.94 [0.78-1.14],0.5215450579581566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRAP,BRCA1-associated protein,20643,265,0.94 [0.84-1.05],0.2565260111789105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,20535,263,0.98 [0.65-1.48],0.9321096297436474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD2,Bromodomain-containing protein 2,20261,268,0.94 [0.63-1.41],0.768153212162807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD3,Bromodomain-containing protein 3,20268,261,0.75 [0.56-1.02],0.0660757766975449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRDT,Bromodomain testis-specific protein,20268,261,1.01 [0.72-1.41],0.952083029762059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,23557,291,1.07 [0.84-1.35],0.5968643068108965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,20261,268,0.70 [0.49-0.99],0.0443342445767429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,20901,269,1.12 [0.82-1.53],0.4713412830924156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,24353,298,6.66 [4.19-10.59],1.0531691351289502e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSND,Barttin,20195,258,1.07 [0.75-1.54],0.699439526792685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,24351,299,0.98 [0.78-1.23],0.8665006882214712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,24351,299,1.73 [1.51-1.99],8.401966863816418e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,23512,290,0.99 [0.85-1.15],0.8943356073128428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,20947,267,1.10 [0.62-1.98],0.7384723849016075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,20195,258,0.98 [0.83-1.15],0.7823368723455987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,20790,269,0.88 [0.64-1.22],0.4481689547252097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,24204,299,1.84 [1.24-2.72],0.0023403421220415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,24087,294,1.49 [1.15-1.95],0.0029267449853914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTNL10,Butyrophilin-like protein 10,20195,258,0.91 [0.64-1.28],0.5719280333035864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,23557,291,1.23 [1.08-1.40],0.0022899563026316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,20268,261,0.95 [0.64-1.40],0.7842694725668551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,24272,298,1.28 [0.82-1.99],0.2712471004361027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",20901,269,1.03 [0.86-1.23],0.7695939509809019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,20324,257,0.92 [0.70-1.22],0.572543472225195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,24176,296,1.67 [1.34-2.09],6.746398653938883e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20437,253,0.87 [0.63-1.21],0.4159501855250954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,20901,269,1.29 [0.93-1.79],0.1296512973076281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20399,252,0.94 [0.74-1.21],0.6445194694752973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,20947,267,1.66 [1.02-2.69],0.0399877344450024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1RL,Complement C1r subcomponent-like protein,20916,266,1.22 [0.66-2.26],0.5339698355379302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,20947,267,1.98 [1.14-3.43],0.0147247875695463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,24145,296,1.44 [0.89-2.33],0.1412522490281393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,23512,291,1.30 [1.05-1.61],0.0183400929962077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2orf69,UPF0565 protein C2orf69,20341,262,0.95 [0.76-1.19],0.6627425788314705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,19900,250,1.20 [0.95-1.52],0.1343195558010617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,24166,299,0.77 [0.60-0.99],0.0406810333838079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,20947,267,2.52 [1.33-4.78],0.0046235671366505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,20471,262,4.08 [2.88-5.79],3.3628534226040795e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,20872,268,1.41 [0.93-2.12],0.102680589851331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,20947,267,0.88 [0.60-1.29],0.4985427172824711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,20949,268,1.06 [0.85-1.32],0.5945641282100209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9orf40,Uncharacterized protein C9orf40,20845,268,1.18 [1.02-1.37],0.0265781508158599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA1,Carbonic anhydrase 1,23551,291,1.28 [1.07-1.52],0.0059382739212257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA11,Carbonic anhydrase-related protein 11,23512,290,1.13 [0.82-1.56],0.467707967911839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,24013,293,1.58 [1.18-2.11],0.00201755330849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA13,Carbonic anhydrase 13,23824,290,0.94 [0.85-1.04],0.2580069341003752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,24336,301,0.66 [0.50-0.87],0.0035189401210048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA2,Carbonic anhydrase 2,24036,296,1.33 [1.15-1.54],0.0001404534639719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA3,Carbonic anhydrase 3,24361,298,1.21 [1.03-1.42],0.0202442084906173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,24403,298,3.29 [2.22-4.87],2.6234547307157357e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",23674,285,1.32 [1.19-1.47],1.0379106724123376e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,24017,297,0.97 [0.83-1.13],0.7181551489219544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA7,Carbonic anhydrase 7,20535,263,0.80 [0.54-1.17],0.2445118943609553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,20324,257,0.78 [0.46-1.31],0.3427675268630242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,24336,301,1.89 [1.54-2.31],7.15863127633315e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CABP2,Calcium-binding protein 2,20341,262,0.94 [0.77-1.14],0.5267187150583692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,20261,268,0.85 [0.57-1.27],0.4368088770864877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,20268,261,0.97 [0.78-1.22],0.818276728835032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,20261,268,0.90 [0.72-1.11],0.3211138255164594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,20901,269,1.05 [0.91-1.21],0.4687552333600526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACYBP,Calcyclin-binding protein,20397,253,0.96 [0.85-1.08],0.4669999169294623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,20341,262,1.36 [1.07-1.71],0.0107661545847563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB1,Calbindin,24013,293,0.79 [0.62-0.99],0.0416300443005041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,23557,291,1.00 [0.69-1.46],0.993842192735387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,23924,296,1.68 [1.49-1.90],3.4547010286540175e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,20872,268,1.18 [0.89-1.59],0.2542019043244671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,24269,300,0.92 [0.82-1.02],0.0958829004628092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20347,252,0.94 [0.79-1.11],0.4426818776527875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,20268,261,0.95 [0.66-1.36],0.7626839863610372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23512,290,0.93 [0.73-1.19],0.5815077808171196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,20341,262,0.95 [0.76-1.19],0.6683734760262419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,20901,269,0.94 [0.84-1.05],0.2745167757881201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,24049,294,1.46 [0.87-2.45],0.1492475523854019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,23953,296,1.42 [1.21-1.67],1.4997256481823688e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,20831,269,1.48 [1.14-1.93],0.0030342267323293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,20872,268,1.13 [1.01-1.25],0.026090697230964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,23557,291,1.24 [1.01-1.53],0.0364501452130868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,20341,262,1.06 [0.80-1.41],0.6808205742084055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,23557,291,1.12 [0.97-1.29],0.1146687196182406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,23557,291,1.11 [0.96-1.29],0.1659479157918282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,24087,294,0.94 [0.80-1.10],0.4147095560696088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP3,Caspase-3,24403,298,0.95 [0.84-1.07],0.383855687834551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,20535,263,0.95 [0.87-1.03],0.1971578757075155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP7,Caspase-7,20872,268,1.00 [0.87-1.16],0.9959859943028712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP8,Caspase-8,24278,299,1.01 [0.86-1.19],0.8961153777634466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP9,Caspase-9,20324,257,0.93 [0.76-1.14],0.4739645698293921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASQ2,Calsequestrin-2,20268,261,0.85 [0.64-1.12],0.2398252140525866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAT,Catalase,20630,264,1.41 [1.14-1.73],0.0013620435462957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,24077,295,1.30 [1.12-1.51],0.0007040431274065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,20261,268,1.00 [0.89-1.13],0.999285128615182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,24336,301,0.53 [0.38-0.73],0.0001027377285944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,20347,252,1.46 [1.19-1.79],0.0002517714826692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBX2,Chromobox protein homolog 2,20268,261,0.97 [0.70-1.35],0.8553027090160494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,23969,296,1.00 [0.87-1.16],0.95257542961751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,20872,268,1.07 [0.87-1.31],0.5320764202650572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,20831,269,1.02 [0.80-1.31],0.8477990311036976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,20341,262,0.87 [0.58-1.32],0.5186785738902409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,20901,269,1.06 [0.91-1.23],0.4654614622591663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,24107,295,2.17 [1.63-2.88],9.851545082919648e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20347,252,0.86 [0.70-1.04],0.1206580566212483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,24394,299,1.83 [1.40-2.38],7.5438443990353555e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL13,C-C motif chemokine 13,24349,299,0.99 [0.85-1.15],0.8800581523210889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,24017,294,0.96 [0.74-1.24],0.7417942885170767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,24403,298,1.48 [1.19-1.83],0.000453960414682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,24403,298,1.82 [1.49-2.21],2.9815389643710754e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,24034,296,1.15 [1.03-1.29],0.0120841201030383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,23755,294,0.99 [0.85-1.15],0.8862536640505814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,24351,299,1.06 [0.98-1.15],0.1399765624657486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,23926,296,1.25 [1.03-1.52],0.0235958404672666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,24394,299,1.38 [1.25-1.53],1.6344596967015206e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,24204,299,1.94 [1.62-2.33],9.752247678736961e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,23817,290,1.63 [1.35-1.97],3.748042625638425e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,24204,299,1.22 [0.96-1.55],0.1110739824654572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,24166,298,1.13 [1.00-1.28],0.0437941607950883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,24394,299,1.55 [1.26-1.90],2.472252170773873e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,24087,294,1.18 [1.06-1.30],0.0018186247763442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,24107,295,1.20 [1.01-1.42],0.0347457673854731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,24016,291,1.37 [1.17-1.61],0.0001038027731606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,24087,294,1.14 [1.01-1.30],0.0392957721118242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,24119,298,1.06 [0.91-1.23],0.4521187760434102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,24176,296,0.95 [0.85-1.05],0.290650536768679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,24087,294,1.32 [1.13-1.54],0.0004766940721242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,24307,299,0.99 [0.84-1.17],0.9228446327154852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,23981,291,1.11 [0.97-1.28],0.125366672591015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,24097,297,1.01 [0.85-1.21],0.9023451421433942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,24361,297,1.73 [1.30-2.29],0.0001380479095764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,24336,301,1.05 [0.81-1.36],0.712779775769441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,24103,297,1.10 [0.84-1.44],0.4839233636832183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCND2,G1/S-specific cyclin-D2,20535,263,1.09 [0.78-1.51],0.6172530187795687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCNE1,G1/S-specific cyclin-E1,20324,257,0.97 [0.83-1.13],0.6997400329173066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCS,Copper chaperone for superoxide dismutase,23969,296,1.16 [0.94-1.44],0.1740996168982905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,23512,290,0.88 [0.69-1.13],0.3146067014611835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,20845,268,1.49 [1.12-2.00],0.006847349594802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,24103,297,1.22 [0.89-1.67],0.2181181451698138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,23569,290,2.02 [1.59-2.57],7.133647744398345e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD160,CD160 antigen,24394,299,0.89 [0.71-1.11],0.2949032056436721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,24176,296,1.92 [1.53-2.40],1.3361634760197202e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164,Sialomucin core protein 24,24103,297,1.07 [0.72-1.59],0.7367377637914451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,20341,262,1.13 [0.82-1.56],0.4648995845952751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,24066,295,0.99 [0.91-1.08],0.8632663018361149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,24166,299,1.00 [0.65-1.54],0.9880048056050136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2,T-cell surface antigen CD2,20268,261,0.86 [0.61-1.21],0.3930961105519529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200,OX-2 membrane glycoprotein,24087,294,0.96 [0.64-1.43],0.8258272648866776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,23995,293,0.96 [0.70-1.31],0.7856190279948032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,23604,288,1.63 [1.24-2.13],0.0003811923128157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,24162,295,0.91 [0.69-1.19],0.4856134787704491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD22,B-cell receptor CD22,24394,299,0.73 [0.57-0.94],0.0144663788194932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,20324,257,0.64 [0.47-0.86],0.0029162697057989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD244,Natural killer cell receptor 2B4,24394,299,0.76 [0.52-1.12],0.1720841039994293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,20923,268,0.85 [0.64-1.14],0.2895124072059097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,24166,299,1.92 [1.51-2.44],9.482389011282865e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,23969,296,1.92 [1.46-2.52],3.0190450570298017e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,24075,295,1.82 [1.35-2.45],7.838986068173344e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,23512,290,1.35 [1.02-1.79],0.0381936850368422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,24107,295,1.07 [0.91-1.26],0.4302230750947521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,20437,253,2.10 [1.40-3.14],0.0003124024401565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,24351,299,2.07 [1.56-2.75],4.568588141193631e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,24264,301,1.65 [1.30-2.11],5.447939363237527e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,24336,301,1.50 [1.25-1.81],1.5135271244826376e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,24103,297,1.01 [0.77-1.33],0.9541941150754872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,24013,293,2.86 [2.11-3.88],1.1105746752272594e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,24166,299,1.12 [0.98-1.29],0.0911053571788674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,24260,299,0.61 [0.40-0.94],0.0260462227402993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,20324,257,0.97 [0.75-1.25],0.8027613977868081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24013,293,1.13 [0.85-1.50],0.4051657623056138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,20261,268,0.86 [0.59-1.25],0.4258776027671777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,20535,263,0.82 [0.55-1.22],0.3221514659682916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,20324,257,0.95 [0.82-1.09],0.4612762916074325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,24048,292,1.51 [1.14-2.00],0.0040264047356242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,24081,297,1.21 [0.99-1.47],0.0620809779638484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,24394,299,1.01 [0.88-1.15],0.9029074621664288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,23936,292,1.27 [0.88-1.83],0.199172417016135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,24166,298,2.13 [1.51-2.99],1.3560076174324788e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,24307,299,0.98 [0.72-1.32],0.8855090656979896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,23237,278,1.82 [1.27-2.61],0.0011321766045036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD58,Lymphocyte function-associated antigen 3,24028,294,2.87 [1.59-5.18],0.0004913784895712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,23199,286,2.39 [1.60-3.59],2.2480159636935888e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,20833,266,1.19 [0.92-1.53],0.1795580914184613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,24353,298,0.85 [0.70-1.03],0.0972668219536798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,23926,296,1.07 [0.87-1.32],0.5016661299974423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,23977,294,0.98 [0.87-1.11],0.7514482306969417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,20291,257,1.11 [0.83-1.48],0.4814893178494041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,24087,294,1.29 [1.02-1.64],0.0353206337728119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD72,B-cell differentiation antigen CD72,20437,253,0.96 [0.71-1.30],0.8044127123825796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,24351,299,1.94 [1.47-2.57],3.1075450336326325e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,24394,299,1.34 [1.06-1.70],0.015190764393977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,20929,268,2.44 [1.79-3.33],1.9007267982682536e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD82,CD82 antigen,20535,263,0.96 [0.69-1.33],0.7986474804302871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,24087,294,2.53 [1.93-3.31],1.5438348438844292e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD84,SLAM family member 5,24087,294,1.00 [0.72-1.40],0.9778351350176422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,20845,268,1.31 [0.88-1.95],0.1896128746167583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,24351,299,0.95 [0.77-1.17],0.6227591893286204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,23166,285,1.71 [1.23-2.40],0.0016484838975162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,24103,297,2.33 [1.47-3.70],0.0003479620035972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,24103,297,1.70 [1.11-2.59],0.0146336754678621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,20894,268,1.03 [0.82-1.31],0.7884059530064285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDAN1,Codanin-1,20872,268,0.70 [0.39-1.27],0.2391693803100336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC123,Cell division cycle protein 123 homolog,20195,258,0.87 [0.70-1.09],0.2190117571373625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC25A,M-phase inducer phosphatase 1,20195,258,0.88 [0.64-1.21],0.4278992594444231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,20808,267,0.92 [0.77-1.10],0.3495807849857805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,23512,290,0.93 [0.78-1.12],0.4430578272728456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,24166,299,1.01 [0.89-1.14],0.8928015533077494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,20845,268,0.95 [0.85-1.07],0.4318507919841134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,23969,296,2.04 [1.73-2.41],4.581020362271756e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,23273,283,1.26 [1.00-1.58],0.0495274292640166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,24306,299,1.10 [0.94-1.30],0.2401484952102723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH17,Cadherin-17,24107,295,1.15 [0.99-1.34],0.0687513404625505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,24107,295,2.54 [1.93-3.34],3.083985985375223e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH22,Cadherin-22,20535,263,1.01 [0.66-1.56],0.9564675936160636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,20872,268,0.87 [0.54-1.40],0.5621414988212687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,24351,299,0.88 [0.65-1.18],0.3995447068556906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH4,Cadherin-4,20261,268,1.02 [0.79-1.32],0.8599707093348085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,24403,298,1.00 [0.71-1.41],0.999956558870018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH6,Cadherin-6,24107,295,1.02 [0.78-1.34],0.8625271701646613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,23557,291,0.91 [0.69-1.20],0.497284781993379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,24013,293,1.63 [1.43-1.86],3.33522043810758e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,24107,295,0.63 [0.49-0.82],0.000505763044415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK1,Cyclin-dependent kinase 1,20195,258,0.95 [0.68-1.33],0.772985333112785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,20901,269,0.89 [0.71-1.10],0.2737824747363779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,20261,268,1.02 [0.82-1.27],0.8712611304811111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,24013,293,0.93 [0.85-1.03],0.1843957514338899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,24013,293,0.98 [0.87-1.10],0.696879178380188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,24013,293,0.97 [0.71-1.34],0.8586152929844121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,24119,297,2.50 [1.69-3.68],4.258393586232179e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,24316,297,1.19 [0.94-1.51],0.1555585567770536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,24131,298,7.20 [4.70-11.03],1.1465353325925662e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,20845,268,0.55 [0.48-0.63],3.452036481175257e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20535,263,0.97 [0.82-1.15],0.7410029307261347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,20845,268,1.73 [1.29-2.32],0.0002424834537707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20535,263,1.23 [0.98-1.55],0.0776430148015232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,24087,294,1.13 [1.00-1.27],0.0443119152448574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23512,290,1.08 [0.87-1.35],0.4824724089655857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23192,282,1.63 [1.41-1.88],1.543696014069602e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,20923,268,1.71 [1.38-2.12],8.793224808335657e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,23674,285,1.60 [1.33-1.93],7.639818178401827e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,20324,257,0.94 [0.65-1.34],0.7195380759642713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,23674,285,1.53 [1.20-1.95],0.0006863814960788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,20923,268,0.82 [0.68-0.99],0.0426344975839908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,24358,297,0.84 [0.70-1.01],0.0637568617523281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20437,253,1.42 [0.93-2.18],0.1048357024325306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,20324,257,1.34 [0.99-1.83],0.0607504123506243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,20261,268,1.03 [0.83-1.28],0.7956554578151541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPF,Centromere protein F,20535,263,1.20 [0.98-1.47],0.0823798611069877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPJ,Centromere protein J,20535,263,0.94 [0.78-1.13],0.5105388741110343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP112,Centrosomal protein of 112 kDa,20268,261,1.14 [0.88-1.47],0.3228368694373678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,20195,258,0.85 [0.63-1.15],0.2971942291540382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP164,Centrosomal protein of 164 kDa,23650,292,1.03 [0.88-1.21],0.7012079705404652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP170,Centrosomal protein of 170 kDa,20347,252,0.96 [0.82-1.13],0.6325165372098212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,23512,290,1.06 [0.92-1.23],0.4136626303763818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP290,Centrosomal protein of 290 kDa,20535,263,0.95 [0.75-1.21],0.6762158538012493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP350,Centrosome-associated protein 350,20195,258,0.86 [0.61-1.21],0.3990843944965863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,23485,280,1.05 [0.90-1.23],0.5238951849770715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,23512,290,0.97 [0.82-1.15],0.7111501525810788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CERT,Ceramide transfer protein,23557,291,1.02 [0.86-1.21],0.8164368381057597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,24142,295,1.23 [1.09-1.38],0.000742629328165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,24013,293,1.43 [1.20-1.69],4.20649402524051e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES3,Carboxylesterase 3,24013,293,0.95 [0.82-1.11],0.5116678613935606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,23557,291,0.87 [0.74-1.02],0.0823558718878584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN3,Centrin-3,20845,268,0.99 [0.85-1.16],0.9356853956920328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,20564,260,1.77 [1.23-2.54],0.0020291838371758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFC1,Cryptic protein,23512,290,0.99 [0.79-1.25],0.9482009034441508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,20947,267,1.68 [1.02-2.78],0.0419903815125918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,19747,252,3.28 [1.96-5.50],5.987599408192405e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR2,Complement factor H-related protein 2,20793,264,1.07 [0.86-1.32],0.566402661514528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR4,Complement factor H-related protein 4,20910,267,1.03 [0.87-1.22],0.7154611689513212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,20684,266,1.48 [1.10-1.98],0.0088241421113999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,20947,267,2.09 [1.15-3.78],0.0152847796136855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,20947,267,1.09 [0.66-1.81],0.7458989181620621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,24103,297,0.88 [0.79-0.97],0.0097715103218577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,20949,268,0.84 [0.62-1.14],0.2624012034894851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,20341,262,1.53 [1.19-1.97],0.0010241220472662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,24107,295,1.60 [1.26-2.03],0.0001263605978267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23512,290,1.13 [0.95-1.35],0.1564842187577802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,20437,253,0.83 [0.65-1.06],0.1385604558871441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",20872,268,2.37 [1.89-2.97],5.756419389707738e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,20831,269,2.13 [1.58-2.86],6.102626378557022e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,23674,285,0.98 [0.71-1.37],0.9229588488693308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,20923,268,1.59 [1.42-1.78],6.099543014977885e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGB,Secretogranin-1,24261,299,0.98 [0.75-1.27],0.8715371436554712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,23522,285,1.67 [1.49-1.86],4.062571510956138e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHIT1,Chitotriosidase-1,24201,297,1.06 [0.98-1.15],0.1312837898989311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,24142,294,1.51 [1.10-2.08],0.0117065140518543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,20341,262,0.95 [0.77-1.17],0.6478881705252553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,23969,296,0.93 [0.82-1.07],0.326683281266934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP6,Charged multivesicular body protein 6,20929,268,0.98 [0.79-1.21],0.85911359343551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHP1,Calcineurin B homologous protein 1,20261,268,0.88 [0.73-1.06],0.172299314748186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,24166,298,1.93 [1.39-2.67],7.393215924054738e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,24107,295,1.07 [0.89-1.28],0.4914236713991063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,20341,262,0.99 [0.70-1.39],0.9389772465443472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIAPIN1,Anamorsin,24166,299,1.04 [0.87-1.23],0.6864374009468546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,20923,268,1.83 [1.47-2.27],7.239119347805633e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,20535,263,0.93 [0.69-1.26],0.6508173199883791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,20845,268,0.99 [0.88-1.13],0.9180816997525604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,20341,262,1.50 [1.20-1.87],0.0003079672986159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,24268,297,2.35 [1.69-3.26],3.632886690070323e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,20923,268,1.72 [1.41-2.08],4.558807418744769e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",23990,294,1.24 [1.05-1.47],0.0102555818972193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLASP1,CLIP-associating protein 1,20195,258,0.89 [0.73-1.09],0.2569892570444071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,24078,294,1.21 [1.05-1.40],0.0098462630913451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,23969,296,1.38 [1.03-1.84],0.0304413288106482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,24058,297,1.21 [0.97-1.51],0.0885912141441007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,20324,257,0.97 [0.51-1.84],0.932655529485574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,24103,297,2.62 [1.91-3.60],2.523075587848658e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,23674,285,1.63 [1.19-2.24],0.0024476714568271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,24351,299,0.97 [0.87-1.08],0.5254841955931941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,20341,262,0.89 [0.67-1.17],0.3963821380129643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,20471,260,0.30 [0.17-0.53],4.188920840897446e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,24087,294,0.65 [0.49-0.86],0.0027342536928719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,24087,294,1.01 [0.81-1.26],0.9104123256282975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,24087,294,1.56 [1.34-1.82],1.2568652159023749e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,24087,294,0.95 [0.69-1.29],0.7278529671284555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,20887,268,0.93 [0.73-1.18],0.5629977530844513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,24021,294,1.98 [1.43-2.74],3.3994341200271934e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,23512,290,1.92 [1.56-2.36],5.639906990343361e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,24394,299,1.10 [0.91-1.33],0.3059394683649417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,20341,262,1.89 [1.50-2.38],9.45639420712714e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,20341,262,1.33 [0.98-1.81],0.0640915418035419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLINT1,Clathrin interactor 1,20195,258,0.94 [0.73-1.22],0.6591342170005303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,24087,294,0.94 [0.86-1.04],0.219731144231128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,24336,301,1.05 [0.65-1.68],0.8474972144910629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLNS1A,Methylosome subunit pICln,20341,262,0.98 [0.68-1.40],0.8925356436259367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",23924,296,1.11 [1.00-1.24],0.0588188950014366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,24070,296,0.75 [0.64-0.87],0.0001554252680375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSPN,Claspin,23512,291,1.05 [0.77-1.42],0.7699519401091878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN1,Calsyntenin-1,23557,291,0.96 [0.77-1.18],0.675477093077695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,24394,299,1.63 [1.30-2.05],2.844070280970264e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,20872,268,1.78 [1.24-2.56],0.0018930499189905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLTA,Clathrin light chain A,23674,285,1.06 [0.85-1.32],0.6091163956926291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,20947,267,1.06 [0.76-1.49],0.7239772219423772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,24064,295,0.73 [0.58-0.91],0.0059387216673338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,20929,268,1.01 [0.88-1.15],0.8876764564767102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMIP,C-Maf-inducing protein,20831,269,0.92 [0.79-1.06],0.2503081378820263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,24176,296,0.60 [0.49-0.73],4.556529243725005e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,20261,268,0.84 [0.64-1.10],0.2041006961218532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",20314,252,0.99 [0.85-1.16],0.913464243155306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY2,Protein canopy homolog 2,23674,285,1.10 [0.94-1.30],0.2364152757830633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY4,Protein canopy homolog 4,24013,293,0.98 [0.86-1.13],0.8238067261501186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNST,Consortin,24107,295,0.98 [0.88-1.08],0.6287860702738894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTF,Ciliary neurotrophic factor,20261,268,0.87 [0.60-1.25],0.4474151516161685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,24403,298,0.35 [0.24-0.51],3.2144969457521526e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN2,Contactin-2,24336,301,1.01 [0.80-1.28],0.928373302996651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,24103,297,1.64 [1.21-2.22],0.0013380612534325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,24103,297,1.17 [0.75-1.82],0.4989960459369839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,24185,299,0.38 [0.29-0.52],1.3675945823933348e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,24087,294,1.06 [0.83-1.34],0.6517562933205543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,20341,262,0.95 [0.83-1.09],0.4688191142250529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,20929,268,1.52 [1.20-1.93],0.0005230515396554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,20923,268,2.45 [1.62-3.70],2.1217464527657223e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,24182,297,4.01 [2.58-6.23],6.044305616913938e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,24403,298,1.14 [0.75-1.74],0.5403225661346633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,20845,268,1.03 [0.83-1.29],0.759881220479917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,20341,262,0.81 [0.69-0.95],0.0115339119153309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL2A1,Collagen alpha-1(II) chain,20347,252,0.93 [0.80-1.09],0.3854169193965506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,20923,268,1.93 [1.21-3.08],0.0058280945019266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,24107,295,1.90 [1.49-2.42],2.819265159527118e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,20501,263,1.21 [0.95-1.55],0.1262694983391653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,20437,253,1.75 [1.33-2.30],5.990971287942329e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,24403,298,2.63 [2.00-3.44],2.630481632704203e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,24087,294,2.16 [1.79-2.62],3.910251452119221e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,20535,263,0.99 [0.76-1.30],0.9584440358907718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,24075,295,2.46 [1.66-3.63],6.544333981022757e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,20347,252,0.87 [0.71-1.07],0.1833060974753181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,20831,269,0.67 [0.48-0.93],0.0165487796759307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMP,Cartilage oligomeric matrix protein,23831,293,1.30 [0.96-1.76],0.0948052855428672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,23405,279,1.13 [1.00-1.29],0.0588128225397911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPB2,Coatomer subunit beta',20268,261,0.75 [0.55-1.03],0.0731090490666557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPE,Coatomer subunit epsilon,23557,291,0.82 [0.63-1.05],0.1191518249504285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20347,252,1.31 [1.02-1.68],0.031856295323951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,23621,289,0.95 [0.84-1.07],0.3847455704555591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO6,Coronin-6,20261,268,1.08 [0.79-1.49],0.6150820441022411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",24013,293,1.24 [1.07-1.43],0.0045007853002967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,20929,268,0.97 [0.67-1.40],0.8696938533095815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,24403,298,1.14 [0.97-1.34],0.1151100815431719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,24267,298,0.87 [0.74-1.02],0.0906385676198814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,20033,250,1.24 [0.92-1.67],0.1493102445247611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,24403,298,1.07 [0.90-1.26],0.4451727195606543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,20902,267,1.15 [0.68-1.94],0.5940215016389709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPE,Carboxypeptidase E,24162,298,0.97 [0.75-1.26],0.8260646075303583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPLX2,Complexin-2,20195,258,0.85 [0.55-1.31],0.4653455026665009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,24241,298,2.30 [1.74-3.04],4.8915441156421975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20324,257,1.53 [1.01-2.33],0.0442523579047354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,24351,299,1.23 [1.05-1.43],0.0088796970117775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,20891,267,1.14 [0.83-1.57],0.4278114021401347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,20268,261,0.79 [0.56-1.09],0.1512349924572659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,24291,301,1.24 [0.95-1.62],0.1119238353818566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,24166,299,1.09 [0.94-1.27],0.2358769132496466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,20929,268,1.91 [1.25-2.92],0.0029597282757207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR1,Complement receptor type 1,20867,268,0.92 [0.65-1.29],0.6337436145301953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,24176,296,0.67 [0.53-0.84],0.0005728232686029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23512,290,0.89 [0.78-1.01],0.0792680478984986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRADD,Death domain-containing protein CRADD,23924,296,0.98 [0.86-1.13],0.8283392578789948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,20195,258,1.04 [0.84-1.30],0.697703891637619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,20195,258,0.64 [0.38-1.07],0.0855641014168063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,23771,292,2.20 [1.74-2.80],7.251701317984498e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,20437,253,2.20 [1.59-3.03],1.5734869175570763e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,24166,298,1.15 [0.94-1.41],0.1664141772777541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,23473,289,0.82 [0.72-0.93],0.0019231803126967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,24075,295,2.47 [1.72-3.55],1.064788772311421e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,23674,285,1.00 [0.83-1.20],0.9852178281215354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,24204,299,3.27 [2.07-5.15],3.324776259899847e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,23969,296,1.64 [1.28-2.10],0.0001124799409088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,24336,301,1.01 [0.87-1.19],0.8631205542895093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,20756,267,0.60 [0.39-0.93],0.022394395658575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRKL,Crk-like protein,24119,297,0.97 [0.88-1.07],0.5804704624725384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,24204,299,1.34 [0.90-1.98],0.1498454950800266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,23392,293,1.04 [0.89-1.22],0.6480945159879858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,24403,298,0.55 [0.39-0.76],0.0002858541780527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,23969,296,0.93 [0.75-1.14],0.4703857808049012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,20341,262,0.86 [0.64-1.15],0.3046539643880236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRX,Cone-rod homeobox protein,23674,285,0.96 [0.86-1.07],0.4632886653304807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB1,Beta-crystallin B1,20929,268,1.03 [0.86-1.22],0.7779839929040848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,20872,268,1.14 [0.95-1.36],0.1481149224889082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYGD,Gamma-crystallin D,20872,268,0.96 [0.85-1.09],0.5499165746462339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYM,Ketimine reductase mu-crystallin,20261,268,1.02 [0.87-1.19],0.8059761906304368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,20347,252,0.93 [0.81-1.07],0.3198627933075179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSDE1,Cold shock domain-containing protein E1,20268,261,0.98 [0.87-1.10],0.7222440346654815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,24204,299,2.64 [1.86-3.74],4.534702348484529e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,20949,268,1.44 [1.10-1.90],0.0090615770428407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,20268,261,1.02 [0.73-1.44],0.9042074678274674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,23969,296,1.36 [1.16-1.60],0.0001945859879804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,20324,257,1.19 [0.89-1.59],0.2380412081558054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,23650,292,0.89 [0.72-1.11],0.3028945314590369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,20324,257,1.11 [0.77-1.61],0.5786799922762074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,20949,268,1.05 [0.76-1.44],0.7840083381106342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK1D,Casein kinase I isoform delta,20324,257,0.97 [0.79-1.18],0.7645477645585074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,20901,269,0.98 [0.75-1.29],0.8998548847720644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,20923,268,0.96 [0.68-1.36],0.8300741701635628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,20261,268,0.71 [0.53-0.94],0.0176252137350497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,20268,261,1.11 [0.99-1.26],0.0765681412954567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,18117,221,0.93 [0.81-1.07],0.3301073745482366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,24137,295,2.53 [1.80-3.58],1.1944863252105948e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST5,Cystatin-D,23674,292,1.10 [0.90-1.34],0.3539930913522875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,23471,290,1.11 [0.89-1.38],0.3716270052338715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,24119,298,1.17 [1.06-1.28],0.0013645027477792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,23766,292,1.64 [1.30-2.06],2.9330652298678368e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,20492,262,0.86 [0.67-1.11],0.2557079333895022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,20659,264,1.87 [1.20-2.92],0.0056685194322724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTF1,Cardiotrophin-1,23674,285,0.94 [0.82-1.07],0.3215711592885979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,20923,268,3.42 [2.35-4.99],1.3963947957567346e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,20923,268,1.13 [0.76-1.67],0.5492622026605225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTNNA1,Catenin alpha-1,20261,268,0.69 [0.45-1.06],0.0876602398657604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,24103,297,0.76 [0.62-0.92],0.0059183425836679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,24074,296,0.73 [0.62-0.86],0.0001757412080502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,20872,268,0.72 [0.61-0.86],0.0002326317345915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,24102,295,1.27 [1.04-1.54],0.0172255694910398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,24034,297,1.75 [1.40-2.19],9.320727970527936e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,22455,274,2.23 [1.80-2.76],1.595580615029232e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSE,Cathepsin E,20437,253,1.46 [1.17-1.83],0.0009781313716604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,24166,299,1.15 [0.90-1.47],0.2593734932814849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,23599,285,1.11 [0.96-1.29],0.1586453661579245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,24107,295,4.03 [2.72-5.96],3.608076897174045e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,24394,299,2.18 [1.58-3.00],1.6742521700575984e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,19035,235,3.73 [2.23-6.22],4.7127504975984484e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,24257,300,0.91 [0.70-1.16],0.4369287422755179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,24086,296,2.24 [1.62-3.10],9.843129028651148e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,20341,262,1.20 [0.91-1.57],0.1957078380218703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,20741,267,1.16 [0.97-1.39],0.0942301026975308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CX3CL1,Fractalkine,23969,296,1.18 [0.86-1.60],0.3047368372361714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,24087,294,1.99 [1.68-2.36],9.346298006502772e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL1,Growth-regulated alpha protein,24038,298,0.85 [0.75-0.96],0.0075298317175441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,24204,299,1.20 [1.04-1.39],0.0118540930699466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,24351,299,1.13 [1.00-1.28],0.0429376147496316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,23650,292,1.35 [1.04-1.74],0.0230259928901843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,24351,299,1.22 [1.04-1.42],0.0125848513863895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,23650,292,1.12 [0.95-1.31],0.1850552165090042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,24356,297,2.65 [1.74-4.04],6.201443983986096e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,24394,299,1.99 [1.69-2.35],2.8710094082763273e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL3,C-X-C motif chemokine 3,24081,297,0.84 [0.75-0.94],0.0015862720429453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,24024,295,0.85 [0.77-0.93],0.0003579210248982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,24394,299,0.85 [0.74-0.98],0.0211244071046184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,23911,300,1.29 [1.13-1.47],0.0001235823319067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,24204,299,1.34 [1.17-1.55],4.418940119144413e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,20195,258,1.13 [0.96-1.33],0.143802240725499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,20597,263,1.50 [1.24-1.81],2.910365762382742e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",20268,261,0.97 [0.84-1.12],0.6775423010135585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTH3,Cytohesin-3,20195,258,1.03 [0.87-1.22],0.7446780346805175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,20923,268,2.43 [1.55-3.80],0.0001157544065112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,20437,253,0.94 [0.81-1.09],0.4006794882447742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAB2,Disabled homolog 2,24336,301,0.98 [0.89-1.07],0.6580355304369822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,24204,299,1.31 [1.06-1.62],0.0121326189463271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAND5,DAN domain family member 5,20324,257,0.87 [0.69-1.10],0.2408235432182256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,20324,257,1.13 [0.93-1.37],0.2306023921534331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,24087,294,0.97 [0.89-1.06],0.5681095928446023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",23924,296,0.90 [0.78-1.04],0.1546371133400506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBH,Dopamine beta-hydroxylase,20914,268,0.96 [0.86-1.06],0.3956085036366499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,23981,295,1.07 [0.94-1.22],0.3113559257854461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBN1,Drebrin,20324,257,0.87 [0.68-1.12],0.2778636628671368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBNL,Drebrin-like protein,24204,299,0.98 [0.87-1.09],0.6763909059409295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24166,299,1.86 [1.40-2.47],1.6497041006238005e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,20341,262,1.02 [0.62-1.68],0.9235887988624616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,20195,258,0.95 [0.77-1.17],0.6414817522769093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCLRE1C,Protein artemis,20195,258,0.77 [0.50-1.16],0.2121596317057749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCN,Decorin,23674,285,1.35 [0.83-2.20],0.2223645703350849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTD,Deoxycytidylate deaminase,20437,253,0.92 [0.81-1.05],0.2262232273121726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN1,Dynactin subunit 1,24336,301,0.92 [0.78-1.08],0.3167131553559249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,24013,293,0.87 [0.77-0.98],0.0178159421056164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN6,Dynactin subunit 6,23557,291,0.92 [0.79-1.08],0.3120516528709158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,24107,295,1.30 [0.95-1.79],0.1052786559497908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,20261,268,1.01 [0.85-1.19],0.9386584833402744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D2,DCN1-like protein 2,20195,258,1.16 [1.01-1.34],0.0327940759373274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,24166,299,1.43 [1.21-1.69],2.52199856105214e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,20268,261,1.02 [0.74-1.42],0.8849693684784579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24013,293,1.73 [1.41-2.11],1.06831431103206e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,24077,295,1.45 [1.20-1.76],0.0001442842882668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDHD2,Phospholipase DDHD2,20901,269,0.96 [0.80-1.15],0.6677255347424252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDI2,Protein DDI1 homolog 2,20437,253,1.20 [1.02-1.41],0.0247668860382324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,24351,299,2.65 [1.87-3.76],4.9524292698074303e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,20923,268,1.55 [1.19-2.01],0.0009669184359262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,20845,268,0.94 [0.73-1.20],0.6036181162751166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,20341,262,0.81 [0.56-1.17],0.2575994435349938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,20324,257,0.68 [0.38-1.22],0.1956015094589317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,20324,257,0.88 [0.68-1.15],0.3528083645119058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,20341,262,0.88 [0.62-1.25],0.4825264892197451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,23512,290,1.05 [0.88-1.24],0.6022103335172777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24087,294,1.12 [1.00-1.25],0.0471463240908356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,23587,288,1.07 [0.88-1.30],0.4790223730746201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,20183,256,1.07 [0.79-1.45],0.6581748406947328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,20261,268,1.18 [0.98-1.42],0.0883554187873709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB116,Beta-defensin 116,20261,268,1.01 [0.86-1.19],0.8911935331000552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB118,Beta-defensin 118,20261,268,0.94 [0.76-1.16],0.5646120428593076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,23755,289,1.15 [1.07-1.23],7.355023922562486e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENND2B,DENN domain-containing protein 2B,20268,261,0.96 [0.75-1.25],0.7825381695926366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENR,Density-regulated protein,20324,257,0.90 [0.72-1.12],0.3342581124820082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,24394,299,1.06 [0.91-1.23],0.4661786854187416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,20261,268,1.18 [0.93-1.50],0.1750989308735596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,20324,257,1.04 [0.83-1.31],0.7186461638802124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKZ,Diacylglycerol kinase zeta,23650,292,1.07 [0.80-1.43],0.6498644267012601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHODH,Dihydroorotate dehydrogenase,20268,261,0.81 [0.60-1.09],0.1697802034518258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHPS,Deoxyhypusine synthase,20831,269,0.92 [0.68-1.25],0.5913997196664855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,20872,268,1.26 [0.99-1.59],0.0572118000893162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",24021,294,0.97 [0.88-1.07],0.5015561340737402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,20341,262,1.02 [0.75-1.38],0.8935967273256268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,20437,253,0.88 [0.56-1.38],0.5827412730760706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,24351,299,0.95 [0.80-1.12],0.524685629491623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,24403,298,1.16 [0.82-1.64],0.3983857716235276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,23922,295,1.17 [0.95-1.45],0.1446061943494789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,24013,293,0.94 [0.83-1.06],0.3144693612416976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLG4,Disks large homolog 4,20872,268,0.89 [0.75-1.06],0.1910596166991094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLGAP5,Disks large-associated protein 5,20901,269,0.98 [0.76-1.26],0.8772417800330193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,24403,298,0.76 [0.63-0.91],0.0031483444681591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,24166,299,2.70 [1.95-3.75],2.913398791963754e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,20347,252,1.09 [0.97-1.22],0.1346422273338618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,20347,252,0.96 [0.75-1.23],0.7253933618404997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,20347,252,0.88 [0.73-1.07],0.2125029394426452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,20195,258,0.90 [0.68-1.20],0.4733324942363863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,24309,298,0.99 [0.87-1.13],0.916530353765538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,20872,268,1.21 [1.02-1.43],0.0247492018404797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,24013,293,1.09 [0.96-1.23],0.1697059262453046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,20845,268,0.98 [0.82-1.18],0.8516573375349763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,20437,253,1.13 [0.90-1.41],0.2981975220398494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,20254,253,0.95 [0.82-1.10],0.4961364238975522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,23674,285,0.87 [0.70-1.07],0.1805170896938353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,20872,268,0.89 [0.65-1.23],0.4887171159769822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,20347,252,1.01 [0.88-1.18],0.8458386438502903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,20845,268,1.19 [1.02-1.39],0.0264455798894894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,24039,296,1.00 [0.68-1.48],0.9881156180679108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,20261,268,0.99 [0.86-1.14],0.9205298051920624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM1,Dynamin-1,20845,268,0.92 [0.83-1.02],0.1051047312220097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,20901,269,1.10 [0.89-1.35],0.3896853062303756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,23969,296,1.00 [0.84-1.18],0.9766712409759593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPEP,Aspartyl aminopeptidase,20872,268,1.14 [0.93-1.39],0.2153761143367478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,24157,298,1.49 [1.22-1.82],0.0001113271791427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,20341,262,1.02 [0.74-1.42],0.8912875357197007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,20261,268,1.03 [0.93-1.14],0.5715272648519918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK1,Docking protein 1,20872,268,0.96 [0.88-1.04],0.3127617956049681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,24107,295,0.98 [0.90-1.07],0.7239629793091724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,23924,296,1.15 [0.92-1.43],0.2250667995639447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,24013,293,1.75 [1.23-2.48],0.0018594297671747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,24087,294,1.51 [1.18-1.92],0.0008733251294297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,23603,288,1.07 [0.74-1.53],0.7242411033069537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,24013,293,0.51 [0.37-0.69],1.5458294405715088e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,23901,293,1.58 [1.34-1.87],4.875952440598902e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPT,Dermatopontin,24403,298,0.80 [0.54-1.17],0.2482577410183376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,24270,301,1.32 [1.14-1.53],0.0002681309158892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRAXIN,Draxin,23969,296,0.98 [0.76-1.26],0.8630515976117511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,24013,293,0.95 [0.79-1.15],0.5947360013095847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,23798,297,1.47 [1.11-1.97],0.0081192842007369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,20901,269,0.79 [0.56-1.11],0.1684289562594041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,24103,297,0.82 [0.56-1.20],0.3085401973867107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,24261,300,1.38 [1.04-1.84],0.0266214390840006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG4,Desmoglein-4,23932,291,0.92 [0.74-1.14],0.4293181946544103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,20437,253,0.92 [0.80-1.06],0.2624304008841991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,20794,268,1.65 [1.32-2.07],1.2872319509226048e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,20341,262,0.83 [0.67-1.04],0.1064640592411042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24013,293,2.66 [1.83-3.85],2.6739919380322335e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTYMK,Thymidylate kinase,20929,268,1.16 [0.97-1.37],0.0977306099465917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUOX2,Dual oxidase 2,23674,285,0.91 [0.77-1.07],0.2447579606589185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,20831,269,1.06 [0.80-1.42],0.6786321113791536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP29,Dual specificity phosphatase 29,20341,262,0.87 [0.71-1.07],0.1854134652736898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,23557,291,1.00 [0.89-1.14],0.9516939882040352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",20845,268,1.07 [0.95-1.20],0.2602677656300675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DXO,Decapping and exoribonuclease protein,20872,268,1.16 [0.90-1.51],0.2495259359518479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,20831,269,0.85 [0.64-1.13],0.2709563789105178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,20341,262,1.02 [0.88-1.19],0.7600739732340538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,20831,269,0.88 [0.66-1.16],0.3522135705957262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,23969,296,1.00 [0.89-1.12],0.9627624519469676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,24307,301,1.19 [0.88-1.62],0.2635895380014931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,23557,291,1.38 [1.02-1.86],0.034509920210013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",20929,268,1.33 [1.16-1.52],3.740675595621009e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",20347,252,1.17 [1.04-1.32],0.0115013900916235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,20268,261,1.11 [0.92-1.33],0.2729345510361443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECM1,Extracellular matrix protein 1,20373,263,0.92 [0.66-1.28],0.6304155202069669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,20261,268,0.96 [0.74-1.25],0.7646616101892869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,24336,301,1.96 [1.51-2.54],4.343407369496939e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,24087,294,0.74 [0.66-0.83],3.557450873212482e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,20831,269,1.31 [1.15-1.50],7.980568997646507e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,20268,261,0.91 [0.63-1.31],0.6173196207962266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,20901,269,0.95 [0.80-1.14],0.5866824001402207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,23674,285,2.12 [1.67-2.71],1.0325602666372858e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,20347,252,2.24 [1.50-3.35],8.492905255085856e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDNRB,Endothelin receptor type B,20324,257,1.10 [0.84-1.44],0.502284841740998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,20929,268,1.02 [0.90-1.16],0.7329780037511483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,20845,268,1.44 [0.99-2.10],0.0533321323920795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,20535,263,1.06 [0.76-1.48],0.7136556960076277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24130,295,1.83 [1.33-2.52],0.0001812289782522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,20901,269,1.50 [1.12-2.00],0.006375807609514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,24060,297,1.83 [1.27-2.65],0.001236935696772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,23926,296,2.25 [1.63-3.10],8.298601271189516e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,20341,262,1.08 [0.90-1.30],0.4035712877871781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,24037,296,0.94 [0.85-1.04],0.2153568950875416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,23512,290,1.58 [1.24-2.03],0.000254117015404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,20845,268,1.05 [0.71-1.54],0.8186775236885996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,24403,298,0.22 [0.12-0.42],4.472131158929464e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,24087,294,1.36 [1.18-1.56],1.1944109604139762e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHBP1,EH domain-binding protein 1,20929,268,0.95 [0.80-1.11],0.5012355637346555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHD3,EH domain-containing protein 3,20347,252,0.95 [0.85-1.05],0.3108913994346246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",20872,268,1.00 [0.80-1.25],0.9944050652000712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",20784,268,1.02 [0.91-1.14],0.7268656993332278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,20268,261,0.91 [0.75-1.10],0.3154307367878414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20347,252,0.96 [0.70-1.30],0.7797991005483211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,23969,296,0.98 [0.81-1.18],0.8432797480891828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,20324,257,1.03 [0.90-1.18],0.658711131074572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24107,295,1.39 [1.20-1.62],1.7715201627180744e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24394,299,1.00 [0.90-1.11],0.9624743631491356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,20901,269,0.84 [0.69-1.01],0.0661030031592928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,20268,261,0.93 [0.70-1.24],0.6138549419327377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,23650,292,0.90 [0.63-1.28],0.5439188207182779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,20901,269,0.97 [0.85-1.12],0.7214555213399358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,20261,268,1.02 [0.88-1.18],0.8036877349941078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,20929,268,1.33 [0.96-1.84],0.0913367199534005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,24013,293,1.32 [1.13-1.53],0.0002931362390682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOB,Elongin-B,20268,261,0.99 [0.72-1.37],0.9541863933069544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,23650,292,1.29 [1.04-1.60],0.0197630598986641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,19340,247,1.35 [1.09-1.66],0.0058246555859354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,24403,298,2.75 [1.50-5.04],0.0010741011555219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,24096,297,1.03 [0.90-1.18],0.6933362987518672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO2,Gamma-enolase,24351,299,0.92 [0.79-1.08],0.3060153281630362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,20347,252,1.13 [0.93-1.36],0.2174519399516411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,20831,269,0.87 [0.67-1.12],0.2715432198500509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20268,261,1.09 [0.70-1.71],0.7092392098718259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,20268,261,1.06 [0.81-1.39],0.6787309761423548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24403,298,0.74 [0.53-1.03],0.077667301963721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24204,299,0.99 [0.78-1.24],0.9114384386444778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,20347,252,0.60 [0.43-0.85],0.0036307325103133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23407,288,1.36 [1.20-1.53],6.782887571923339e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENSA,Alpha-endosulfine,20831,269,0.95 [0.76-1.20],0.6916132577660093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23512,290,1.64 [1.32-2.04],6.366999285622918e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,23674,285,0.95 [0.57-1.56],0.8292963072177687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,23674,285,2.23 [1.43-3.48],0.0004116010219582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,20347,252,1.24 [1.04-1.49],0.019435995776062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EP300,Histone acetyltransferase p300,20324,257,0.81 [0.54-1.22],0.3138703276730059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPB41L5,Band 4.1-like protein 5,20341,262,0.98 [0.82-1.17],0.8228444008187674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,24086,295,1.00 [0.89-1.12],0.9804314061272588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPGN,Epigen,20831,269,1.16 [0.93-1.43],0.1903657735586111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,24157,298,1.65 [1.22-2.24],0.0010540048016806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,23557,291,1.16 [1.00-1.34],0.0493674237834638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,23267,288,2.43 [1.83-3.22],8.197320340254803e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,20437,253,1.05 [0.68-1.61],0.832288502309239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,24403,298,2.72 [1.85-3.98],3.136130557566859e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB6,Ephrin type-B receptor 6,23924,296,0.87 [0.61-1.22],0.4171894355451691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,23674,285,1.16 [0.99-1.36],0.064285966089531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPN1,Epsin-1,20535,263,0.89 [0.65-1.22],0.4705151737203988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,24087,294,1.11 [0.98-1.25],0.1051647931374449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,20347,252,1.26 [1.09-1.46],0.0016891524172997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24299,301,2.48 [1.85-3.31],9.005486431885943e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,24166,299,3.16 [2.18-4.57],1.0184430966491534e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,23987,295,1.26 [0.75-2.13],0.378271541880587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,24166,299,1.03 [0.67-1.56],0.9070539736979945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBIN,Erbin,24013,293,0.95 [0.86-1.06],0.343401155390756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERC2,ERC protein 2,20341,262,0.94 [0.79-1.12],0.4964106297698819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,20195,258,0.62 [0.41-0.95],0.0276407038934289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,23924,296,1.00 [0.88-1.14],0.9857884204959688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,20535,263,1.49 [1.09-2.05],0.0127721045038465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERMAP,Erythroid membrane-associated protein,20324,257,1.14 [0.87-1.49],0.3474947332215032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,20831,269,1.14 [0.84-1.55],0.385818309674948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,20437,253,0.96 [0.87-1.07],0.4904314157257835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,23981,291,1.29 [0.86-1.94],0.2183176934693641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,20268,261,0.85 [0.63-1.13],0.2547783503717412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,24403,298,1.35 [0.99-1.84],0.057820621227804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,24075,295,0.99 [0.74-1.34],0.9704389256173024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESPL1,Separin,20195,258,0.89 [0.68-1.15],0.3648601554534684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESR1,Estrogen receptor,20324,257,0.94 [0.74-1.19],0.5922148902478064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,20872,268,0.96 [0.83-1.11],0.5744552022643704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI2B,Protein EVI2B,20195,258,0.81 [0.56-1.18],0.2765234531637062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,20324,257,0.93 [0.81-1.07],0.3386769203314718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVPL,Envoplakin,20535,263,1.05 [0.72-1.52],0.8113893182343888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,20268,261,0.99 [0.81-1.22],0.9617894433152128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,20268,261,0.78 [0.58-1.03],0.083931723472369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,24351,299,2.00 [1.35-2.97],0.0005543963159927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,20949,268,1.55 [0.99-2.43],0.0561027913779422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,20645,265,0.88 [0.59-1.31],0.5172677805134982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,24103,297,1.05 [0.87-1.26],0.6144811257340583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,20947,267,1.13 [0.84-1.51],0.4183194425520861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,20833,266,1.47 [0.93-2.33],0.0994217875973741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2,Prothrombin,20947,267,1.15 [0.51-2.60],0.7336231671948559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,24166,298,1.01 [0.85-1.21],0.8776050713690606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,24183,299,1.02 [0.70-1.50],0.9103719813903652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,24137,296,1.10 [0.77-1.57],0.5972751757057377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,24145,296,3.21 [1.81-5.70],6.743225974466072e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",24075,295,1.44 [1.31-1.59],2.1614362971422802e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",24107,295,1.22 [1.07-1.38],0.0022135305652727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",20929,268,1.71 [1.41-2.07],6.68295025725443e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",24403,298,1.26 [1.04-1.53],0.0169199205316854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,24278,298,1.21 [1.04-1.41],0.0122175354616302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP6,Gastrotropin,23640,284,0.94 [0.77-1.14],0.5144926951095423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP9,Fatty acid-binding protein 9,24087,294,1.21 [1.00-1.45],0.0504676638649805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FADD,FAS-associated death domain protein,24107,295,0.94 [0.82-1.08],0.3635843523080893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM13A,Protein FAM13A,20845,268,1.00 [0.83-1.19],0.961956746586592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,20901,269,0.99 [0.92-1.07],0.8094959084832697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171B,Protein FAM171B,20831,269,1.10 [0.71-1.71],0.6598909229627707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,20347,252,0.78 [0.63-0.96],0.0168702529427046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,20929,268,2.90 [1.95-4.32],1.4051035858713418e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,24013,293,1.65 [1.22-2.23],0.00108829073666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,24077,295,1.61 [1.13-2.27],0.0075107634444379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,20845,268,1.22 [1.05-1.41],0.0072421699498202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,24403,298,1.02 [0.70-1.47],0.9308582411362042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,20341,262,0.99 [0.82-1.18],0.8819777877608072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,24317,297,1.42 [1.10-1.85],0.0075077569586814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,24394,299,0.61 [0.47-0.79],0.0002100007593837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,20923,268,2.37 [1.67-3.38],1.6480627299346203e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBN2,Fibrillin-2,20341,262,1.09 [0.89-1.35],0.4034258275061092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",24107,295,1.43 [1.26-1.63],3.1180676137869954e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,20929,268,0.86 [0.73-1.02],0.0826027721577248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,24087,294,1.79 [1.44-2.23],2.1258811987419357e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,20901,269,1.36 [0.82-2.27],0.2343420565510497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24103,297,0.85 [0.68-1.05],0.1338229261447739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,23980,293,1.09 [0.90-1.33],0.3559951583894033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23512,290,1.26 [1.07-1.49],0.0059995605005702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,24103,295,1.12 [0.91-1.38],0.290412539352979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,20914,268,1.80 [1.42-2.29],1.41520048990325e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,23976,295,0.82 [0.65-1.05],0.1170032985811642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,24107,295,0.73 [0.57-0.94],0.0127784062352751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL2,Fc receptor-like protein 2,24287,297,0.99 [0.79-1.23],0.9044399644045666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL3,Fc receptor-like protein 3,23650,292,0.97 [0.79-1.19],0.7552301841238379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,24103,297,1.37 [1.15-1.63],0.0005419003069645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,24087,294,0.98 [0.84-1.14],0.7571895159885997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,23512,290,1.54 [1.33-1.79],1.879430754429696e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",20268,261,1.19 [1.01-1.41],0.0351866403907538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",20268,261,1.24 [1.01-1.51],0.0377411699005753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FEN1,Flap endonuclease 1,23512,290,1.09 [0.95-1.26],0.2125133815571245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,23512,290,0.94 [0.75-1.19],0.6217228067399407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FETUB,Fetuin-B,24145,296,0.92 [0.68-1.25],0.5964964882581347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,20451,259,1.50 [1.03-2.20],0.0363014181596644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",20901,269,0.95 [0.82-1.11],0.536913266969171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,20324,257,1.06 [0.81-1.39],0.6726842066860017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF16,Fibroblast growth factor 16,20324,257,0.74 [0.55-0.99],0.0419855450171873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,24204,299,1.20 [1.05-1.37],0.0067715267658871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,24087,294,1.11 [0.96-1.30],0.1615700765471779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF20,Fibroblast growth factor 20,20324,257,1.04 [0.79-1.36],0.7874099697701566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,24307,301,1.39 [1.30-1.50],2.7982884726306384e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,24295,301,1.20 [1.04-1.39],0.0134515196261841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF3,Fibroblast growth factor 3,20324,257,0.74 [0.48-1.16],0.1962997717545216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,23650,292,1.21 [0.88-1.66],0.2412079181844987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,20324,257,1.21 [0.96-1.54],0.1110710738274964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,20195,258,1.01 [0.86-1.18],0.9177605720494306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF9,Fibroblast growth factor 9,20156,257,1.02 [0.75-1.39],0.8878709792966181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,24166,299,0.56 [0.41-0.77],0.0003402415626394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,20923,268,0.84 [0.66-1.06],0.1437453562868841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,20872,268,0.75 [0.54-1.03],0.0794733371992534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,24166,299,3.93 [2.66-5.81],6.075996280867491e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,20437,253,0.83 [0.65-1.04],0.1060297720822448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,20949,268,1.76 [1.48-2.09],1.6521576817554482e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,23557,291,1.21 [1.05-1.41],0.0096403995554498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FH,"Fumarate hydratase, mitochondrial",20261,268,1.01 [0.87-1.17],0.9428810809193744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,20268,261,0.87 [0.67-1.13],0.3025729704143366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,23557,291,1.04 [0.90-1.20],0.6270312522142654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,24072,297,1.13 [1.00-1.29],0.0577707966603141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,20901,269,1.03 [0.91-1.16],0.6834573734864399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,24202,296,0.92 [0.84-1.02],0.1049539105842977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,23969,296,1.66 [1.30-2.12],5.8407306614681634e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,23969,296,1.06 [0.95-1.19],0.28199314580312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23512,291,1.11 [0.90-1.37],0.3294849861189953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBPL,FK506-binding protein-like,20845,268,1.08 [0.89-1.32],0.4357417000994161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,23512,290,1.00 [0.90-1.10],0.9527060488742962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,23969,296,1.20 [0.83-1.72],0.33670383669701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,23970,293,2.22 [1.64-3.02],2.936200110368729e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,23512,290,0.68 [0.46-0.98],0.0406298375800599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,24394,299,1.54 [1.14-2.09],0.0049151803205082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,24166,299,1.03 [0.77-1.40],0.8267935806882379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,23557,291,1.17 [1.02-1.34],0.0240190457286009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMR1,Synaptic functional regulator FMR1,23512,290,1.14 [0.84-1.56],0.4023230421275204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,20947,267,2.07 [1.34-3.20],0.0010011283426134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,20872,268,1.16 [0.90-1.50],0.2559689960311981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,20831,269,1.28 [0.93-1.77],0.1243816580997868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,20324,257,1.01 [0.89-1.14],0.9092875141090196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,24055,298,1.21 [0.86-1.71],0.2746905353322482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,24351,299,1.27 [0.91-1.79],0.1625159546376586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR3,Folate receptor gamma,24088,297,1.05 [1.00-1.10],0.0614157631361839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,20156,257,1.35 [0.97-1.87],0.0725445899945481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOSB,Protein fosB,23557,291,1.16 [0.90-1.49],0.2553121329131859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,20324,257,0.85 [0.64-1.12],0.2514132040588761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,24087,294,1.00 [0.88-1.13],0.961900669752122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,23512,290,1.08 [0.97-1.20],0.1745203734165373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,20268,261,0.87 [0.72-1.05],0.1460326227355329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD7,FERM domain-containing protein 7,20341,262,0.98 [0.69-1.39],0.89440260763688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,23892,296,1.60 [1.07-2.40],0.0228899083934022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,20347,252,0.69 [0.59-0.82],1.8020937081034145e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,24166,298,1.19 [0.98-1.46],0.0841739696782665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,20347,252,3.62 [2.26-5.79],7.940184029415179e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,24051,297,2.93 [2.20-3.90],1.6099697392131156e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,20835,267,1.19 [1.04-1.35],0.0097431303003755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,24227,297,1.18 [1.03-1.36],0.0173429660898618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,20437,253,1.49 [1.25-1.77],8.083813436554924e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,24166,299,1.49 [1.10-2.01],0.0099269427736468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,23471,290,1.23 [0.96-1.59],0.1053342056795441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20497,263,1.09 [0.92-1.29],0.3205101758231529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24351,299,2.09 [1.69-2.60],1.376701369014774e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",23969,296,0.92 [0.77-1.11],0.3990850060682053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",24336,301,1.12 [0.97-1.29],0.1113343710942063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,23650,292,0.94 [0.79-1.11],0.4621023682786437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,24070,296,0.95 [0.85-1.07],0.3984477984371216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,20341,262,1.13 [0.93-1.37],0.2353072795170832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD8,Frizzled-8,20261,268,0.89 [0.65-1.22],0.4769569482868671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,20831,269,0.94 [0.73-1.22],0.645066198229586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20535,263,0.93 [0.75-1.14],0.4722168584327598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,20261,268,0.99 [0.82-1.20],0.9545094457730552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD1,Glutamate decarboxylase 1,20195,258,0.88 [0.55-1.42],0.6022477266570841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD2,Glutamate decarboxylase 2,20324,257,0.92 [0.68-1.23],0.5521578321181286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20535,263,1.02 [0.81-1.28],0.8728048996285683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,20347,252,1.02 [0.81-1.28],0.8733973510548221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,20195,258,0.95 [0.77-1.18],0.6408772790685425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,24204,299,1.00 [0.86-1.17],0.9986244552276858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24013,293,3.01 [2.15-4.22],1.482573998344143e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24336,301,0.98 [0.66-1.46],0.9132906859043898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,23650,292,1.19 [0.92-1.53],0.1853304998735346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,20929,268,3.25 [2.15-4.92],2.2682985101343562e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,24013,293,1.09 [0.65-1.84],0.7330587982977863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,20268,261,0.96 [0.67-1.37],0.8315708919247867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,20010,250,1.29 [0.83-2.01],0.2530544042398761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,20901,269,0.94 [0.60-1.49],0.8073023358627324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS2,Growth arrest-specific protein 2,20535,263,1.22 [1.00-1.50],0.0520357587809801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,24231,297,2.12 [1.44-3.12],0.0001269968011778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,20268,261,0.81 [0.61-1.09],0.1648418812871901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,20872,268,1.43 [1.32-1.55],2.226321870699784e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,20195,258,0.86 [0.54-1.38],0.5435513327211817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",20347,252,0.98 [0.83-1.15],0.7632966227887579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,20341,262,1.27 [1.03-1.57],0.0252470174576485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,20835,267,1.32 [1.10-1.57],0.0024824458946159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,23650,292,1.19 [1.00-1.41],0.0461712803001942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP4,Guanylate-binding protein 4,23557,291,1.05 [0.85-1.30],0.6581382221944644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP6,Guanylate-binding protein 6,20268,261,0.83 [0.60-1.15],0.25901741676418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GC,Vitamin D-binding protein,20947,267,1.24 [0.78-1.98],0.36423464009788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,20872,268,1.00 [0.89-1.12],0.9956166254685268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,23512,290,1.02 [0.94-1.11],0.5865189012561367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,19944,246,1.90 [1.59-2.28],2.505048132152275e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,20268,261,1.16 [0.92-1.47],0.2119303307193581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24013,293,1.37 [1.01-1.85],0.0415839364856144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,24403,298,2.20 [1.92-2.52],3.193419739894544e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,24107,295,0.81 [0.61-1.07],0.1446574694042062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,23557,291,1.62 [1.26-2.08],0.0001860443387699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,20929,268,1.08 [0.89-1.31],0.4286016861409932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFAP,Glial fibrillary acidic protein,23478,290,0.84 [0.65-1.09],0.1867249798416596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,23512,290,1.33 [1.14-1.56],0.0002954509269968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23512,290,0.95 [0.86-1.03],0.2212038081474978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,24307,301,2.46 [1.73-3.49],5.162118915303198e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,24013,293,1.28 [0.78-2.11],0.3268845193998805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,23892,295,0.74 [0.51-1.09],0.1332649046966052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,20261,254,0.84 [0.69-1.03],0.0981964340770138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,23557,291,1.03 [0.89-1.20],0.6717725997186558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,20929,268,0.96 [0.81-1.14],0.6596733209263911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,20896,267,1.07 [0.84-1.37],0.5872749514989485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,23651,289,1.43 [1.06-1.93],0.0180939280409342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,24060,297,2.19 [1.88-2.55],3.9186843774155596e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,23969,296,4.15 [2.82-6.11],5.997077066681296e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,24077,295,1.01 [0.96-1.07],0.649957736814353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,23512,290,0.97 [0.91-1.04],0.4647841102753183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,20437,253,0.54 [0.35-0.82],0.0041367610893562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,23557,291,0.93 [0.75-1.14],0.4774565444536038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,24107,295,0.99 [0.87-1.12],0.8410193537648101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,20901,269,1.09 [0.79-1.51],0.6104795019665311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,20901,269,0.98 [0.84-1.15],0.7986537055844148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP7,GTPase IMAP family member 7,20437,253,0.91 [0.62-1.32],0.6108422847125294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,20195,258,1.13 [0.90-1.43],0.2932821759584129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,20347,252,1.38 [1.06-1.80],0.0174424554372938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,20872,268,3.13 [2.24-4.38],2.8726133172098543e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,20845,268,0.97 [0.85-1.09],0.5703403717580384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,20324,257,0.99 [0.76-1.29],0.9342371825133464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,20324,257,0.95 [0.83-1.08],0.4228616710614891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GJA8,Gap junction alpha-8 protein,20195,258,0.89 [0.71-1.12],0.3242484012322323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,23102,287,2.15 [1.47-3.13],7.262404137731339e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,20397,253,2.03 [1.50-2.74],4.3269506091111546e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,23969,296,1.67 [1.33-2.10],1.1698193286516569e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLI2,Zinc finger protein GLI2,20324,257,0.97 [0.65-1.45],0.8897986830361442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,23674,285,1.66 [1.39-1.99],3.9583327099056804e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,24034,296,1.36 [1.01-1.82],0.0415975238521937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,20261,268,0.95 [0.68-1.32],0.766386899390089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,23965,293,1.23 [1.03-1.47],0.0211583291620598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20437,253,1.08 [0.94-1.23],0.2907332234866565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23557,291,0.91 [0.71-1.16],0.4492975028642187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,20831,269,1.10 [0.91-1.32],0.3420455956579892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,20435,261,1.69 [1.35-2.13],6.132626591708105e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMFG,Glia maturation factor gamma,20929,268,0.97 [0.82-1.14],0.7044403976852192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,24394,299,1.17 [0.94-1.45],0.1519766724191203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR2,GMP reductase 2,20437,253,1.03 [0.86-1.24],0.7488543273642079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNAS,Neuroendocrine secretory protein 55,20901,269,1.01 [0.89-1.15],0.8599315857713661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23512,290,1.05 [0.89-1.24],0.5523172823201394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,20341,262,0.89 [0.68-1.17],0.4199211986066326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,24103,297,1.00 [0.82-1.22],0.9968865653905788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,20347,252,0.85 [0.58-1.25],0.4015922854137457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,20437,253,0.86 [0.62-1.19],0.3672666073406134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLGA3,Golgin subfamily A member 3,20901,269,0.97 [0.83-1.14],0.7314461214479941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,24351,299,2.37 [1.53-3.68],0.0001144434338773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,24087,294,0.98 [0.88-1.08],0.64553840713847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,20845,268,0.97 [0.74-1.25],0.7878299852259868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",20923,268,1.75 [1.40-2.18],6.763841866088415e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,23984,294,0.95 [0.68-1.31],0.741514855770047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,20268,261,0.94 [0.78-1.12],0.4740242673720253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23362,281,1.15 [1.02-1.30],0.0267706352281053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP5,Platelet glycoprotein V,20437,253,0.77 [0.55-1.07],0.1139741541091021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP6,Platelet glycoprotein VI,24070,296,0.97 [0.86-1.09],0.5820422669665388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPA33,Cell surface A33 antigen,24013,293,0.96 [0.88-1.04],0.3040695847237774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,24336,301,0.93 [0.66-1.31],0.670085175827545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,23969,296,0.62 [0.52-0.75],6.758843879239591e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,20831,269,1.51 [1.23-1.85],6.674530401989026e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,20845,268,0.92 [0.69-1.21],0.541073997959438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,20949,268,1.14 [0.90-1.45],0.278726839587718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,20845,268,0.98 [0.83-1.15],0.7984476513619188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,23557,291,1.60 [1.22-2.11],0.0007100472998942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,23454,287,1.35 [0.93-1.97],0.1162550398027784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR101,Probable G-protein coupled receptor 101,20261,268,1.06 [0.89-1.28],0.515369010327748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR158,Probable G-protein coupled receptor 158,20901,269,1.00 [0.72-1.41],0.9839820907146692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,20845,268,1.55 [1.29-1.85],1.693278571824421e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,23674,285,1.45 [1.24-1.71],5.880825918152827e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,20831,269,1.53 [1.31-1.79],1.382579172603266e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRAP2,GRB2-related adapter protein 2,24107,295,0.97 [0.89-1.05],0.4170047298749344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,20929,268,1.23 [1.02-1.48],0.0283820926280947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",20901,269,0.83 [0.60-1.15],0.2671352405327226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",20261,268,0.89 [0.70-1.14],0.3471379504057885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,23674,285,0.96 [0.77-1.20],0.7272198813390682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,23983,295,2.77 [1.89-4.07],1.854447084094e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,20347,252,1.10 [0.87-1.38],0.4286069078626749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",24013,293,1.69 [1.48-1.94],5.928775797587618e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRSF1,G-rich sequence factor 1,20079,256,0.99 [0.84-1.16],0.8790181612899495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSAP,Gamma-secretase-activating protein,23512,290,0.92 [0.81-1.06],0.2389034437920614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,20873,268,0.44 [0.24-0.79],0.0060111973759152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",20831,268,1.59 [0.95-2.65],0.0757337470732287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,24078,294,1.19 [1.06-1.34],0.002839495789756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,23512,290,1.15 [1.01-1.31],0.0408357923622211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,20268,261,0.97 [0.81-1.15],0.7106290210217989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTP1,Glutathione S-transferase P,23407,287,0.94 [0.79-1.11],0.4419657872402303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,20872,268,0.94 [0.90-0.99],0.0256310845323316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20535,263,0.97 [0.81-1.17],0.7785077839392698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTPBP2,GTP-binding protein 2,20341,262,0.93 [0.80-1.08],0.3420396319557345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,23988,296,1.29 [0.94-1.76],0.1098585155778645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,20535,263,1.03 [0.89-1.19],0.6848183094585861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUK1,Guanylate kinase,20268,261,1.00 [0.74-1.33],0.973808505467978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,24187,297,1.84 [1.57-2.16],3.102321649549284e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",23674,285,1.01 [0.90-1.14],0.8104155403699544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMA,Granzyme A,24394,299,0.96 [0.71-1.30],0.7925509435611339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMB,Granzyme B,24087,294,1.07 [0.92-1.24],0.376035144111007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,23674,285,1.15 [1.01-1.30],0.0349558405631216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",H2AP,Huntingtin-interacting protein M,20195,258,0.96 [0.72-1.28],0.7734388576624891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",20268,261,1.01 [0.83-1.22],0.9512797169876362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",24278,299,1.22 [1.06-1.41],0.0046369025658701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,24336,301,1.22 [1.13-1.31],1.732300406064114e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",24103,297,0.99 [0.86-1.14],0.8977093095649252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,24307,299,1.71 [1.48-1.97],1.358511898220507e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,24103,297,2.34 [1.78-3.09],1.6682837055615421e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,24278,299,0.86 [0.74-0.99],0.0355642404636041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,24336,301,1.06 [0.89-1.26],0.5269089639524929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBZ,Hemoglobin subunit zeta,20929,268,1.04 [0.93-1.17],0.4409819604181312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCG22,Protein PBMUCL2,20268,261,0.95 [0.75-1.20],0.6746774001024365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,24394,299,1.07 [0.88-1.29],0.4905694715839673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC8,Histone deacetylase 8,20324,257,0.99 [0.80-1.23],0.9510859157948618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC9,Histone deacetylase 9,20261,268,0.93 [0.75-1.14],0.48237383326299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,20845,268,1.03 [0.79-1.35],0.8187028513755567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGF,Hepatoma-derived growth factor,24309,300,1.13 [1.01-1.27],0.0277494324671886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,20872,268,1.13 [0.94-1.36],0.1936936872886414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,23674,285,0.95 [0.77-1.18],0.6411779870462202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,20437,253,3.78 [2.54-5.64],6.227053511061389e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPACAM2,HEPACAM family member 2,20872,268,0.76 [0.57-1.00],0.0542050560004826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,20929,268,2.11 [1.32-3.37],0.0018638659525778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,24087,294,1.03 [0.91-1.18],0.636540264208743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,24394,299,2.89 [2.25-3.71],1.0671076259168611e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,20758,268,0.92 [0.61-1.40],0.7086898578446996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23512,290,1.06 [0.93-1.22],0.3935814778920731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,20872,268,1.10 [0.95-1.29],0.2100277500141347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,20324,257,0.95 [0.79-1.15],0.6265906169481208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,20268,261,0.74 [0.50-1.10],0.1390342634496979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,20839,267,1.58 [1.32-1.90],1.0025763418457683e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,20901,269,1.39 [1.10-1.78],0.0069283325575861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HK2,Hexokinase-2,23674,285,1.07 [0.72-1.59],0.7399367566598583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",20901,269,1.49 [1.02-2.17],0.0397750598746045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24013,291,1.35 [1.01-1.81],0.0431991213934395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24087,294,2.13 [1.50-3.03],2.6451487002932967e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMBS,Porphobilinogen deaminase,24336,301,1.67 [1.30-2.14],5.461415548476015e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMCN2,Hemicentin-2,20399,253,1.13 [0.91-1.40],0.2695474744497063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20347,252,1.11 [0.87-1.42],0.3971757217201076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20268,261,0.97 [0.72-1.31],0.8604883449595271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMMR,Hyaluronan mediated motility receptor,20158,257,1.21 [0.95-1.55],0.1209749903720839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,23830,293,1.45 [1.19-1.76],0.0001971503256815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,23557,291,1.43 [1.18-1.72],0.000180701747435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,20341,262,1.05 [0.91-1.22],0.5098175524707058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,23852,296,1.72 [1.40-2.11],2.289975467111641e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,23587,284,1.05 [0.91-1.20],0.4997853918079966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,20901,269,1.35 [1.09-1.68],0.0062338229657692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPCAL1,Hippocalcin-like protein 1,24394,299,0.96 [0.83-1.10],0.5545984191864266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,23512,290,0.45 [0.34-0.60],8.131914709086967e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,20662,265,1.07 [0.94-1.22],0.2739374549412927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRAS,GTPase Hras,20505,263,0.98 [0.85-1.12],0.74035385006112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20347,252,0.79 [0.54-1.17],0.2436453334628363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,20833,266,1.09 [0.75-1.58],0.6573387296711717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,20347,252,0.97 [0.84-1.11],0.6395798674609253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24013,293,1.22 [0.93-1.61],0.1563181790000277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24336,301,0.69 [0.51-0.94],0.0196806153728207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,20324,257,1.08 [0.76-1.53],0.6640306446781905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSBP1,Heat shock factor-binding protein 1,20347,252,0.84 [0.73-0.96],0.0101442818869836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,24087,294,2.04 [1.57-2.64],6.144643419566713e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,20872,268,1.17 [0.97-1.42],0.0987620743047403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,20268,261,0.80 [0.61-1.06],0.1213455345985741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20347,252,1.19 [0.93-1.53],0.1668219401976326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSP90B1,Endoplasmin,23448,287,0.91 [0.75-1.09],0.3043757801679555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,24157,298,1.09 [0.94-1.25],0.2465608750430925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,20831,269,1.34 [0.97-1.85],0.073516007119515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB1,Heat shock protein beta-1,23717,290,1.00 [0.86-1.17],0.9963353287870552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,24336,301,1.56 [1.23-1.98],0.0002904038579468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23898,292,2.63 [1.84-3.75],9.516337830206889e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,20261,268,1.13 [0.99-1.30],0.0701473839283483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,20261,268,0.93 [0.68-1.27],0.6461116858731765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",24166,299,1.27 [1.08-1.49],0.0046908801861148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,23944,293,2.52 [1.67-3.80],1.114120408837137e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,24403,298,1.16 [0.72-1.86],0.5347576521281959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,23650,292,0.96 [0.84-1.10],0.5375072338238045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,23988,294,3.43 [2.53-4.66],2.1967438395166448e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,24403,298,1.16 [0.83-1.62],0.3748357916745879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,24403,298,1.69 [1.15-2.49],0.0078470745939407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM4,Intercellular adhesion molecule 4,24087,294,1.05 [0.86-1.28],0.6549706204175683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,24107,295,2.06 [1.63-2.59],9.316740544426934e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,24013,293,0.64 [0.37-1.10],0.1046638621800448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,20535,263,0.95 [0.71-1.26],0.7133730910546114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,23557,291,1.29 [1.04-1.59],0.0220855615774527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",20347,252,1.09 [0.91-1.32],0.3513110948899439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,24394,299,0.47 [0.16-1.40],0.1755543097313933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,24336,301,1.39 [1.10-1.74],0.0048595302973947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20349,263,2.84 [2.23-3.63],5.642989887786493e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20535,263,0.96 [0.75-1.23],0.740771748440369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20535,263,1.14 [0.85-1.53],0.3855497574681465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,20845,268,1.24 [0.80-1.93],0.328666987976619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,23650,292,1.05 [0.95-1.15],0.3403547437779241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,24204,299,1.64 [1.04-2.60],0.0346352138860553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,23969,296,1.35 [1.12-1.64],0.0018401771591236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,23557,291,1.30 [1.04-1.61],0.0200164421135935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL2,Interferon lambda-2,20261,268,1.05 [0.88-1.25],0.6032423004132383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,24087,294,1.35 [1.04-1.75],0.0265084702118616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNW1,Interferon omega-1,20268,261,0.85 [0.58-1.26],0.421954291741586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,20341,262,0.93 [0.69-1.25],0.6422802741599333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,20901,269,1.16 [0.95-1.41],0.1384528668743577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,20261,268,1.03 [0.83-1.28],0.7944130779963116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,20923,268,1.06 [0.68-1.65],0.8116235155863459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,24013,293,1.42 [0.96-2.09],0.0775355501284829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,20268,261,0.82 [0.60-1.12],0.2158957440378041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,24103,297,2.56 [1.68-3.90],1.315715087660594e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,24361,298,1.18 [1.08-1.28],0.0001384188560985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,24353,298,1.47 [1.25-1.74],4.459069887654201e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,24176,296,0.36 [0.27-0.49],2.1336742181425725e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,23794,293,2.28 [1.85-2.82],2.9226382013983626e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,23991,294,1.32 [0.96-1.81],0.0841424172319819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,24403,298,2.80 [2.17-3.62],1.961782137756522e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24107,295,2.85 [2.18-3.72],1.559838584644159e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFL4,Insulin growth factor-like family member 4,20324,257,1.05 [0.91-1.22],0.4977208215405279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,20268,261,0.93 [0.74-1.16],0.5070069269394172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,20919,267,2.14 [1.63-2.79],3.225890371802101e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,20195,258,0.91 [0.77-1.07],0.2435954413057508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,20347,252,1.02 [0.75-1.37],0.9054020107582516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,24013,293,1.80 [1.46-2.21],2.7746795815078336e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,24107,295,1.45 [1.04-2.03],0.028919422189657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,20929,268,1.37 [1.20-1.56],1.8693708142715417e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,24087,294,0.93 [0.83-1.05],0.2584993905009713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKZF2,Zinc finger protein Helios,23512,290,1.00 [0.88-1.14],0.96144862095759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,23650,292,1.15 [1.02-1.30],0.0226370014801979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,23650,292,1.11 [0.94-1.31],0.2154771075361667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,24204,299,2.96 [2.23-3.93],7.689222237300488e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,23650,292,1.14 [0.98-1.32],0.0952041438538701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,24013,293,1.00 [0.87-1.15],0.9641051154889844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,24394,299,0.91 [0.76-1.10],0.3200690197474803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,23650,292,1.22 [0.91-1.63],0.1852227404906082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,20324,257,1.11 [0.83-1.49],0.4966381082168005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,23650,292,0.89 [0.69-1.14],0.364354223300664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,23787,292,1.13 [0.70-1.81],0.6193084174606835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,20261,268,0.93 [0.61-1.43],0.7479726925184518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,24087,294,2.61 [1.97-3.47],3.224072969943414e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,23650,292,1.65 [1.21-2.23],0.0013550574613696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,24394,299,1.22 [0.98-1.53],0.0749101937175509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,23609,291,1.32 [1.08-1.61],0.0065470398957468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,23650,292,1.52 [1.33-1.72],3.274488751305377e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17D,Interleukin-17D,23650,292,1.02 [0.74-1.39],0.9141165602941432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,23650,292,1.07 [0.94-1.22],0.3287458245645854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RA,Interleukin-17 receptor A,24103,297,1.22 [0.96-1.55],0.1024065312755266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,23782,291,1.06 [0.88-1.28],0.5506929395957773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,23989,294,2.02 [1.66-2.46],2.749740871454097e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,24176,296,3.10 [2.30-4.18],1.4212913671030588e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,24394,299,2.10 [1.58-2.79],2.891720375485216e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,23810,296,0.99 [0.93-1.06],0.8288926520647186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,23511,290,1.57 [1.38-1.78],3.341190958285784e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1A,Interleukin-1 alpha,23650,292,1.02 [0.85-1.24],0.8008588377891376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,23531,290,1.24 [1.06-1.46],0.0082893842007793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,24060,297,2.75 [1.82-4.15],1.7046810557081087e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,24036,295,3.56 [2.08-6.07],3.3410034554314534e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,24103,297,0.51 [0.39-0.67],7.2046906897072e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,24317,297,2.75 [2.25-3.36],8.209002000238813e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,23650,292,0.43 [0.33-0.55],1.2067969023870716e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,24037,297,1.58 [1.35-1.84],8.987888318053698e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,23650,292,1.47 [1.03-2.10],0.032452560376574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,23650,292,1.00 [0.81-1.25],0.9745205290277636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,23650,292,0.89 [0.68-1.15],0.3700494735813352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,20324,257,1.00 [0.75-1.33],0.983163238381906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,20324,257,1.01 [0.80-1.28],0.9245369023484928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,20831,269,1.84 [1.61-2.10],1.6158932932191168e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,23650,292,1.12 [0.88-1.43],0.3499383744026846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL24,Interleukin-24,23650,292,1.00 [0.79-1.28],0.968419140006393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,20125,257,1.20 [0.84-1.72],0.3119394542273332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,23951,292,2.59 [2.05-3.26],1.2383318044351545e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,23650,292,0.87 [0.64-1.18],0.3585088120113785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,20831,269,1.27 [0.93-1.72],0.1314614523132321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,20195,258,1.07 [0.86-1.33],0.5516223440140768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31,Interleukin-31,20324,257,1.06 [0.86-1.30],0.6142987425073574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,20251,256,1.17 [0.87-1.59],0.3023775787175095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,24087,294,1.50 [1.22-1.84],0.0001116467802352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL33,Interleukin-33,23650,292,1.05 [0.79-1.39],0.7322199880256515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,23515,288,1.26 [0.92-1.72],0.1454202816109634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,20324,257,1.20 [0.99-1.44],0.0589499756658134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,20256,257,1.31 [1.13-1.53],0.0004785555569558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,23650,292,1.66 [1.21-2.28],0.0018033143375136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4,Interleukin-4,23650,292,1.13 [0.99-1.29],0.0777678856808687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,24087,294,2.54 [2.01-3.22],1.2542943936355806e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5,Interleukin-5,23650,292,0.96 [0.89-1.04],0.338540608831498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,24087,294,1.19 [0.99-1.44],0.066188745441067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,24013,293,1.44 [1.30-1.60],4.355952341870192e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,23942,294,1.11 [0.81-1.50],0.517662991840649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,24107,295,3.83 [2.20-6.66],2.06235935172707e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7,Interleukin-7,24087,294,0.97 [0.82-1.14],0.6793752673631578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,24103,297,0.71 [0.59-0.86],0.000312651835135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL9,Interleukin-9,20535,263,1.08 [0.88-1.32],0.4460491435309112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23525,290,0.99 [0.82-1.20],0.9454504873182386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,20831,269,1.73 [1.42-2.12],9.203823173816565e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPA1,Inositol monophosphatase 1,23969,296,0.89 [0.74-1.06],0.1792015500691681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPACT,Protein IMPACT,20872,268,1.17 [0.94-1.46],0.1579928174842564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,20261,268,0.93 [0.62-1.39],0.7074846662880842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,23512,291,0.98 [0.78-1.25],0.8856576270072032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,20437,253,2.00 [1.61-2.49],4.4946587834499854e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,24103,297,1.35 [1.04-1.76],0.0245846761551051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,24013,293,0.99 [0.82-1.20],0.951561441634106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20347,252,1.20 [0.98-1.48],0.0737798874326483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",20901,269,1.13 [0.85-1.52],0.3990310572335276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24013,293,0.96 [0.86-1.07],0.4845315997285564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,20872,268,1.16 [1.07-1.26],0.0003857623382678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,20831,269,0.99 [0.79-1.23],0.9123627370144556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,20845,268,1.31 [1.17-1.47],2.327517371647617e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,20324,257,3.22 [1.66-6.23],0.0005200839037354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,23926,296,1.12 [1.00-1.26],0.0597114016922469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,24013,293,1.20 [1.00-1.44],0.0538983088839897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",23674,285,0.92 [0.81-1.04],0.1733319183554414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,23650,292,0.98 [0.84-1.14],0.7730145708917746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,24087,294,0.99 [0.89-1.10],0.828116757001016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,23200,288,1.13 [0.86-1.49],0.3872764838968365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,24087,294,1.42 [1.09-1.84],0.0087896673417436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM2,Isthmin-2,20923,268,0.97 [0.74-1.27],0.8022708773413496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IST1,IST1 homolog,20692,266,1.00 [0.89-1.13],0.9742533836136849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,24087,294,0.54 [0.40-0.73],7.84502904493175e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,20437,253,0.42 [0.29-0.61],3.62976066476199e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,24103,297,3.12 [2.11-4.60],1.1497886301998533e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA6,Integrin alpha-6,24087,294,0.84 [0.68-1.03],0.0905661405642862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,20324,257,1.19 [0.89-1.60],0.2397021577964351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,24103,297,0.55 [0.39-0.77],0.0004523294990788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,24336,301,0.27 [0.15-0.49],1.5278491361392484e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,20535,263,1.13 [0.90-1.42],0.2889523549756529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,24060,295,0.98 [0.60-1.61],0.9496498251120696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,23512,290,1.12 [0.87-1.45],0.3824798717640795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,23674,285,0.99 [0.90-1.09],0.7782338144429007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,23951,294,0.57 [0.39-0.83],0.0031788572689831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB5,Integrin beta-5,24166,299,0.94 [0.72-1.23],0.6623241348330926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB6,Integrin beta-6,23650,292,1.35 [0.96-1.89],0.0853436772937515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,24336,301,1.32 [1.07-1.63],0.0102966131520148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,20923,268,1.93 [1.46-2.54],3.165664295105578e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,20947,267,0.74 [0.38-1.43],0.3668728810459902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24176,296,1.57 [1.21-2.05],0.0008137539756387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,20947,267,1.09 [0.72-1.65],0.6883743993837868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,20831,269,1.02 [0.78-1.33],0.8901766556210928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITM2A,Integral membrane protein 2A,24087,294,1.12 [0.94-1.34],0.2176129083258677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,20268,261,1.19 [0.99-1.42],0.0619884740391836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20347,252,0.94 [0.78-1.13],0.4924524325371133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",20261,268,0.85 [0.64-1.14],0.2712599669751872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23557,291,1.11 [0.90-1.36],0.3462601174836559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,20195,258,1.01 [0.79-1.29],0.9413035395681804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,24351,299,1.03 [0.68-1.55],0.8929500519756486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,20437,253,1.03 [0.81-1.30],0.8135789934880172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,23650,292,1.15 [0.97-1.37],0.110043501645078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,20195,258,0.79 [0.62-1.02],0.0690490890208806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,20845,268,0.98 [0.85-1.13],0.7972860586717023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,23650,292,1.08 [0.88-1.32],0.475184293377322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24013,293,0.86 [0.69-1.08],0.1921042042434952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,20845,268,0.96 [0.85-1.07],0.4450311486939318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,20261,268,0.92 [0.72-1.17],0.5029781439782524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,20341,262,0.91 [0.75-1.09],0.3038222873860046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNIP4,Kv channel-interacting protein 4,23557,291,0.87 [0.68-1.10],0.2486031275806642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,20470,265,1.36 [1.07-1.73],0.0115933937909808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDM3A,Lysine-specific demethylase 3A,20324,257,1.01 [0.88-1.17],0.8597616696733711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,24166,299,1.15 [0.77-1.73],0.496174493098128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KEL,Kell blood group glycoprotein,23557,291,1.38 [1.04-1.84],0.0245882377802594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHDC3L,KH domain-containing protein 3,20195,258,0.89 [0.73-1.09],0.2526004627990718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,20347,252,1.17 [0.97-1.41],0.1109300843950514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,20872,268,0.78 [0.53-1.17],0.2303978091484082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,20535,263,1.15 [0.97-1.37],0.1019883972422699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,20535,263,0.98 [0.62-1.53],0.9142674115244264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,20831,269,1.07 [0.88-1.31],0.4713891753406348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,20268,261,1.29 [0.99-1.68],0.0611419091723399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF20B,Kinesin-like protein KIF20B,20261,268,1.11 [0.95-1.29],0.1910347627888136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF22,Kinesin-like protein KIF22,20268,261,1.05 [0.95-1.16],0.3762997276758406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIFBP,KIF-binding protein,24013,293,0.96 [0.84-1.09],0.5255121826360376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,20831,269,1.12 [0.97-1.28],0.1259169455630581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23512,290,1.08 [0.94-1.25],0.2669556798904526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,20845,268,1.03 [0.96-1.10],0.4555534234636639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23512,290,1.03 [0.94-1.12],0.4964150876814018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,20195,258,1.01 [0.87-1.17],0.8877810784413736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,20261,268,0.97 [0.78-1.20],0.7573503935834021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,23557,291,0.84 [0.64-1.11],0.2236625577772518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,24145,296,0.47 [0.33-0.67],2.847581332933608e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,24107,295,0.44 [0.34-0.56],8.898720439539689e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLB,Beta-klotho,23557,291,0.91 [0.79-1.05],0.2128690861910032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,20261,268,1.55 [1.20-2.00],0.0007797139993784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,20901,269,1.17 [0.94-1.45],0.161625153091437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,23858,294,1.03 [0.95-1.12],0.4616621023399169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,24090,298,1.59 [1.23-2.04],0.0003180159783581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,23936,297,1.83 [1.35-2.48],9.353335659553812e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK12,Kallikrein-12,23512,290,1.00 [0.93-1.08],0.9860922601685308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,23575,283,1.54 [1.22-1.95],0.0002662077632579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,24336,301,1.07 [0.86-1.33],0.5420302622036963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK15,Kallikrein-15,20798,268,1.17 [0.92-1.48],0.1938418371107002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,20923,268,1.23 [1.13-1.33],1.5108880063524298e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,24336,301,1.10 [0.94-1.28],0.2577681119390871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,24133,299,0.99 [0.70-1.38],0.9302249844984224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK7,Kallikrein-7,19908,250,1.24 [0.91-1.69],0.1706645165766074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,23281,286,1.96 [1.48-2.61],3.1025859506401445e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,20550,264,0.64 [0.40-1.03],0.0652753373405115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,24394,299,0.84 [0.63-1.11],0.21817839529396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,20261,268,0.97 [0.79-1.19],0.7569193871329003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,24394,299,0.98 [0.79-1.23],0.8877024611207334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,20324,257,1.28 [1.00-1.63],0.0477234023336301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,20872,268,1.19 [0.90-1.56],0.2190376455951617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",22808,277,0.89 [0.60-1.32],0.5761387938326648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",20268,261,1.07 [0.77-1.50],0.6706667303270786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",24013,293,1.40 [1.26-1.56],5.921745380831833e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",24055,293,1.46 [1.27-1.68],1.1109252570414279e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",23557,291,1.21 [1.00-1.47],0.0530612516959661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",20268,261,0.88 [0.63-1.24],0.4719074951479389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",20261,268,1.23 [1.06-1.41],0.0048752680811382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,24060,294,1.14 [0.95-1.37],0.1471227212728916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,24394,299,1.76 [1.44-2.16],5.2666322855195784e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,24166,299,1.43 [1.00-2.04],0.0499407108227309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,20929,268,1.09 [0.96-1.25],0.1859870074133098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACRT,Extracellular glycoprotein lacritin,20794,268,0.95 [0.73-1.23],0.6925633265812274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACTB2,Endoribonuclease LACTB2,24107,295,1.02 [0.87-1.20],0.810859772918022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,24013,293,0.79 [0.60-1.02],0.0719944214128557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24075,295,1.56 [1.25-1.94],8.48833476234561e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,23969,296,0.98 [0.88-1.09],0.7096650123858608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA1,Laminin subunit alpha-1,20268,261,1.10 [0.91-1.35],0.3263650401526885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,24204,299,1.15 [0.85-1.55],0.3613694933072253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,20347,252,0.67 [0.45-1.00],0.0472361552806821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,20344,260,1.60 [1.19-2.15],0.001695480525962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,23381,287,1.17 [0.67-2.04],0.5790143520399018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,24353,298,1.93 [1.63-2.29],2.2900285608027292e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,20831,269,0.94 [0.70-1.25],0.6669423920038835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,23650,292,1.24 [1.00-1.53],0.0487164455873646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,20831,269,1.01 [0.84-1.22],0.927447257988751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT,Linker for activation of T-cells family member 1,24394,299,0.97 [0.85-1.12],0.6960624505472122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,24013,293,1.02 [0.94-1.11],0.656244956574349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,20324,257,1.01 [0.87-1.16],0.9457069030256628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,23924,296,1.91 [1.42-2.57],1.6120971760617448e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,24176,296,1.25 [1.05-1.49],0.0103374304517964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,24351,299,1.17 [1.02-1.34],0.0241111281430205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,20949,268,0.70 [0.41-1.18],0.181544282188949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,20901,269,1.22 [1.04-1.44],0.0153423256119598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,23341,287,1.53 [1.19-1.96],0.0008229261622657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,20923,268,1.10 [0.86-1.40],0.4566937415914531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,24175,295,0.89 [0.73-1.09],0.2558363568991868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,20901,269,0.97 [0.86-1.10],0.657635496381184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,20929,268,1.02 [0.85-1.23],0.8037798863221186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEFTY2,Left-right determination factor 2,24307,301,0.71 [0.59-0.86],0.0003683155111749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,19714,243,1.28 [1.08-1.52],0.0040943224732411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,20261,268,1.11 [0.95-1.30],0.1852744240594686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,20901,269,1.51 [1.11-2.05],0.0087016428039103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEP,Leptin,24107,295,0.76 [0.68-0.85],1.205502303661798e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,24107,295,1.63 [1.24-2.15],0.0005638910768738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,20901,269,1.24 [1.00-1.54],0.0483514591088334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,24107,295,1.15 [0.85-1.56],0.3649047032495417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,24171,296,1.78 [1.28-2.47],0.0005961552329121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,20947,267,1.60 [1.13-2.27],0.008519675770932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,24075,295,1.96 [1.65-2.33],2.244196206509185e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,24067,299,1.39 [1.10-1.75],0.005219530693743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,24351,299,0.97 [0.82-1.15],0.7254918338456695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,24081,297,2.53 [1.88-3.41],1.0226053038782907e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,24204,299,2.39 [1.83-3.13],1.4247419554730578e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,23512,290,0.94 [0.83-1.08],0.3849270440060938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,24122,298,1.40 [1.19-1.65],4.256957414975913e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,23557,291,1.26 [1.05-1.51],0.014936251828696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,24087,294,1.97 [1.37-2.84],0.0002576702511499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24103,297,1.38 [1.02-1.86],0.0341552232944401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,20923,268,0.98 [0.90-1.06],0.6227181360073251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,20268,261,1.01 [0.79-1.28],0.9543832263327392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24077,295,2.22 [1.61-3.06],1.1447042418909343e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,20929,268,1.14 [0.96-1.34],0.1250746762466214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24403,298,1.51 [1.03-2.20],0.0339871595041296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24267,297,1.59 [1.16-2.17],0.0036944604689055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,23650,292,1.54 [1.21-1.96],0.0005173499616066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24403,298,1.12 [0.96-1.31],0.1591559318288569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,20347,252,1.24 [1.02-1.51],0.0339601806697588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB1,Lamin-B1,20803,267,1.12 [0.94-1.34],0.2103629015543511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,20872,268,2.09 [1.40-3.11],0.0003055143881148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,20901,269,1.80 [1.39-2.34],8.54939622996913e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,20261,268,0.97 [0.79-1.19],0.7967501068636746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",20347,252,1.07 [0.93-1.22],0.372740007518592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPA,Apolipoprotein(a),20435,262,1.03 [0.96-1.11],0.3754607585773756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,24013,293,1.18 [0.97-1.43],0.0977082317715149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,24107,295,0.80 [0.66-0.97],0.0244305664008971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,23354,291,1.21 [1.02-1.44],0.0314587133851354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPP,Lipoma-preferred partner,20268,261,0.91 [0.76-1.09],0.3093451523974966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20268,261,1.19 [1.01-1.40],0.0330949176066393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,20341,262,0.84 [0.63-1.11],0.224570469667043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,20947,267,2.38 [1.56-3.63],6.119420037966329e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24278,299,1.06 [0.79-1.41],0.7104183229114303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,20252,257,1.02 [0.65-1.58],0.9464755404029592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,24013,293,1.22 [0.84-1.78],0.2997048382386708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,24107,295,1.42 [1.06-1.90],0.0177793091586523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,20341,262,1.09 [0.77-1.54],0.6152647327823166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2BP,LRP2-binding protein,20341,262,1.00 [0.86-1.16],0.9495127799005106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24351,299,1.15 [0.97-1.36],0.0977070514898986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,24013,293,1.81 [1.43-2.28],5.845130482280455e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,20845,268,1.13 [0.86-1.50],0.3844131698798979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,20341,262,1.21 [0.95-1.54],0.1232082812982886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,20929,268,1.01 [0.79-1.29],0.9217817097559492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,20831,269,1.06 [0.84-1.35],0.6239950532476182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,23650,292,0.51 [0.39-0.67],6.467816653296204e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,20341,262,0.98 [0.72-1.34],0.8911613321494852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,20901,269,0.31 [0.19-0.51],3.709665916943514e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,23512,290,1.04 [0.87-1.25],0.645787096952869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,20535,263,0.82 [0.68-0.99],0.0410311413304657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,24087,294,1.50 [1.18-1.91],0.0010925698695653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA,Lymphotoxin-alpha,24087,294,0.84 [0.64-1.10],0.1983952597212765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,24336,301,1.28 [1.10-1.49],0.0012682353826766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,20831,269,0.67 [0.44-1.01],0.0544599753873766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,24403,298,2.43 [1.82-3.24],1.946235931437646e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,23512,290,1.55 [1.33-1.80],1.6038318227981436e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,23943,293,2.67 [1.90-3.75],1.6268975671742e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTO1,Protein LTO1 homolog,23650,292,0.82 [0.62-1.10],0.1853793697999509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,20831,269,1.00 [0.75-1.32],0.974654764198962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,23844,294,1.00 [0.86-1.17],0.9816561246811188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,23952,296,1.37 [1.05-1.80],0.0218302799079995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY75,Lymphocyte antigen 75,24087,294,1.18 [0.90-1.56],0.2329683250254706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,23862,287,1.46 [1.02-2.08],0.0382277265970135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,23969,296,2.30 [1.81-2.93],1.5781366511672895e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,23512,290,1.00 [0.81-1.22],0.962425046706786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYN,Tyrosine-protein kinase Lyn,24013,293,1.01 [0.89-1.15],0.8713437690541594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,23557,291,1.14 [0.99-1.32],0.069653753625518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,23987,296,1.41 [1.04-1.90],0.0253171047053798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,23512,290,1.14 [0.93-1.39],0.207103126144169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,20261,268,1.00 [0.89-1.13],0.992723781430786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,20341,262,1.04 [0.92-1.17],0.5283675623787469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,20947,267,1.56 [0.84-2.87],0.1582162368978905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,20195,258,0.90 [0.65-1.25],0.5349573328722061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,20437,253,0.91 [0.76-1.08],0.2758063084117278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,20347,252,1.10 [0.81-1.48],0.5468477711606209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,23890,296,1.33 [1.13-1.57],0.0007307324299199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,23512,290,1.02 [0.77-1.34],0.9062952532142204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAG,Myelin-associated glycoprotein,20341,262,0.83 [0.64-1.07],0.1556565258979161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGEA3,Melanoma-associated antigen 3,20535,263,0.97 [0.84-1.13],0.7389834946776075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGED1,Melanoma-associated antigen D1,23512,290,1.13 [0.90-1.41],0.285102492507242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,20929,268,1.51 [1.07-2.12],0.018483099447173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,20831,269,1.23 [1.01-1.49],0.0398667582143171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20347,252,1.22 [0.76-1.94],0.4115398691155438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,20929,268,1.36 [1.11-1.67],0.0028460201340543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",20195,258,1.20 [0.95-1.52],0.1340984571536024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,24204,299,0.99 [0.91-1.08],0.8128524048508327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,24166,299,1.75 [1.22-2.50],0.0022143429820343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,20268,261,1.21 [1.01-1.45],0.038358612438919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,20261,268,0.71 [0.48-1.05],0.0863323765729279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,20268,261,0.98 [0.80-1.20],0.8748839749546892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,20872,268,1.14 [0.89-1.46],0.2976103266868328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,20845,268,0.97 [0.80-1.17],0.7283401922041648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,24087,294,0.93 [0.84-1.03],0.1703943134960722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23512,290,0.88 [0.79-0.99],0.032394305890648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,23924,296,0.97 [0.88-1.07],0.5547070245717298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,20195,258,1.14 [0.88-1.46],0.3217060530588699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,24087,294,0.96 [0.76-1.23],0.7588222473246865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,20535,263,0.83 [0.70-0.98],0.0311698290583585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,20195,258,0.97 [0.87-1.07],0.5320960190742026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPT,Microtubule-associated protein tau,23557,291,1.04 [0.84-1.29],0.6906751085824472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,24107,295,1.72 [1.15-2.58],0.008103917314624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",20397,253,0.96 [0.83-1.11],0.5691794049049855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,23924,296,0.88 [0.56-1.39],0.5936612950732654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,24119,297,1.96 [1.40-2.75],9.326672759675772e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,23926,296,1.39 [1.00-1.93],0.0475854329364484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,23512,290,0.97 [0.86-1.10],0.6552345177577636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAX,Protein max,23557,291,1.01 [0.91-1.12],0.8602249533397727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MB,Myoglobin,24403,298,1.25 [1.06-1.48],0.0079176580876273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,20648,264,1.14 [1.02-1.28],0.0204391628093521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,24176,296,1.12 [0.82-1.53],0.4615278136916267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",20901,269,0.85 [0.63-1.14],0.2844131030876127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,20324,257,1.12 [0.98-1.28],0.0883619558188354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,24006,294,1.13 [0.89-1.43],0.3162094845797836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,20845,268,1.01 [0.63-1.61],0.980496068677436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,23969,296,0.91 [0.78-1.05],0.2099469982639764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",20832,268,1.21 [0.91-1.61],0.1854572140272151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,24085,297,1.49 [1.25-1.78],7.549912376448114e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDM1,Nuclear protein MDM1,20341,262,0.85 [0.57-1.27],0.4380998269994171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",20347,252,1.08 [0.94-1.23],0.2616073620389207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,23512,290,0.93 [0.81-1.07],0.3349636703223247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,20268,261,0.79 [0.59-1.07],0.1284495893225868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,24075,295,1.23 [0.95-1.60],0.1207247239948162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,20268,261,0.64 [0.41-1.00],0.0477592071639984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,24317,297,1.96 [1.21-3.17],0.0059798986827868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MELTF,Melanotransferrin,20929,268,1.11 [0.74-1.66],0.6013806066623334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,20437,253,0.50 [0.30-0.83],0.0078372833337779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,20845,268,1.16 [0.99-1.36],0.0589175801363542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,24107,295,0.80 [0.74-0.88],9.98994187335978e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,24075,295,0.81 [0.55-1.20],0.2985620693657539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,24394,299,2.41 [1.65-3.51],4.819037619244177e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MESD,LRP chaperone MESD,24103,297,0.99 [0.91-1.08],0.8435686363380029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,24175,294,0.55 [0.32-0.94],0.0277128097603813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1,Methionine aminopeptidase 1,23557,291,1.04 [0.73-1.50],0.8139638752355159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",24087,294,1.11 [0.98-1.26],0.0949592000853169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,24307,301,1.11 [0.93-1.34],0.2489651933195883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,23674,285,0.88 [0.69-1.12],0.3042741504968679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,20341,262,0.96 [0.79-1.17],0.6696221014791326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,20437,253,1.22 [0.84-1.77],0.3062218784117153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP5,Microfibrillar-associated protein 5,24403,298,1.04 [0.80-1.34],0.7702064402127439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,24103,297,1.79 [1.45-2.21],7.269800188090603e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGLL,Monoglyceride lipase,24166,298,0.94 [0.84-1.06],0.3356905352004148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,24087,294,0.95 [0.87-1.04],0.2714103637690803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,24166,299,0.82 [0.62-1.10],0.189098369176312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,20341,262,0.87 [0.72-1.06],0.1733196908150407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24087,294,1.21 [1.10-1.33],7.474161712845836e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIF,Macrophage migration inhibitory factor,24061,297,1.04 [0.89-1.22],0.6099832351224883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,23650,292,1.28 [1.05-1.56],0.015274793168175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,20831,269,0.93 [0.84-1.04],0.2346646671292787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINK1,Misshapen-like kinase 1,20872,268,0.98 [0.86-1.11],0.7305292153599086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MITD1,MIT domain-containing protein 1,23969,296,0.96 [0.86-1.07],0.4243593228935777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MKI67,Proliferation marker protein Ki-67,20324,257,1.04 [0.78-1.39],0.7973007672672539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLLT1,Protein ENL,20195,258,1.03 [0.86-1.23],0.7355009650339938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,24087,294,1.14 [1.01-1.28],0.0294127974084093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,24013,293,1.47 [1.31-1.66],2.338876674223279e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,23246,281,1.22 [1.08-1.38],0.001955857801268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,24050,296,1.35 [1.15-1.59],0.0003106234119792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,24161,298,2.21 [1.85-2.64],1.6530522948239401e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,23557,291,1.28 [0.91-1.80],0.1566280097058744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,20929,268,0.91 [0.70-1.18],0.4641944427567194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,24103,297,1.61 [1.36-1.90],2.770165889441218e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,23639,284,2.05 [1.62-2.59],2.553752635765224e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,24313,299,1.52 [1.34-1.73],9.950516634975974e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,24069,297,1.77 [1.49-2.09],4.022269890603532e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",20268,261,0.92 [0.71-1.20],0.5422879218229116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MN1,Transcriptional activator MN1,20341,262,0.84 [0.66-1.06],0.1466206598517327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,20535,263,0.86 [0.64-1.15],0.3100658754261446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,24078,294,1.17 [1.07-1.28],0.0005705629305284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,20437,253,1.07 [0.89-1.28],0.4875754352546163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,24336,301,0.63 [0.46-0.86],0.0039126215029206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,20872,268,0.94 [0.61-1.46],0.7890954691670848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,20535,263,1.00 [0.74-1.35],0.991479055001842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,20195,258,1.06 [0.75-1.50],0.7420066743448313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORN4,MORN repeat-containing protein 4,20195,258,0.86 [0.72-1.03],0.0971902624429289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,23674,285,0.97 [0.84-1.12],0.6792367425296205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,24013,293,0.99 [0.87-1.12],0.8318529342726821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,24166,298,0.97 [0.85-1.11],0.6768742896387904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,24103,297,1.39 [1.14-1.69],0.0011033400295192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,20793,269,1.03 [0.79-1.36],0.8091428028596037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,20949,268,4.42 [3.01-6.49],3.528645668833124e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,20341,262,1.18 [0.98-1.42],0.0869769980911798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",20268,261,0.99 [0.71-1.38],0.9590299652681108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",20901,269,0.89 [0.61-1.30],0.554611657038052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",23557,291,1.26 [0.86-1.84],0.2404208110988509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",20158,257,1.39 [0.87-2.22],0.1732878641228221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",20901,269,1.08 [0.92-1.26],0.351939073356147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",20324,257,1.08 [0.72-1.64],0.6993607870129681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,23977,293,1.64 [1.41-1.89],3.7428073927558217e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,20341,262,0.89 [0.63-1.25],0.4928696189741529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,24034,294,1.47 [1.26-1.71],6.435040358935043e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,24351,299,2.36 [1.91-2.91],1.5377715157231897e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,24166,299,0.99 [0.85-1.14],0.8611672025996429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,20654,267,1.28 [1.01-1.62],0.0394971029193498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,23674,285,0.82 [0.68-0.99],0.0345938338776864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,20324,257,1.06 [0.93-1.21],0.38728381283906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",20872,268,1.45 [0.96-2.19],0.0807661846607641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20535,263,1.04 [0.93-1.16],0.4905742131370291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",20845,268,1.07 [0.94-1.23],0.2987869804008414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTPN,Myotrophin,23674,285,0.80 [0.56-1.15],0.2328852702656991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTR,Methionine synthase,20268,261,0.82 [0.66-1.01],0.0661037122998281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS1,Protein MTSS 1,20845,268,0.95 [0.86-1.07],0.4075707181420837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,20831,269,1.08 [0.95-1.21],0.229012678697521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,20535,263,1.50 [1.28-1.77],1.018840732646702e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,23557,291,1.30 [1.07-1.57],0.0084383549932483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC16,Mucin-16,24013,293,0.98 [0.93-1.04],0.5920625713125879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC2,Mucin-2,20923,268,0.97 [0.85-1.11],0.6587750461721458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUCL3,Mucin-like protein 3,20195,258,0.85 [0.62-1.16],0.3150137182349455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,23650,292,1.46 [1.30-1.63],1.7290964780066106e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,20437,253,0.59 [0.40-0.88],0.0091488330204804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",20929,268,1.18 [1.01-1.37],0.0374767695186156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",20347,252,1.06 [0.93-1.22],0.3740252202629647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,20901,269,1.06 [0.89-1.26],0.5170012068450873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,20929,268,1.03 [0.92-1.16],0.6158721613601363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,20268,261,0.85 [0.62-1.15],0.2845539947990425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,20195,258,1.14 [0.87-1.49],0.3357275871707175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH9,Myosin-9,20923,268,1.01 [0.91-1.13],0.8110629187096938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",20268,261,1.12 [0.85-1.49],0.4259608800977063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,20347,252,1.04 [0.89-1.22],0.5983721274701691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL4,Myosin light chain 4,20347,252,1.23 [0.99-1.53],0.057141423428465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,20341,262,1.11 [0.98-1.26],0.1124922569133369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",20341,262,1.33 [1.10-1.60],0.0033013507374145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO6,Unconventional myosin-VI,20901,269,0.87 [0.61-1.23],0.4253862437246685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,23650,292,0.94 [0.80-1.11],0.480868555695079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOC,Myocilin,24103,297,1.29 [1.03-1.62],0.0261756200048422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM1,Myomesin-1,20261,268,1.10 [0.86-1.39],0.4562885422143926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM2,Myomesin-2,20268,261,1.11 [0.89-1.40],0.351801419032411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,20437,253,1.09 [0.96-1.23],0.1673434948584821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,24157,298,1.79 [1.48-2.16],1.651591187950879e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,23512,290,0.81 [0.65-1.01],0.0646720892419023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA10,N-alpha-acetyltransferase 10,20268,261,1.11 [0.87-1.42],0.3993509307696629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA80,N-alpha-acetyltransferase 80,20341,262,0.96 [0.87-1.07],0.4884700803505829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,23848,295,1.01 [0.85-1.20],0.9220901207719888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,20831,269,1.04 [0.84-1.30],0.6889337424791907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NADK,NAD kinase,24107,295,1.29 [1.10-1.51],0.0015280749157684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,20291,257,0.99 [0.79-1.24],0.926698013178164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,20314,252,0.98 [0.79-1.21],0.8221041192460623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20437,253,2.77 [1.59-4.84],0.0003181138196145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,23512,290,1.26 [1.07-1.47],0.005036687824778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,20808,267,1.15 [0.85-1.57],0.3626481427533001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,20872,268,1.02 [0.71-1.47],0.9110780147190476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",20901,269,0.91 [0.70-1.17],0.4528097120413205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24166,299,2.09 [1.43-3.07],0.0001641675341943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,23650,292,1.19 [1.01-1.40],0.0346427732288765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,24176,296,1.10 [0.80-1.52],0.5582441928529489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,24103,297,1.16 [0.78-1.72],0.4560540081357018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,24351,299,0.44 [0.34-0.57],7.679049178195191e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,24040,293,1.28 [1.15-1.42],3.702958541520834e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCK2,Cytoplasmic protein NCK2,24204,299,0.97 [0.88-1.07],0.5874435609204245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCLN,Nicalin,23650,292,0.99 [0.80-1.23],0.9295377438467712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,24053,294,0.91 [0.68-1.22],0.5374271016237684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,20845,268,2.19 [1.63-2.94],2.027003763860528e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,24336,301,2.44 [1.74-3.43],2.740556151935876e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDRG1,Protein NDRG1,23557,291,1.09 [0.95-1.24],0.2198107986274674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,20831,269,0.99 [0.82-1.20],0.9280202072763096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,20282,255,1.04 [0.73-1.47],0.8371677798969309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,20845,268,0.90 [0.78-1.03],0.1176960163361161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23512,290,1.05 [0.93-1.19],0.427103455817921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,20268,261,1.31 [0.99-1.73],0.0597428329456799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,20268,261,1.04 [0.87-1.24],0.6923742678257674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN1,Nectin-1,20324,257,0.76 [0.50-1.17],0.2113061764691791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,24077,295,2.36 [1.71-3.24],1.4519006402553101e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,24166,299,1.95 [1.46-2.59],5.884435844557514e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,20324,257,1.14 [0.87-1.49],0.3577863426321268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD9,Enhancer of filamentation 1,20324,257,1.10 [0.78-1.55],0.5909065005563965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,23480,290,1.87 [1.51-2.31],9.897874731464616e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,20535,263,0.88 [0.72-1.07],0.1955013898019345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,24166,299,0.80 [0.62-1.03],0.0862796815073424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,24204,299,0.96 [0.67-1.38],0.82326042630697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,20831,269,0.98 [0.87-1.11],0.7760902738080663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEO1,Neogenin,20901,269,1.07 [0.62-1.84],0.8203288450856427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEXN,Nexilin,20949,268,0.95 [0.80-1.14],0.5749398340784779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,24394,299,2.38 [1.71-3.33],3.268373563334891e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,20324,257,0.97 [0.84-1.12],0.65647415280489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24087,294,0.94 [0.85-1.05],0.3035936546171753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",23650,292,1.74 [1.50-2.01],9.169038568384577e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,20347,252,0.88 [0.74-1.04],0.1343702419285199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,20901,269,1.30 [1.05-1.62],0.0154510847623841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,20268,261,1.03 [0.87-1.21],0.7481906644574307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,20535,263,1.17 [0.99-1.38],0.0624768245019671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,23512,290,1.08 [0.87-1.33],0.5107445718923123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",20845,268,1.05 [0.93-1.18],0.4272572061766958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFX1,Transcriptional repressor NF-X1,20268,261,0.93 [0.77-1.12],0.4422287467806709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,20268,261,1.14 [0.86-1.51],0.3534404004501683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGF,Beta-nerve growth factor,23969,296,1.74 [0.79-3.86],0.1714487288416744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,20929,268,1.35 [0.96-1.89],0.0831522589042199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,20872,268,1.41 [0.81-2.44],0.2238136907832714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,19978,249,1.91 [1.28-2.85],0.001616192871311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,24102,295,1.54 [1.19-2.01],0.0012533193670737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,24103,297,1.01 [0.87-1.16],0.9102248695021188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,23512,290,1.14 [0.95-1.36],0.1651587877802248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,20347,252,0.86 [0.65-1.12],0.2574059104490506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT2,Omega-amidase NIT2,20852,265,1.11 [0.94-1.30],0.206134607607338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN1,Neuroligin-1,20341,262,0.98 [0.82-1.17],0.803070879442765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN2,Neuroligin-2,20261,268,1.14 [0.89-1.45],0.3059735594568183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME1,Nucleoside diphosphate kinase A,20324,257,0.66 [0.36-1.20],0.1688299582225492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,24119,297,1.85 [1.27-2.68],0.0011915889331831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,20741,267,1.05 [0.89-1.24],0.5294063290731108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,23969,296,1.19 [1.05-1.35],0.0053017292896305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,20195,258,0.87 [0.63-1.19],0.3820054521133764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,20901,269,0.99 [0.82-1.20],0.9293940875714256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,24103,297,1.69 [1.12-2.55],0.0126704674976437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOP56,Nucleolar protein 56,20268,261,1.02 [0.91-1.15],0.7057615298490654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",23557,291,1.33 [1.11-1.59],0.0021722515156866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS2,"Nitric oxide synthase, inducible",20268,261,1.33 [1.01-1.75],0.0406799624781778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",23557,291,1.46 [1.23-1.74],1.1754474523932e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,24403,298,0.65 [0.34-1.26],0.2010510453754685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,20923,268,1.09 [0.66-1.81],0.7293634159737303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,24403,298,0.90 [0.68-1.21],0.4915870570562577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,20582,262,2.81 [2.10-3.75],2.2385678456496764e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,24107,295,1.89 [1.41-2.54],2.3474486269034007e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS1,Nephrin,20324,257,1.18 [0.84-1.66],0.3303619767353002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,20324,257,0.96 [0.85-1.08],0.4904541826212428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,20929,268,2.27 [1.80-2.87],3.5351606930608845e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,23674,285,1.07 [0.98-1.17],0.1292926649152818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,24087,294,1.44 [1.21-1.73],5.427467300832501e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,20268,261,0.91 [0.64-1.29],0.5778161812985538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTN,Neuroplastin,23512,290,1.02 [0.90-1.16],0.7187379821290105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,24103,297,1.60 [1.27-2.01],5.758889085033857e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,20923,268,3.09 [2.29-4.16],1.2852591639613228e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,24107,295,0.62 [0.45-0.86],0.0037811215855373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,24336,301,0.96 [0.83-1.12],0.608565521720966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,24107,295,0.83 [0.57-1.20],0.3136006974360742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRGN,Neurogranin,20949,268,0.97 [0.85-1.11],0.6665404072058037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,20901,269,1.17 [0.89-1.54],0.2743721652734043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,24222,296,2.46 [1.71-3.54],1.2609566305963388e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,24103,297,1.16 [0.81-1.66],0.4126921665699242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRTN,Neurturin,23650,292,1.13 [0.93-1.38],0.2270331232962894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRXN3,Neurexin-3,20341,262,0.80 [0.53-1.20],0.2718162380049462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NSFL1C,NSFL1 cofactor p47,24351,299,1.14 [0.97-1.33],0.1149663349546631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",20929,268,1.03 [0.88-1.21],0.6990185058631615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,20872,268,2.24 [1.73-2.90],1.278913559759948e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,24045,293,0.88 [0.78-0.99],0.040111312019252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,24166,299,1.42 [1.19-1.69],7.284899341711568e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,24087,294,1.09 [0.81-1.46],0.5808335023535369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF4,Neurotrophin-4,23512,290,0.98 [0.75-1.28],0.8919615165449414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,24107,295,0.69 [0.46-1.04],0.0740680035886148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,24351,299,0.56 [0.35-0.90],0.0157143397720923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24107,295,1.16 [1.05-1.28],0.0041745594951259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUB1,NEDD8 ultimate buster 1,24087,294,0.96 [0.85-1.09],0.537435094809109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,20831,269,1.07 [0.94-1.22],0.2849856185666869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,24305,300,1.17 [0.90-1.54],0.2427747538499128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,24394,299,1.00 [0.84-1.17],0.9524490940305406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20347,252,1.03 [0.61-1.73],0.9131257334755928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20268,261,1.09 [0.88-1.36],0.4179462801974116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,20811,268,1.06 [0.92-1.20],0.4291174780138503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],24013,293,0.85 [0.70-1.03],0.1031140719734031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,24103,297,1.24 [1.02-1.51],0.0347102447820562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUMB,Protein numb homolog,20324,257,0.99 [0.86-1.15],0.9442009796930444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,20268,261,0.94 [0.62-1.43],0.7875879307752383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPE4,NXPE family member 4,20268,261,0.82 [0.54-1.23],0.3302414864903112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH1,Neurexophilin-1,23557,291,0.75 [0.56-1.00],0.0490003603434198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,20324,257,0.65 [0.44-0.96],0.0300411496819337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,23884,296,1.25 [1.08-1.45],0.0032602188727807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,20901,269,2.85 [2.30-3.53],1.0743252629349225e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,23515,288,0.67 [0.53-0.84],0.0006732710078296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,20535,263,0.98 [0.82-1.18],0.83968184806891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGA,Protein O-GlcNAcase,20845,268,1.00 [0.85-1.19],0.9559638093583732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGFR,Opioid growth factor receptor,24013,293,1.16 [0.85-1.59],0.3448562720633689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,24103,297,1.04 [0.81-1.34],0.7529825107389558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20535,263,0.79 [0.62-1.00],0.0546380764329694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,19692,244,1.19 [1.08-1.32],0.0005875028404519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,23874,293,1.45 [1.25-1.67],5.203760530452078e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,24204,299,0.73 [0.58-0.91],0.0060399912272463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,24013,293,0.67 [0.57-0.78],3.564286177118717e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMP,Olfactory marker protein,20261,268,1.13 [0.88-1.44],0.3328097363509171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPHN1,Oligophrenin-1,20872,268,1.00 [0.89-1.12],0.9716916672810294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPLAH,5-oxoprolinase,20347,252,1.05 [0.88-1.26],0.59237165807824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPTC,Opticin,24013,293,0.72 [0.56-0.93],0.0130390204403143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,20871,267,2.22 [1.26-3.93],0.0058578992519042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,20872,268,1.10 [0.83-1.46],0.5022005462327659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24119,297,2.44 [1.78-3.34],3.063220772653999e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,23962,292,1.59 [1.38-1.83],7.079428582731823e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,24222,296,3.67 [2.26-5.96],1.429853855252266e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSTN,Osteocrin,20341,262,0.93 [0.68-1.27],0.6474666229070238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTOA,Otoancorin,20261,268,1.06 [0.85-1.33],0.5972788253434027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,20845,268,0.95 [0.77-1.17],0.6248475095306443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,20901,269,1.05 [0.88-1.27],0.5730437967698527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20347,252,1.02 [0.86-1.21],0.8234832461945597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,24351,299,1.12 [1.04-1.20],0.0025949700323622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,23971,295,1.46 [1.12-1.90],0.0045657530079985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,20268,261,0.92 [0.75-1.12],0.39332348021449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI2,Protein-arginine deiminase type-2,23650,292,1.00 [0.83-1.21],0.974565354638572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI4,Protein-arginine deiminase type-4,23515,288,1.13 [0.99-1.28],0.0705447949586908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,23969,296,0.88 [0.81-0.96],0.0020644682803024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,20901,269,0.96 [0.85-1.08],0.4809700240759103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20535,263,0.96 [0.74-1.24],0.7347133434874473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,23674,285,1.11 [0.93-1.33],0.2518893282031357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,20347,252,0.81 [0.61-1.09],0.1603742780352176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,20156,257,0.85 [0.66-1.10],0.2221194123471744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,23557,291,1.00 [0.84-1.19],0.9717576659049264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALLD,Palladin,20324,257,0.92 [0.65-1.29],0.6176949297633989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,20734,266,1.11 [0.75-1.65],0.5980686259375094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,20872,268,2.51 [1.98-3.18],2.5323043326573112e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM3,Paralemmin-3,20268,261,1.02 [0.86-1.21],0.8383043138151547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,24275,298,1.23 [0.84-1.80],0.2885947891832774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,24103,297,0.98 [0.68-1.43],0.9310257161956242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAPPA,Pappalysin-1,23650,292,1.29 [1.05-1.59],0.0177920670323894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARD3,Partitioning defective 3 homolog,20535,263,0.93 [0.78-1.11],0.4310290789697871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARK7,Parkinson disease protein 7,24103,297,1.13 [0.92-1.38],0.2420351595416359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,24087,294,1.26 [1.09-1.45],0.0015380574031979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,20437,253,1.27 [0.99-1.63],0.0582977129113348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,20195,258,1.05 [0.71-1.57],0.7957651278121449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,23557,291,1.15 [0.95-1.40],0.1612117147051055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,20845,268,1.02 [0.70-1.48],0.9312716012317984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCARE,Photoreceptor cilium actin regulator,20261,268,0.92 [0.79-1.07],0.2856758681180282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20391,253,1.58 [1.27-1.95],3.66098221896888e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBP2,Poly(rC)-binding protein 2,20901,269,1.05 [0.89-1.24],0.5841803843852245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH1,Protocadherin-1,24323,297,1.52 [0.97-2.39],0.0688816463475271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,20901,269,1.61 [1.05-2.45],0.027623612993658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,24107,295,1.32 [1.00-1.75],0.0498678229974623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH7,Protocadherin-7,20845,268,0.60 [0.40-0.90],0.0144985212285896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,20845,268,0.75 [0.54-1.05],0.0905824577879989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,20831,269,1.12 [0.83-1.51],0.4515417992534768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCNA,Proliferating cell nuclear antigen,20195,258,1.08 [0.92-1.27],0.3303827910751071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,20831,269,0.93 [0.71-1.23],0.6264355492793583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,24403,298,1.27 [0.99-1.64],0.0621799587225147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,20845,268,1.11 [0.95-1.29],0.2027123495389735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,20929,268,0.99 [0.88-1.12],0.8961322867946456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1,Programmed cell death protein 1,24299,300,1.19 [0.93-1.53],0.166490942019321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,24013,293,1.51 [1.09-2.08],0.0123366243385881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,24351,299,1.26 [1.06-1.51],0.008513453974697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,24107,295,1.05 [0.90-1.23],0.5000718505882368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCL2,Phosducin-like protein 2,20195,258,0.84 [0.64-1.12],0.2387807611558988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",20195,258,0.95 [0.74-1.23],0.7148087865402492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",20268,261,1.00 [0.82-1.23],0.9810460011527988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20437,253,0.92 [0.81-1.03],0.144453303734441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,24403,298,0.98 [0.85-1.14],0.8163350776963733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,24204,299,1.08 [0.96-1.22],0.1990983889170711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,23512,290,1.43 [1.00-2.05],0.0500076767625901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,24107,295,1.68 [1.19-2.39],0.0035552693628215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,24403,298,1.16 [0.86-1.57],0.3353529823799845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA2,Protein disulfide-isomerase A2,20195,258,1.00 [0.72-1.39],0.9910917691344407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,20437,253,1.08 [0.68-1.71],0.7559243425459679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA4,Protein disulfide-isomerase A4,20923,268,1.04 [0.86-1.25],0.715570678791329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,20195,258,1.08 [0.89-1.31],0.446950917620745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,20901,269,0.96 [0.87-1.07],0.4780500481027936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,24204,299,0.95 [0.87-1.03],0.1942599461757438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23512,290,1.08 [0.88-1.33],0.4824931343800064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,20341,262,1.03 [0.81-1.31],0.8207548525561728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,20195,258,1.11 [0.92-1.34],0.262715030291947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,20268,261,1.09 [0.90-1.32],0.3938722541856249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20324,257,1.77 [1.45-2.17],3.3187794081460415e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,24403,298,0.89 [0.56-1.41],0.6139379926016346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,24103,297,1.22 [1.02-1.45],0.0287238170612197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,24103,297,1.28 [0.91-1.79],0.1603978821634241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,20347,252,1.02 [0.67-1.56],0.9257544311587432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,20437,253,1.36 [0.93-1.99],0.1093696425667194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,20949,268,1.43 [0.91-2.24],0.1175062817045404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,20324,257,1.10 [0.99-1.21],0.0720717410396684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,20787,266,0.99 [0.88-1.12],0.908248093228094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN2,Prefoldin subunit 2,23557,291,0.97 [0.79-1.18],0.7277643089972489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN4,Prefoldin subunit 4,20195,258,0.84 [0.65-1.08],0.1791841239336671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN6,Prefoldin subunit 6,20341,262,0.92 [0.75-1.14],0.460236324101774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",23981,291,1.08 [0.94-1.24],0.2708527183853669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,20949,268,1.97 [1.65-2.34],2.0159888274069007e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",20929,268,1.17 [0.95-1.45],0.1454829331333123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,24394,299,2.17 [1.68-2.81],4.360157952217753e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,24267,297,1.35 [1.08-1.70],0.0094704969277888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,20673,265,1.37 [0.91-2.07],0.1277110392129837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,20268,261,1.10 [0.92-1.32],0.2888071779428919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGM2,Phosphoglucomutase-2,20341,262,0.99 [0.80-1.23],0.9539582968508328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGR,Progesterone receptor,20324,257,0.94 [0.81-1.08],0.3784363672926379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,20901,269,1.00 [0.90-1.11],0.9450783335122784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,20845,268,1.06 [0.85-1.33],0.5781001176147298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,20195,258,0.95 [0.82-1.09],0.4559565313815693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,23969,296,1.39 [0.95-2.02],0.0869631779724458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20437,253,1.21 [0.92-1.60],0.1661203593624551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,20949,268,0.88 [0.54-1.44],0.6207364178481782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,23763,293,1.76 [1.50-2.06],3.092734316810001e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",20901,269,0.99 [0.85-1.16],0.9479792868022228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,23791,294,3.57 [2.85-4.48],3.950603026270009e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24087,294,1.34 [1.13-1.57],0.0005785013863404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24103,297,1.74 [1.20-2.52],0.0036970756252956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,20324,257,1.06 [0.86-1.30],0.6165110166617298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24103,297,1.95 [1.51-2.51],2.984078956886012e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,24107,295,1.44 [1.18-1.75],0.0002605449892992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20437,253,1.07 [0.89-1.29],0.4651085836448626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PITHD1,PITH domain-containing protein 1,20156,257,0.99 [0.84-1.16],0.891006878387979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,20929,268,1.60 [1.03-2.47],0.0353953903387143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,20268,261,1.08 [0.88-1.31],0.4617402311331916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKLR,Pyruvate kinase PKLR,24119,297,1.34 [1.15-1.56],0.0001853775554848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,20535,263,1.01 [0.86-1.18],0.8839035882092631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,23969,296,1.15 [0.96-1.38],0.1175001118350579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,24166,299,5.52 [3.90-7.80],4.331574802773145e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,24356,298,0.43 [0.34-0.55],1.0565456818831954e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",24055,296,1.09 [0.92-1.31],0.3192159306938537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,24204,299,0.97 [0.86-1.09],0.649408960023097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,24103,297,0.78 [0.57-1.08],0.1371253929367797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,24317,297,1.89 [1.56-2.30],1.3335937570947677e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,24103,297,1.78 [1.34-2.37],7.03509411130486e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,23911,293,5.04 [3.71-6.85],4.109308567496802e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",20872,268,1.18 [0.97-1.45],0.0975873551056896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",20324,257,1.12 [0.88-1.42],0.3628810010145579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",20872,268,0.99 [0.88-1.12],0.92782161473324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,20872,268,1.01 [0.85-1.20],0.8904271582643254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,20402,259,2.18 [1.33-3.58],0.002106316975346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,23557,291,1.05 [0.78-1.42],0.7321574909439367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,24107,295,1.04 [0.82-1.32],0.7671238901408399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,24107,295,1.07 [0.91-1.25],0.4127380333375443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,20843,268,1.10 [0.90-1.35],0.3423997870605363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,24308,298,0.89 [0.68-1.17],0.4119457879796205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,23512,290,0.60 [0.40-0.88],0.0094745114935704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,20872,268,1.26 [0.84-1.89],0.2656974793596767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNA4,Plexin-A4,24087,294,0.98 [0.86-1.11],0.7352680209407949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,24292,297,2.36 [1.57-3.55],3.90092498205333e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB3,Plexin-B3,24022,294,0.83 [0.66-1.04],0.1052876750505727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24009,294,1.03 [0.97-1.09],0.2961544424056719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMCH,Pro-MCH,20268,261,0.93 [0.77-1.11],0.3927662261996554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMM2,Phosphomannomutase 2,20268,261,0.94 [0.77-1.16],0.5773061263154519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,20341,262,1.34 [1.08-1.67],0.0079391436747244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMVK,Phosphomevalonate kinase,23520,291,1.01 [0.91-1.11],0.8992469518086822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,20949,268,0.76 [0.63-0.92],0.0042779921983533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,20872,268,0.99 [0.85-1.15],0.9213670407031188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,24075,295,1.00 [0.97-1.04],0.8954169996614415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,20347,252,0.97 [0.78-1.21],0.7909274291154605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,20261,268,0.92 [0.68-1.25],0.5952932053581295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",23650,292,1.00 [0.91-1.10],0.9991337784854296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,24013,293,1.39 [0.69-2.80],0.3633558936852122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,24166,299,0.89 [0.62-1.28],0.5259132473024652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,20324,257,1.30 [1.01-1.68],0.0454474774919414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,20324,257,0.70 [0.44-1.11],0.1284412006430015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24013,293,1.61 [1.30-1.99],1.5922803934975493e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,20347,252,0.95 [0.81-1.12],0.5585810563072643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,20949,268,0.81 [0.54-1.23],0.3233205311445012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,23674,285,1.77 [1.30-2.39],0.0002522696413658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,24204,299,0.73 [0.56-0.96],0.0226855510843026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,20923,268,1.09 [0.80-1.50],0.5809053455421396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,20774,266,0.92 [0.80-1.06],0.2726863960292569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,24351,299,1.19 [0.96-1.48],0.1139213258282847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,24100,294,0.98 [0.88-1.10],0.7511179148668721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,20535,263,1.11 [0.94-1.32],0.2275068700793876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",20923,268,1.13 [0.94-1.36],0.1797414439351204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,20324,257,1.94 [1.44-2.60],1.1411234012751447e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1A,Protein phosphatase 1A,23512,290,0.76 [0.52-1.12],0.1630616791604449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1B,Protein phosphatase 1B,20324,257,0.98 [0.79-1.22],0.8738089789520906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1F,Protein phosphatase 1F,20929,268,0.95 [0.76-1.18],0.630198778765475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPME1,Protein phosphatase methylesterase 1,24013,293,1.18 [0.99-1.42],0.0698432848957591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,20831,269,0.91 [0.78-1.05],0.1959469087836711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,24166,299,1.04 [0.93-1.16],0.5112306648573428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20535,263,1.04 [0.88-1.23],0.6175656164591794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,20901,269,0.92 [0.78-1.08],0.2917846894308107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,20901,269,1.44 [1.08-1.91],0.0127164360402995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,24107,295,0.96 [0.84-1.10],0.55202663233643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R9B,Neurabin-2,24394,299,0.98 [0.88-1.10],0.7468968393603801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,20845,268,0.97 [0.88-1.07],0.5207844038464337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,23969,296,0.94 [0.73-1.21],0.6447179281249238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,20341,262,1.15 [1.01-1.31],0.0418981529237957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,24052,297,0.96 [0.86-1.06],0.4178798887783307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,23512,290,1.09 [0.91-1.29],0.3553710412892459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,20195,258,0.84 [0.51-1.37],0.4753639549352294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,20923,268,2.93 [2.16-3.97],4.074528424527723e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,20831,269,1.11 [0.87-1.42],0.406673019389934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,24226,298,2.29 [1.69-3.12],1.222011797817342e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX1,Peroxiredoxin-1,23469,290,0.93 [0.82-1.05],0.2508800604734752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX2,Peroxiredoxin-2,20622,266,1.27 [1.05-1.53],0.0127345019515241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",23650,292,1.19 [1.03-1.37],0.0164861636701251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",24394,299,1.00 [0.85-1.16],0.9714373609701727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,24336,301,0.80 [0.67-0.96],0.0151186241091921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,23650,292,1.64 [1.21-2.22],0.0014601767030089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRELP,Prolargin,24075,295,1.08 [0.66-1.78],0.7623775002285718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,20923,268,1.47 [1.18-1.84],0.0006492254765911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,20923,268,1.39 [1.10-1.77],0.0056235105359588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,23650,292,1.00 [0.83-1.22],0.9684137940155793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20341,262,1.01 [0.66-1.54],0.962743087296319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,24107,295,1.00 [0.88-1.14],0.9648533614823138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,20828,268,1.05 [0.91-1.22],0.5161405459519484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKCQ,Protein kinase C theta type,23650,292,1.00 [0.78-1.28],0.9885888850535312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,20268,261,0.72 [0.51-1.00],0.0529452081426442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,20437,253,0.97 [0.88-1.07],0.5707205896259242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23512,290,1.03 [0.87-1.21],0.7555810741301745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,24351,299,0.95 [0.83-1.09],0.4401823786533809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,20872,268,1.53 [1.24-1.88],6.047480753668252e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,24145,296,0.78 [0.53-1.17],0.2318735391644083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROCR,Endothelial protein C receptor,20268,261,1.03 [0.75-1.40],0.8752772138014874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,24087,294,1.30 [1.13-1.48],0.0001739148487449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,20947,267,1.40 [0.88-2.22],0.1500660946385506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR4,Proline-rich protein 4,20302,252,1.06 [0.89-1.26],0.5337104066100888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR5,Proline-rich protein 5,20324,257,1.06 [0.81-1.40],0.6571486025653941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,20347,252,0.98 [0.70-1.35],0.8874427944674298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,24176,296,1.27 [1.06-1.53],0.0110512531546374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,20324,257,2.07 [1.63-2.63],2.2225707047616403e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,24021,294,0.84 [0.65-1.10],0.2079899250830487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,20872,268,1.49 [1.10-2.00],0.0088305112082592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,24002,297,3.17 [2.56-3.93],6.932109665644173e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23557,291,0.92 [0.83-1.01],0.0820508124386315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,24336,301,2.52 [1.76-3.59],3.6552696019188213e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,23494,288,1.12 [0.91-1.38],0.2986420164174749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,20535,263,1.80 [1.32-2.44],0.0001702900409689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,20740,263,2.68 [1.94-3.70],2.363452854111164e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,20845,268,1.25 [1.00-1.58],0.0550538109008442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSCA,Prostate stem cell antigen,20845,268,1.03 [0.98-1.08],0.210695839162736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,23969,296,1.18 [1.06-1.31],0.0020249817126344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,24087,294,1.12 [0.97-1.30],0.1189343703972341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,23512,290,1.10 [0.88-1.38],0.4164789817739212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,20195,258,0.89 [0.58-1.37],0.603989923211786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,20901,269,0.99 [0.78-1.26],0.9440392213747456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,20341,262,0.86 [0.66-1.12],0.2561885413979849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,24013,293,1.23 [1.03-1.46],0.0234928842420508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,23941,296,1.40 [1.07-1.85],0.0161083867985107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,23869,295,1.60 [1.21-2.13],0.000984959877652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG3,Proteasome assembly chaperone 3,24087,294,1.39 [1.13-1.69],0.0014495224570257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG4,Proteasome assembly chaperone 4,20324,257,1.30 [1.06-1.59],0.0122030385113784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,24087,294,1.30 [1.19-1.41],5.3180566429643565e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,23512,290,1.19 [1.00-1.41],0.0500758071293199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,19674,246,0.95 [0.84-1.07],0.3874145807898045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23557,291,1.32 [0.93-1.88],0.1233239664285435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,23915,294,1.63 [1.18-2.26],0.0031486849034577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,20167,255,1.13 [0.90-1.41],0.2867310169703375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,20929,268,1.24 [1.08-1.42],0.0025614956326093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH,Parathyroid hormone,20341,262,1.13 [0.97-1.30],0.1098646297593308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,24087,294,1.33 [1.06-1.68],0.0137930273364237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,23557,291,1.43 [1.10-1.86],0.0073755378160783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,23674,285,1.37 [1.12-1.68],0.0026529054901682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,20324,257,1.27 [1.03-1.57],0.0256915037487417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,23969,296,1.00 [0.87-1.15],0.9821104292780822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,24166,298,0.96 [0.85-1.08],0.4580100442414672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,20284,257,1.12 [0.83-1.52],0.4586597208182902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,20929,268,3.22 [2.27-4.56],4.646120202841777e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,20923,268,1.48 [0.90-2.45],0.1244434978794913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,24403,298,1.12 [0.78-1.60],0.5349131255084405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,20845,268,1.08 [0.85-1.37],0.5163923623239399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,20845,268,1.33 [0.82-2.17],0.2460254902465237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,24044,293,1.41 [0.92-2.15],0.1118027220034565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,23877,295,0.90 [0.65-1.25],0.5247910703402124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,20872,268,0.63 [0.46-0.88],0.0057224571651359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,24403,298,0.55 [0.36-0.84],0.0060658167474051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,20929,268,1.48 [1.03-2.14],0.0345063145052581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20437,253,0.92 [0.74-1.13],0.4046127554101041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,23459,288,1.46 [1.23-1.72],8.443759741336192e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTTG1,Securin,20535,263,0.83 [0.62-1.12],0.2269832500133652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,24087,294,1.58 [1.25-2.01],0.0001668120845278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVALB,Parvalbumin alpha,24247,298,0.95 [0.87-1.04],0.311716261565241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,24351,299,2.26 [1.80-2.85],3.309067452016654e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXDNL,Peroxidasin-like protein,20831,269,1.02 [0.84-1.24],0.8075603325299728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,23557,291,1.30 [1.09-1.56],0.0035134652299026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYDC1,Pyrin domain-containing protein 1,20347,252,1.34 [1.03-1.74],0.0299874737365676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,20268,261,1.24 [1.09-1.40],0.0006657190386675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,20947,267,0.65 [0.53-0.79],1.490838382587629e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,23992,294,1.30 [1.02-1.65],0.0339573448157731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,24102,297,1.65 [1.11-2.46],0.0135261606222084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,20525,264,1.37 [1.12-1.68],0.0019197262830434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB10,Ras-related protein Rab-10,20929,268,1.07 [0.86-1.33],0.5527522488685862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,20929,268,0.97 [0.87-1.08],0.5873682109002045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB27B,Ras-related protein Rab-27B,20929,268,0.95 [0.82-1.10],0.5322454041467397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB2B,Ras-related protein Rab-2B,20831,269,0.97 [0.79-1.18],0.7308355016542403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB33A,Ras-related protein Rab-33A,20268,261,0.94 [0.78-1.13],0.4829740463757016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB37,Ras-related protein Rab-37,23650,292,1.00 [0.88-1.14],0.9783217605390798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB39B,Ras-related protein Rab-39B,20268,261,1.01 [0.88-1.15],0.9314862558748525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,20261,268,0.76 [0.58-0.98],0.038105651722858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB44,Ras-related protein Rab-44,20831,269,1.21 [0.99-1.47],0.0635479566644241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,24087,294,0.51 [0.40-0.65],7.800863451579828e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,23557,291,1.03 [0.82-1.31],0.7847988042639251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,20437,253,0.96 [0.82-1.13],0.6488030861907943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,23512,290,1.12 [0.95-1.33],0.181207329602139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,23650,292,1.16 [0.98-1.38],0.0805089389603959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,20341,262,1.01 [0.84-1.21],0.9165123705808084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,23512,290,1.06 [0.83-1.34],0.6468171096738785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,20535,263,1.06 [0.84-1.32],0.6378036105176004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,20324,257,0.93 [0.61-1.43],0.7540654390086485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,20831,269,1.27 [1.04-1.56],0.0192760557353288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,20347,252,1.15 [0.90-1.45],0.2663659421181813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,20261,268,0.68 [0.46-1.01],0.0578542948520128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,23512,290,1.03 [0.83-1.29],0.7663285142313765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,20324,257,0.97 [0.80-1.19],0.794439532544586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,20535,263,0.94 [0.75-1.19],0.6111501823804613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,23512,290,0.99 [0.71-1.38],0.9685817937710548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,24222,296,1.26 [1.03-1.54],0.0247479296970828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASA1,Ras GTPase-activating protein 1,23557,291,1.23 [0.90-1.67],0.1904135291551929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20195,258,0.88 [0.66-1.18],0.3838075839635839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,23512,290,1.25 [1.08-1.44],0.0033701893771406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,20901,269,2.26 [1.83-2.81],1.0419908730139672e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,23575,292,1.64 [1.35-1.98],5.669954322375336e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM17,Splicing factor 45,20901,269,0.90 [0.77-1.06],0.2070113914471831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM19,Probable RNA-binding protein 19,20268,261,0.69 [0.51-0.95],0.0208617055878925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM25,RNA-binding protein 25,20195,258,0.78 [0.58-1.04],0.092568497697251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP1,Retinol-binding protein 1,20341,262,0.99 [0.82-1.19],0.8803393584556636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,24013,293,1.35 [1.19-1.54],5.587247194399753e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,24013,293,1.55 [1.32-1.83],7.54599557014421e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,20845,268,1.36 [1.16-1.59],0.0001461458928722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,20324,257,0.98 [0.81-1.20],0.8502488595106393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,20347,252,0.92 [0.82-1.04],0.2085846442440133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,20831,269,1.09 [0.87-1.36],0.4599367018878729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCOR1,REST corepressor 1,23674,285,1.20 [0.97-1.48],0.0989703769529483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,20347,252,0.77 [0.44-1.37],0.3783504180550354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,20901,269,0.93 [0.76-1.14],0.4846939472962362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,23962,295,1.66 [1.38-2.00],8.36970023739117e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,24403,298,1.44 [1.22-1.70],1.2627196156863808e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,24403,298,1.39 [1.19-1.63],3.831038286486272e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,20831,269,1.00 [0.73-1.36],0.9970476305634898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,24119,297,1.48 [1.20-1.82],0.0002490753880949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,20324,257,1.25 [1.02-1.54],0.0298551416900872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,24103,297,2.33 [1.67-3.25],6.435308953521548e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,24107,295,1.78 [1.58-2.00],2.572595973957687e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,20324,257,0.97 [0.70-1.35],0.8695618741745837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REST,RE1-silencing transcription factor,20195,258,0.89 [0.62-1.29],0.5434283561253735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,24013,293,0.68 [0.52-0.88],0.0043952750526903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,24038,294,1.05 [0.82-1.33],0.7064889249895921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",20268,261,0.88 [0.66-1.16],0.3666996962914451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,20831,269,1.19 [0.72-1.94],0.5007022185456682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGCC,Regulator of cell cycle RGCC,20901,269,0.95 [0.81-1.12],0.54872942299345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20535,263,1.02 [0.84-1.23],0.8562406635068964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,24351,299,0.61 [0.44-0.86],0.0039433459624797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,24351,299,1.05 [0.71-1.56],0.7996477334185638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS10,Regulator of G-protein signaling 10,20901,269,0.94 [0.77-1.15],0.5438704670811358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS8,Regulator of G-protein signaling 8,23650,292,1.01 [0.86-1.18],0.939609080925506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,23827,294,0.96 [0.88-1.05],0.3867306674104666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,20324,257,0.98 [0.75-1.29],0.9012462725910736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20437,253,1.46 [1.17-1.81],0.0006731080469536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILP,Rab-interacting lysosomal protein,24278,299,1.14 [0.96-1.36],0.1367384593357942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILPL2,RILP-like protein 2,20929,268,0.99 [0.88-1.12],0.8631606534924006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,20268,261,0.86 [0.69-1.06],0.1452723112384353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN1,Prorelaxin H1,20901,269,0.89 [0.74-1.06],0.1918968719455626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,20405,252,0.88 [0.78-1.00],0.0419240311254193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,20949,268,2.77 [1.80-4.26],3.828818150803107e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,20347,252,1.13 [0.88-1.45],0.3387255128951318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE3,Eosinophil cationic protein,23992,293,1.03 [0.94-1.12],0.5548058545427124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,20283,259,2.68 [1.80-3.98],1.108150765843628e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,20802,267,2.46 [1.89-3.21],2.3848063013560728e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,20901,269,0.76 [0.57-1.01],0.0624765439431808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,24271,298,2.81 [1.98-3.99],7.115689842937419e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,20347,252,2.72 [1.89-3.91],7.929777581188189e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,20324,257,0.89 [0.64-1.23],0.475848652164664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,20324,257,0.76 [0.51-1.14],0.1826129397205791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,20535,263,0.90 [0.73-1.11],0.3166974518820947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,23512,290,1.06 [0.91-1.24],0.4529355330492448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,20535,263,1.14 [0.95-1.37],0.1622141070971612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,20347,252,0.88 [0.74-1.04],0.1269027211249046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,24119,297,1.61 [1.06-2.44],0.0261653144952663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO2,Roundabout homolog 2,24351,299,0.76 [0.49-1.17],0.2111755226021078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO4,Roundabout homolog 4,20347,252,0.65 [0.32-1.32],0.2321014517640883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24107,295,0.99 [0.71-1.39],0.9733088572155076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,24013,293,1.10 [0.86-1.40],0.4377447366528821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPA2,Replication protein A 32 kDa subunit,20324,257,0.84 [0.55-1.29],0.4273169257337256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,20535,263,1.02 [0.85-1.22],0.843305940543056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,20341,262,1.10 [0.83-1.46],0.5155861081481635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,20347,252,1.35 [1.04-1.75],0.0263546063282444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPS10,40S ribosomal protein S10,20268,261,0.75 [0.53-1.07],0.1083752019688306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRAS,Ras-related protein R-Ras,20341,262,1.00 [0.91-1.10],0.9971109501148544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23512,290,1.49 [1.26-1.76],2.173691424410557e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23512,290,0.95 [0.81-1.12],0.5537068026433432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,20261,268,1.12 [0.98-1.26],0.0889126574654572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,23969,296,1.27 [0.95-1.69],0.1011955048558909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,24336,301,1.13 [0.78-1.64],0.5069199452922611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTBDN,Retbindin,24013,293,0.85 [0.60-1.23],0.3935064557614043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,20268,261,1.20 [0.99-1.46],0.0639704744832361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",20901,269,1.03 [0.91-1.17],0.6614837673469298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,24336,301,0.81 [0.60-1.10],0.1714353498264416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,23512,290,1.03 [0.93-1.15],0.5791055749798619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RWDD1,RWD domain-containing protein 1,24351,299,1.02 [0.86-1.20],0.8567128838252278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RYR1,Ryanodine receptor 1,20268,261,1.04 [0.72-1.50],0.8479882964458552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,23916,292,1.39 [1.18-1.65],0.0001245840568633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,23774,289,1.35 [1.17-1.54],2.063601116184164e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,20324,257,1.21 [0.85-1.70],0.2876748452264199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,20901,269,1.11 [0.88-1.40],0.3649766260570354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,23515,288,1.30 [1.11-1.51],0.0008529204438705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A3,Protein S100-A3,20831,269,1.06 [0.82-1.37],0.6569726341302744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A4,Protein S100-A4,24166,299,1.02 [0.85-1.23],0.8515878611711174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,20901,269,1.25 [0.98-1.58],0.0675044197793357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,23674,285,1.14 [0.95-1.36],0.1493191828744662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,20947,267,0.97 [0.66-1.45],0.8983012980142583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAFB2,Scaffold attachment factor B2,20901,269,1.21 [0.81-1.81],0.341877281640439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAG,S-arrestin,20261,268,0.92 [0.72-1.18],0.5057987741773409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,24087,294,0.99 [0.86-1.14],0.890467109903119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,20535,263,1.01 [0.85-1.19],0.9506011362830076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,20857,268,0.98 [0.88-1.10],0.7628512851469124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,20268,261,1.35 [1.06-1.72],0.0136891190855662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT1,Diamine acetyltransferase 1,20268,261,0.77 [0.58-1.03],0.0829911831878325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,20535,263,1.07 [0.91-1.26],0.4080034878094428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SATB1,DNA-binding protein SATB1,20901,269,0.82 [0.53-1.29],0.3964205425156734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,20890,268,1.61 [1.15-2.24],0.0052211404667863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,24013,293,1.04 [0.92-1.18],0.5311181712938993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,24351,299,1.56 [1.10-2.22],0.0122992964509069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,23557,291,1.01 [0.83-1.23],0.8860514017181133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,23507,289,1.56 [1.10-2.20],0.0125391824724968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,24403,298,1.10 [0.86-1.40],0.4474220222703896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,24351,299,1.96 [1.36-2.83],0.0003180723997856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,24247,298,1.22 [0.89-1.69],0.2212868561614611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG3,Secretogranin-3,24119,297,0.96 [0.70-1.31],0.7990657940153512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,24135,298,0.61 [0.52-0.72],7.28598453780231e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB2A2,Mammaglobin-A,20268,261,1.15 [0.81-1.63],0.4327102094542056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,20437,253,1.65 [1.03-2.63],0.0373967531895059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,24166,298,1.22 [1.10-1.36],0.0001723531524634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGN,Secretagogin,23650,292,1.02 [0.80-1.30],0.8721275370294632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,20261,268,0.79 [0.65-0.96],0.0161425628194929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,24278,299,1.93 [1.61-2.31],1.1784665257113312e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,20261,268,0.92 [0.70-1.20],0.5245188494295958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2B,Sodium channel subunit beta-2,20341,262,1.31 [0.88-1.96],0.1870125297732252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,20341,262,1.02 [0.74-1.41],0.8883340434939601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3B,Sodium channel subunit beta-3,20261,268,0.73 [0.53-1.00],0.0474734696610969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,20347,252,1.13 [0.85-1.49],0.3954023077179043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,23512,290,1.07 [0.94-1.23],0.3105219680702814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,20276,252,1.28 [1.01-1.61],0.0396075703792007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,20929,268,1.92 [1.35-2.74],0.0002873325213823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,20347,252,1.07 [0.94-1.21],0.3166129181078897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRN1,Secernin-1,24087,294,0.94 [0.78-1.14],0.5503153815048034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,20341,262,0.70 [0.53-0.92],0.0112463733609759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,24107,295,1.51 [1.21-1.89],0.0002852827249383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,24107,295,0.80 [0.64-1.01],0.0576892236519139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,20831,269,0.96 [0.87-1.07],0.5072509824563101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,20845,268,1.26 [1.09-1.46],0.0024472129532306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDK2,Protein sidekick-2,20437,253,0.98 [0.69-1.38],0.8917824017101759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEC31A,Protein transport protein Sec31A,20347,252,0.96 [0.82-1.13],0.6332860800779649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,20347,252,1.32 [0.95-1.83],0.0949772179044858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,24403,298,1.91 [1.55-2.36],2.075145910239813e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,20947,267,0.29 [0.17-0.50],6.036094801521314e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,20947,267,0.51 [0.31-0.86],0.0105534933499963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,24176,296,1.06 [0.89-1.27],0.5074150360503911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,24087,294,1.89 [1.33-2.68],0.00035925405418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,24107,295,1.72 [1.16-2.56],0.0069102925192242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3G,Semaphorin-3G,20437,253,0.92 [0.69-1.23],0.5819907490916578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4C,Semaphorin-4C,24013,293,1.10 [0.76-1.60],0.6154652432445564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4D,Semaphorin-4D,24351,299,0.91 [0.64-1.28],0.5777047601580803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA6C,Semaphorin-6C,20324,257,1.24 [0.78-1.97],0.3589227775107519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA7A,Semaphorin-7A,24317,297,1.21 [0.83-1.76],0.3165091574751166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,20901,269,1.25 [1.08-1.45],0.0032855602273578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN7,Septin-7,20535,263,0.95 [0.75-1.21],0.6950602419470304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,20827,266,2.51 [1.87-3.38],9.129932416023775e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN9,Septin-9,24013,293,0.87 [0.59-1.27],0.4627844971266216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,20579,265,5.23 [1.56-17.53],0.0073861236086452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,24403,298,1.23 [0.97-1.54],0.0820165257903199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,23423,289,0.90 [0.82-1.00],0.0403155465461569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,20884,267,3.60 [1.88-6.91],0.0001165689727132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,20573,261,0.92 [0.56-1.51],0.7394365148271942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,20652,264,0.91 [0.63-1.33],0.6333160084554291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,20947,267,1.29 [0.69-2.41],0.4303536525833975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA7,Thyroxine-binding globulin,20947,267,1.12 [0.60-2.08],0.7167289565026481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,23903,291,1.15 [1.00-1.32],0.0495090803807022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,24027,297,0.99 [0.88-1.11],0.855207827348642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB5,Serpin B5,23674,285,1.15 [0.91-1.46],0.22981635823149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,24273,299,0.92 [0.78-1.10],0.3765008124297069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,24394,299,1.25 [1.08-1.45],0.0022611020752562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB9,Serpin B9,23969,296,0.93 [0.66-1.30],0.6675079630540686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,20902,267,0.62 [0.28-1.37],0.2348649289528336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,20902,267,1.85 [1.22-2.81],0.0035800631648438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,24403,298,1.13 [0.97-1.33],0.1172053388643857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,20929,268,1.05 [0.88-1.26],0.5631082997133822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,20647,265,2.36 [1.53-3.65],9.98827361326513e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,20570,265,0.39 [0.16-0.91],0.0301246666652267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,20902,267,4.78 [2.58-8.86],6.776767952817538e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,20535,263,1.02 [0.93-1.13],0.6114963183505641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,20397,253,0.81 [0.54-1.23],0.3274265804507039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI2,Serpin I2,20845,268,0.83 [0.67-1.02],0.0793161922286448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23557,291,0.96 [0.81-1.14],0.674520262428285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,23893,295,1.61 [1.18-2.18],0.0025749198033152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6,Seizure protein 6 homolog,20341,262,1.03 [0.70-1.52],0.8665899711915962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,24166,299,0.52 [0.36-0.75],0.0005279835034805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,24013,293,1.34 [0.91-1.97],0.1348420824013928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SF3B4,Splicing factor 3B subunit 4,24013,293,0.99 [0.86-1.14],0.9139462130965624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,23879,295,1.46 [1.17-1.82],0.0009147882264731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,20437,253,0.59 [0.44-0.79],0.0004413027770251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,23512,290,1.14 [0.96-1.35],0.13496183063954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,23512,290,1.49 [1.26-1.77],2.69673466593303e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,24107,295,1.17 [1.00-1.37],0.0488926383680922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,20624,267,1.34 [1.10-1.63],0.0035087688455981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,23512,290,0.99 [0.89-1.11],0.8566490666739075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,24087,294,1.10 [0.93-1.31],0.2598024332226136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,20261,268,0.88 [0.70-1.10],0.2509878377197491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BP1,SH3 domain-binding protein 1,20845,268,0.92 [0.71-1.19],0.5399461696658808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GL3,Endophilin-A3,20399,260,0.98 [0.84-1.14],0.7624046630042518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GLB2,Endophilin-B2,20872,268,1.39 [1.16-1.66],0.0002667638524081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,20949,268,1.21 [0.98-1.50],0.0832033330193063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHC1,SHC-transforming protein 1,20195,258,0.96 [0.86-1.08],0.4949175573919178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHD,SH2 domain-containing adapter protein D,20234,261,0.96 [0.83-1.11],0.5873613531062704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHH,Sonic hedgehog protein,20324,257,0.82 [0.60-1.12],0.2147153804013197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,20923,268,3.35 [2.34-4.79],3.6807364819251185e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",24166,298,1.07 [0.95-1.21],0.2625129735926383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHPK,Sedoheptulokinase,20535,263,0.90 [0.64-1.25],0.5167260852301221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,24122,298,1.51 [1.22-1.87],0.0001320177946284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,24204,299,2.06 [1.64-2.59],4.2844878435048255e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24087,294,1.96 [1.46-2.64],6.83173256823259e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,23557,291,0.93 [0.81-1.07],0.300477789159558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,24103,297,1.05 [0.95-1.15],0.3696568294024316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24336,301,0.97 [0.71-1.33],0.8579866155400776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24107,295,2.80 [1.96-4.00],1.820590272729557e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20347,252,1.38 [1.06-1.80],0.0154895152472934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,24307,299,1.47 [1.05-2.06],0.0250825787726315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,20347,252,1.08 [0.76-1.54],0.6689541675314996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,24158,296,1.28 [1.05-1.56],0.0152746682727218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,24028,294,1.63 [1.30-2.05],2.874001468677093e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,20324,257,0.96 [0.82-1.13],0.6058386418121494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,24013,293,1.02 [0.90-1.16],0.7229954915630732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23557,291,0.99 [0.81-1.20],0.8806828381799381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,23650,292,1.14 [0.95-1.37],0.1556644635577434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,23924,296,0.96 [0.83-1.11],0.5514807179082708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,24204,299,0.97 [0.87-1.07],0.502567939376841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKIV2L,Helicase SKI2W,20268,261,0.82 [0.59-1.12],0.2078593066393051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLA2,Src-like-adapter 2,20901,269,0.95 [0.85-1.07],0.3882368643062693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,23650,292,1.43 [1.19-1.72],0.0001226146883794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,23512,290,1.18 [0.89-1.56],0.2481227329785713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,24087,294,1.47 [1.24-1.74],9.239747291798128e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,23512,290,1.64 [1.33-2.02],3.320635308292952e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,20268,261,1.22 [0.79-1.89],0.3733100987091441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC13A1,Solute carrier family 13 member 1,20831,269,0.81 [0.63-1.05],0.1131862609611319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,23557,291,1.34 [1.16-1.55],9.527104194485008e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,20341,262,0.70 [0.53-0.93],0.015384095996419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,23557,291,1.02 [0.87-1.18],0.8331765595586483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,20195,258,1.16 [0.96-1.40],0.1303429375666805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,20195,258,0.79 [0.59-1.05],0.1016199045726511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,23557,291,1.23 [0.89-1.69],0.2077555684462838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,24087,294,1.15 [0.96-1.37],0.1298386935797252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC44A4,Choline transporter-like protein 4,20341,262,0.87 [0.70-1.08],0.1948385258734505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,20923,268,0.94 [0.74-1.21],0.6392093285827798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC51B,Organic solute transporter subunit beta,20268,261,0.94 [0.79-1.11],0.4564089674560612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20437,253,1.00 [0.86-1.15],0.9712174727795788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,20845,268,1.27 [1.05-1.53],0.0139504779373806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",20195,258,0.89 [0.70-1.12],0.3010255761112306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,23557,291,1.21 [1.00-1.48],0.0507571717385409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,20324,257,0.40 [0.27-0.58],1.3299060800617955e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,24336,301,0.56 [0.44-0.72],7.478602775200966e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,23674,285,0.69 [0.50-0.95],0.0235739067834011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,20535,263,0.90 [0.75-1.08],0.2469412013077263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,20845,268,0.96 [0.83-1.11],0.59509724257144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,20779,266,1.21 [0.91-1.61],0.1813076195910982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,23512,290,0.98 [0.86-1.11],0.7703642140232225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,20831,269,1.01 [0.85-1.19],0.9344659706389272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,20831,269,0.79 [0.62-1.02],0.0660381462863443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,24013,293,1.94 [1.13-3.32],0.0166170875189191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,23557,291,1.13 [0.98-1.31],0.0822599497800631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,20195,258,0.97 [0.78-1.22],0.8161314478138258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,20845,268,1.28 [1.11-1.48],0.0006876443754983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,24336,301,1.68 [1.24-2.27],0.0007242599161067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,24204,299,2.21 [1.74-2.81],1.0241863665745315e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,24238,299,1.91 [1.59-2.29],4.0233072908165994e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,20324,257,1.00 [0.80-1.26],0.9726807496295594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24157,298,1.29 [1.10-1.51],0.0019918171904231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,20831,269,1.22 [1.06-1.39],0.0042940948183047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMS,Spermine synthase,20261,268,0.87 [0.70-1.08],0.2034917940993311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,20821,267,1.00 [0.88-1.13],0.98168884807917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP23,Synaptosomal-associated protein 23,24107,295,0.99 [0.87-1.11],0.8140993302486805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP25,Synaptosomal-associated protein 25,20261,268,0.83 [0.64-1.06],0.1364241364533129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,24166,299,1.03 [0.92-1.16],0.5771279478707543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAPIN,SNARE-associated protein Snapin,20901,269,0.91 [0.74-1.12],0.384078883348744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCA,Alpha-synuclein,20437,253,0.98 [0.88-1.09],0.7254701547789657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,23969,296,1.03 [0.88-1.21],0.7162803690445296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",20347,252,1.33 [0.92-1.94],0.1315978057443956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',20872,268,1.29 [1.07-1.56],0.0088395171590303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNU13,NHP2-like protein 1,20268,261,0.91 [0.74-1.12],0.3529324069680968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX15,Sorting nexin-15,20437,253,1.15 [0.92-1.44],0.2098126826681942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX18,Sorting nexin-18,20845,268,0.85 [0.64-1.14],0.2740957171358438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX2,Sorting nexin-2,20831,269,1.04 [0.89-1.21],0.6567593648931438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX5,Sorting nexin-5,20347,252,0.82 [0.53-1.25],0.3469056907794156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX9,Sorting nexin-9,24107,295,1.02 [0.87-1.18],0.8475031424832999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],23588,286,1.30 [1.05-1.61],0.0162083639221757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",24103,297,2.37 [1.90-2.96],1.5923250228193972e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD3,Extracellular superoxide dismutase,20949,268,0.88 [0.70-1.10],0.2602803398105523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,20901,269,1.50 [1.21-1.86],0.0002552298670069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,23512,290,1.60 [1.18-2.17],0.002689555855675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORD,Sorbitol dehydrogenase,24235,298,1.18 [1.02-1.37],0.0253888102219803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,24077,295,1.21 [0.92-1.58],0.1766818713584217
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,24077,295,0.86 [0.66-1.13],0.279424240421676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,20341,262,1.13 [0.90-1.42],0.296100086455599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,20864,268,0.78 [0.46-1.33],0.3591237096013573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX9,Transcription factor SOX-9,20341,262,1.15 [0.73-1.83],0.5436459345031969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,20901,269,1.08 [0.72-1.62],0.7222139584421015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPAG1,Sperm-associated antigen 1,20901,269,0.97 [0.79-1.19],0.7626582232115248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,24166,299,1.05 [0.91-1.22],0.5107492055097035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARCL1,SPARC-like protein 1,24098,293,0.89 [0.60-1.32],0.5486892718371629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,20437,253,0.97 [0.83-1.14],0.6967842793359453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,20929,268,2.00 [1.42-2.81],6.454860247637157e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,24103,297,1.64 [1.32-2.03],7.343392322002261e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,20437,253,1.45 [1.09-1.94],0.0118762438650694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,24087,294,1.25 [1.07-1.47],0.0053126008200684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,24103,297,1.04 [0.76-1.43],0.7867590399356326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,24336,301,1.28 [1.06-1.55],0.0088319048058124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,20268,261,0.79 [0.54-1.16],0.2357025909720069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,24018,297,2.72 [2.04-3.62],6.674860895706745e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,24204,299,1.36 [1.05-1.75],0.0186857970548277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,20845,268,1.12 [1.07-1.17],3.480280733657072e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,23969,296,1.04 [0.69-1.56],0.8531391112735636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,24119,297,2.24 [1.66-3.01],9.960614679277869e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,23989,294,2.34 [1.77-3.09],2.4758992124339195e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,24353,298,1.43 [1.15-1.78],0.0014747775635444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20324,257,0.97 [0.73-1.29],0.8354305292275422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRING1,SREBP regulating gene protein,20195,258,0.92 [0.72-1.19],0.5343259492881659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR1B,Cornifin-B,20535,263,0.88 [0.74-1.04],0.1350257301596995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,20872,268,0.97 [0.81-1.16],0.7286129064874944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,23650,292,1.03 [0.92-1.15],0.6068547065210729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20261,268,1.11 [0.76-1.64],0.5865938203599323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,20872,268,1.04 [0.76-1.41],0.8239824952887785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,24127,297,0.93 [0.85-1.01],0.100194799820366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,24013,293,1.36 [1.16-1.60],0.0001147754598034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,24087,294,1.01 [0.89-1.15],0.8793673064799274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,20929,268,1.13 [0.80-1.60],0.4840383235241257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSB,Lupus La protein,23557,291,1.11 [0.94-1.33],0.2201153643834585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",20324,257,1.07 [0.78-1.47],0.659470696065404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24077,295,0.80 [0.73-0.87],8.428125586272926e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24176,296,1.54 [1.22-1.96],0.0003563931163634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,20195,258,0.62 [0.39-0.99],0.0471595617425703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,20845,268,1.21 [0.97-1.51],0.0927845804688908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST13,Hsc70-interacting protein,20437,253,1.10 [0.88-1.38],0.4154500212067148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",24013,293,1.22 [0.97-1.53],0.0934459257747668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24403,298,1.88 [1.34-2.63],0.0002230074051604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",20324,257,0.88 [0.66-1.19],0.4137506702570819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,20923,268,2.33 [1.59-3.43],1.620389637634534e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAM,Signal transducing adapter molecule 1,20831,269,0.86 [0.61-1.20],0.3811858050391111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAMBP,STAM-binding protein,23924,296,1.02 [0.87-1.21],0.7955782748531824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,20324,257,0.99 [0.84-1.16],0.8550981932823742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,24013,293,0.95 [0.88-1.03],0.2235469236261201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,20195,258,0.95 [0.78-1.17],0.6594974160795126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,24351,299,1.57 [1.26-1.95],4.831069209735839e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,24074,296,1.21 [0.81-1.82],0.3520556898318855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STEAP4,Metalloreductase STEAP4,20261,268,1.02 [0.86-1.21],0.799643555883343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,24061,297,1.12 [0.95-1.31],0.1811354439084953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK11,Serine/threonine-protein kinase STK11,23674,285,0.99 [0.86-1.15],0.9327643363611348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK24,Serine/threonine-protein kinase 24,23557,291,0.92 [0.77-1.10],0.3496270961211386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK4,Serine/threonine-protein kinase 4,24107,295,0.96 [0.85-1.08],0.4920122423488015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",20195,258,0.99 [0.87-1.13],0.9124589687529694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX16,Syntaxin-16,23512,290,0.85 [0.69-1.05],0.1248556022199731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX1B,Syntaxin-1B,20341,262,0.96 [0.72-1.28],0.7969407565020201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX3,Syntaxin-3,20872,268,0.96 [0.68-1.33],0.7895683518041395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,24013,293,1.02 [0.87-1.20],0.8134153985471616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,20324,257,0.77 [0.55-1.08],0.1269343352679985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX6,Syntaxin-6,23512,290,0.97 [0.82-1.15],0.7496056572500005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX7,Syntaxin-7,20324,257,1.18 [0.92-1.51],0.1916978796277443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,24087,294,1.15 [0.94-1.41],0.1677351303377759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP1,Syntaxin-binding protein 1,20901,269,1.01 [0.87-1.19],0.8594639040943551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP3,Syntaxin-binding protein 3,23512,290,1.04 [0.81-1.33],0.7830695282408769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,20845,268,0.81 [0.60-1.10],0.1840954667098121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGT1,Protein SGT1 homolog,23512,290,0.98 [0.85-1.12],0.7386130498524293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT1A1,Sulfotransferase 1A1,24351,299,0.94 [0.87-1.02],0.1311780270965416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,24087,294,1.61 [1.42-1.82],1.1992465150166604e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF1,Formylglycine-generating enzyme,20324,257,1.12 [0.95-1.32],0.1922496829786922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24351,299,1.01 [0.83-1.23],0.9301027822737584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",20901,269,1.25 [1.05-1.48],0.0113853551586325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD1,Sushi domain-containing protein 1,23674,285,0.90 [0.72-1.13],0.3655624378062888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,24103,297,2.22 [1.68-2.94],2.3287512814330788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,20831,269,0.72 [0.53-0.98],0.0360645810250302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,20330,252,1.15 [0.82-1.62],0.4236404545807393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,20341,262,0.99 [0.81-1.21],0.9210656080660792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,20845,268,1.55 [1.18-2.03],0.0015809339733959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYAP1,Synapse-associated protein 1,20437,253,0.94 [0.76-1.17],0.5893520230805213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,20261,268,0.87 [0.69-1.10],0.2438970107802296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,20872,268,1.14 [0.84-1.54],0.3951282464907639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYTL4,Synaptotagmin-like protein 4,20929,268,0.98 [0.84-1.16],0.8553707649710693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20535,263,0.90 [0.80-1.01],0.072030547260822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,24013,293,0.90 [0.82-0.99],0.0259216433121232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,21421,275,1.58 [1.10-2.27],0.0126323673262845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,20831,269,1.00 [0.74-1.35],0.9934427991217034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,24013,293,1.52 [1.14-2.02],0.0043747597585599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAGLN3,Transgelin-3,20195,258,0.90 [0.72-1.11],0.3164488970190965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,20856,267,1.41 [1.11-1.80],0.0054213525176383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,23650,292,1.06 [0.92-1.24],0.4152182788034618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAP1,Antigen peptide transporter 1,20535,263,0.94 [0.76-1.17],0.5804474076581485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,23557,291,0.99 [0.86-1.14],0.9049809257741456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",20341,262,1.10 [0.94-1.28],0.2288768429078947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",20831,269,1.13 [0.82-1.56],0.4537712263616122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,20872,268,1.01 [0.84-1.22],0.918802637683131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D17,TBC1 domain family member 17,23557,291,1.12 [0.89-1.41],0.3466298439313314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,24013,293,0.87 [0.77-0.99],0.0284743578843636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,24087,294,0.93 [0.81-1.07],0.3019926511406161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCA,Tubulin-specific chaperone A,20437,253,1.04 [0.90-1.20],0.5988686822522777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCB,Tubulin-folding cofactor B,23969,296,0.97 [0.88-1.08],0.611660353769576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCC,Tubulin-specific chaperone C,23969,296,0.98 [0.86-1.11],0.7099766180539573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,23512,290,0.88 [0.78-1.00],0.0568183632358742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBR1,T-box brain protein 1,20341,262,0.93 [0.71-1.20],0.5604185108712406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,23925,296,1.02 [0.91-1.13],0.7644058479292225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,23674,285,0.95 [0.82-1.09],0.4478941638990614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,20534,264,1.66 [1.24-2.23],0.0006374677332028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,24353,298,1.57 [1.13-2.18],0.0076832544894452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,20929,268,1.86 [1.39-2.49],2.9912408663016192e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCP11,T-complex protein 11 homolog,20535,263,1.12 [0.93-1.34],0.2337030393115226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,20929,268,3.33 [2.32-4.78],7.356133326992885e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,23557,291,1.12 [1.04-1.21],0.0022373150119338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",20341,262,1.51 [1.22-1.87],0.0001352163666912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,20831,269,1.12 [0.96-1.32],0.1493473242640489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,23557,291,0.99 [0.87-1.12],0.855837308026298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEF,Thyrotroph embryonic factor,20268,261,0.90 [0.66-1.23],0.5119568129170233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,24166,299,2.14 [1.34-3.41],0.0013945399592151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TERF1,Telomeric repeat-binding factor 1,20324,257,0.86 [0.55-1.33],0.4930537690346847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,20505,263,0.96 [0.85-1.09],0.560616451533255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,20341,262,1.35 [1.15-1.60],0.0003454973633195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX33,Testis-expressed protein 33,20535,263,0.93 [0.68-1.29],0.6769739172416327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,20947,267,1.19 [0.68-2.07],0.5448877795932257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,20261,268,0.99 [0.80-1.23],0.9104123858101524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,23990,295,1.56 [1.40-1.75],1.3399895964483828e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,24166,298,2.25 [1.96-2.59],8.224479054201301e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,24071,293,1.50 [1.26-1.77],2.799158669473387e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,24017,294,1.50 [1.13-1.98],0.0047254346004666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,24085,298,1.40 [1.16-1.69],0.0003720047729276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFRC,Transferrin receptor protein 1,24185,295,1.05 [0.80-1.37],0.7317687172801889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,20831,269,0.75 [0.66-0.85],9.735010661293889e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,24087,294,1.64 [1.36-1.99],2.5074913646587964e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,24353,298,1.59 [1.23-2.05],0.0003975868274262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,20831,269,1.15 [0.92-1.43],0.2246795355946392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,23942,294,2.24 [1.54-3.25],2.3145088780518008e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,20324,257,1.41 [0.84-2.37],0.193444982452696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,24166,299,1.95 [1.46-2.61],7.093570803140381e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,24403,298,1.68 [1.19-2.36],0.0031127230492867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,24063,295,1.23 [1.07-1.42],0.003735049828671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,20949,268,1.68 [1.06-2.66],0.0271885124544551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,20156,257,0.88 [0.75-1.02],0.0996539870353849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,24107,295,1.73 [1.21-2.48],0.0027291872235148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,24103,297,2.35 [1.89-2.92],1.6913700133755475e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,24102,295,1.26 [1.00-1.57],0.0470245457347138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,24003,294,2.07 [1.56-2.75],4.308278392394224e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,23674,285,0.86 [0.66-1.14],0.3033608261158386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,20268,261,1.04 [0.94-1.14],0.4685727924510942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,20168,254,0.90 [0.62-1.31],0.5903766785621993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THTPA,Thiamine-triphosphatase,20784,268,1.03 [0.90-1.18],0.6597857806239642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,24351,299,0.98 [0.67-1.42],0.901361721802439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,23412,280,0.99 [0.91-1.09],0.9020858738593938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,24403,298,1.50 [1.12-2.00],0.0059356297416985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23512,291,1.37 [1.11-1.69],0.0030830796979007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20535,263,1.30 [0.94-1.79],0.1073800745605581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24176,296,1.15 [0.91-1.46],0.2343632431795096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,20929,268,1.02 [0.76-1.37],0.8955594011739696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,20872,268,0.99 [0.86-1.14],0.9300227366265538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,23824,291,2.79 [2.03-3.83],2.48604511025038e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,20929,268,1.34 [0.90-1.99],0.1522761366513765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,24204,299,1.06 [0.98-1.14],0.1431543906753725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,24103,297,1.92 [1.53-2.42],2.5134474019130005e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,24032,295,1.33 [0.84-2.11],0.2304714136429315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,24166,299,0.95 [0.83-1.08],0.4160485648055936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,20261,268,0.91 [0.66-1.25],0.5505567047849573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TK1,"Thymidine kinase, cytosolic",20535,263,1.36 [1.08-1.72],0.0097314290226431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,20324,257,1.09 [0.68-1.75],0.7255586862094812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,20535,263,1.18 [0.69-1.99],0.5459709349220547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR3,Toll-like receptor 3,24394,299,1.06 [0.90-1.26],0.4799021714486655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,20324,257,1.57 [1.03-2.40],0.0356276284697995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,20341,262,1.10 [0.87-1.39],0.4415253330151631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,20535,263,0.98 [0.79-1.23],0.8882670339083711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,20268,261,1.03 [0.81-1.31],0.821178190956311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,20268,261,1.06 [0.85-1.32],0.6079724527703486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED8,Protein TMED8,20845,268,0.98 [0.87-1.10],0.6766523126941963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM106A,Transmembrane protein 106A,20831,269,0.96 [0.81-1.13],0.6350694509653153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,20347,252,0.95 [0.77-1.16],0.5922405890274038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM25,Transmembrane protein 25,20901,269,1.02 [0.79-1.32],0.867702794590342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMOD4,Tropomodulin-4,20195,258,0.91 [0.66-1.26],0.5754803632682098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,20261,268,0.91 [0.76-1.08],0.2848800955364975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,20827,266,1.29 [0.95-1.77],0.1072096421937533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,24013,293,1.01 [0.90-1.14],0.8675255779826919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,23844,295,0.91 [0.69-1.20],0.4983945716525314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,24103,297,1.07 [0.93-1.22],0.3624856764699801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,24176,296,1.67 [1.35-2.07],2.661968705590016e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,23638,285,1.39 [1.12-1.72],0.0025356162142188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,20845,268,1.34 [1.09-1.64],0.0056547306224295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,23650,292,1.03 [0.76-1.39],0.8604445795202649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20437,253,0.88 [0.73-1.07],0.2127826621720179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,23969,296,2.51 [1.94-3.25],2.982561348365041e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,23969,296,1.62 [1.43-1.84],8.448026767122174e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24141,296,1.37 [1.10-1.70],0.0042210088341386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24394,299,1.48 [1.14-1.93],0.0033005840432577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24075,295,2.96 [2.18-4.02],3.0987263838006488e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24166,299,2.48 [1.93-3.20],1.778172490928127e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24119,297,1.18 [0.86-1.63],0.3082788103512774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,23650,292,0.77 [0.59-1.00],0.047028078716399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24119,297,1.95 [1.41-2.69],5.456409226131552e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20437,253,1.19 [0.87-1.63],0.2668870606894796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24336,301,1.30 [0.94-1.80],0.1131972323683766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24103,297,3.03 [2.21-4.18],9.39269743183006e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24103,297,1.89 [1.56-2.29],7.434828477780509e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24351,299,1.70 [1.18-2.46],0.0046742872076454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24353,298,1.64 [1.26-2.14],0.0002652716478045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,23969,296,1.90 [1.63-2.21],1.3953585430056923e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24351,299,1.35 [1.08-1.69],0.0075397839953835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,23969,296,1.61 [1.27-2.05],0.0001017828483108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,24394,299,0.74 [0.51-1.08],0.1192544252766866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24087,294,0.76 [0.64-0.90],0.0011963355162144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,24394,299,0.44 [0.31-0.63],7.331549675916997e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24204,299,1.85 [1.27-2.70],0.0013105282651478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24356,297,2.21 [1.63-2.98],2.462653568962351e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,23969,296,1.19 [1.00-1.43],0.0483736206259745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,20923,268,1.32 [0.96-1.80],0.0839874671547726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,20872,268,1.01 [0.88-1.16],0.8356021323064757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,20923,268,0.78 [0.59-1.04],0.0853375787858166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNNI3,"Troponin I, cardiac muscle",23674,285,1.12 [0.98-1.29],0.0939763515741124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNPO1,Transportin-1,20535,263,1.35 [0.96-1.88],0.0800447354867801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,23969,296,0.50 [0.39-0.64],1.844716210207801e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,24103,297,1.51 [1.02-2.23],0.0380949152497376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,20929,268,1.12 [0.96-1.31],0.1343420407150472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,20845,268,1.07 [0.96-1.18],0.2389209747380584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",20195,258,1.03 [0.81-1.32],0.800682026543816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,20324,257,1.10 [0.94-1.27],0.2383097169260162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,20347,252,1.04 [0.84-1.30],0.7061189437040232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53,Cellular tumor antigen p53,23512,290,0.87 [0.67-1.13],0.2897208964285646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,20324,257,1.05 [0.91-1.21],0.5415365811710683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,20004,251,1.31 [1.05-1.64],0.0180684461601298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,23674,285,1.10 [0.81-1.51],0.5368290811937182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP73,Tumor protein p73,20341,262,0.81 [0.57-1.17],0.2625628376365967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPBGL,Trophoblast glycoprotein-like,20341,262,0.90 [0.66-1.24],0.534797764164912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPD52L2,Tumor protein D54,20437,253,0.94 [0.84-1.06],0.3082376642569444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,20929,268,1.53 [1.03-2.26],0.0330477089601228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPM3,Tropomyosin alpha-3 chain,20268,261,1.10 [0.83-1.46],0.4976721536500518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPMT,Thiopurine S-methyltransferase,23512,290,1.04 [0.90-1.21],0.5623794918265586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,23920,294,1.89 [1.60-2.23],6.360336030043326e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,20535,263,1.10 [0.95-1.28],0.1966156049334343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,23557,291,0.94 [0.71-1.26],0.688747082431026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,20268,261,1.26 [1.05-1.52],0.0136404886060312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,20195,258,0.94 [0.76-1.16],0.5516163889683228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSAB1,Tryptase alpha/beta-1,24354,298,0.98 [0.80-1.20],0.8347310423676019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSD1,Tryptase delta,20901,269,0.94 [0.68-1.31],0.7091500613342689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSG1,Tryptase gamma,20324,257,0.95 [0.59-1.53],0.8302090310945924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,23650,292,0.79 [0.65-0.97],0.0260343446880075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF2,TNF receptor-associated factor 2,24087,294,0.93 [0.80-1.08],0.3179709241207827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",20324,257,1.05 [0.77-1.44],0.7557113730687219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,20268,261,0.79 [0.59-1.05],0.1064598426707142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20535,263,0.97 [0.83-1.12],0.6478064310632387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,20923,268,0.96 [0.82-1.12],0.6093461605039727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,24075,295,1.85 [1.55-2.21],1.1118028090124788e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML1,Trem-like transcript 1 protein,20949,268,0.86 [0.69-1.08],0.2001584448477067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,24103,297,0.61 [0.45-0.83],0.0018925014108032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,24336,301,1.16 [0.99-1.37],0.0649218238922961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,24087,294,0.97 [0.85-1.12],0.6951787780667529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,20492,262,0.92 [0.76-1.11],0.4065756162249646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,20845,268,1.00 [0.89-1.12],0.9595852588980234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM26,Tripartite motif-containing protein 26,20195,258,1.03 [0.84-1.27],0.77462996421636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,20341,262,1.00 [0.85-1.17],0.965833064231146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM5,Tripartite motif-containing protein 5,24087,294,0.97 [0.85-1.10],0.6004254786389711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,20831,269,1.01 [0.88-1.16],0.90474847363845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,20268,261,0.99 [0.77-1.28],0.9668588286152312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC1,Hamartin,20324,257,0.91 [0.75-1.11],0.365623340692247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,20901,269,1.09 [0.92-1.30],0.3081302477076919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,24107,295,1.00 [0.87-1.15],0.9891172240757276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSLP,Thymic stromal lymphopoietin,23674,285,1.10 [0.93-1.29],0.285012382818624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSNAX,Translin-associated protein X,20268,261,0.97 [0.71-1.33],0.8631691913807225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,23674,285,1.10 [0.84-1.43],0.4929229327973187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN15,Tetraspanin-15,20268,261,0.94 [0.72-1.22],0.623199973600232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,20261,268,0.93 [0.81-1.08],0.3572915851377136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,20845,268,1.44 [1.28-1.61],8.66988015095159e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,20324,257,1.11 [0.83-1.50],0.4837042661957406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,23519,291,1.00 [0.87-1.15],0.9552977350379248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTF2,Transcription termination factor 2,20341,262,0.88 [0.68-1.14],0.323028284619958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTN,Titin,20268,261,1.08 [0.91-1.29],0.37959976178671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,20719,265,1.30 [0.84-2.01],0.2340792869514777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TUBB3,Tubulin beta-3 chain,20261,268,1.14 [0.75-1.72],0.54675120663104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TWF2,Twinfilin-2,20923,268,1.02 [0.89-1.18],0.7414982771410296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXK,Tyrosine-protein kinase TXK,20535,263,0.89 [0.74-1.07],0.2201478032494107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,23969,296,1.04 [0.92-1.17],0.5490482579868087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXN,Thioredoxin,20611,263,1.28 [0.99-1.65],0.0592337322791699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,24166,299,2.02 [1.42-2.87],8.569915940818958e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,24351,299,1.10 [0.95-1.28],0.2118762758289601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,20872,268,1.03 [0.82-1.29],0.7917988393869679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,20224,268,0.94 [0.82-1.09],0.4426290693063013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",24103,297,1.20 [0.96-1.50],0.1074460587172939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,23958,293,1.14 [0.97-1.33],0.1087874675048794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,24107,295,1.91 [1.32-2.78],0.0006883406474501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20324,257,1.08 [0.88-1.33],0.4823230742777192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,24013,293,1.50 [1.10-2.04],0.0101129714338968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,20831,269,1.13 [0.73-1.74],0.5928210187861545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,20929,268,1.17 [0.96-1.41],0.1124087487374562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,20324,257,0.89 [0.70-1.12],0.3229802551965149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,20268,261,0.96 [0.73-1.27],0.7906109357588789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBXN1,UBX domain-containing protein 1,20437,253,1.04 [0.87-1.24],0.6853380235037068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,20845,268,0.97 [0.89-1.05],0.4534020625335867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,20268,261,1.01 [0.89-1.14],0.8987313529211662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,20268,261,1.04 [0.72-1.50],0.8325985731887587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,23969,296,1.70 [1.31-2.22],8.794460017321084e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,24318,296,0.73 [0.61-0.87],0.0006496853637123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,20324,257,0.55 [0.33-0.92],0.0221985309313168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC79,Protein unc-79 homolog,20195,258,0.94 [0.75-1.18],0.5975288698603303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,20831,269,0.79 [0.54-1.15],0.2189056070017775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,20929,268,1.21 [1.08-1.36],0.0014496700648714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3A,Uroplakin-3a,20261,268,1.06 [0.83-1.37],0.6279560263458477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,20498,262,0.84 [0.65-1.09],0.1908380336020265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROD,Uroporphyrinogen decarboxylase,20437,253,1.04 [0.87-1.24],0.699160290122015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROS,Uroporphyrinogen-III synthase,20341,262,1.01 [0.85-1.22],0.8806218415161547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,24013,293,0.95 [0.84-1.07],0.357041423095349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,20831,269,1.03 [0.87-1.21],0.747171580822748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,20872,268,1.26 [0.96-1.65],0.0995413226981836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,20268,261,0.98 [0.85-1.14],0.8252096764173668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,23674,285,0.98 [0.88-1.10],0.7631466883270428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,23512,290,1.26 [1.04-1.53],0.0166444707863973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,23674,285,1.53 [1.32-1.78],3.9377089981412006e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,20324,257,1.03 [0.90-1.18],0.682783323658068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,24087,294,0.98 [0.86-1.12],0.8007210992923003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,23716,293,1.06 [0.72-1.56],0.7689142428576696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,20949,268,0.99 [0.84-1.16],0.8665379678211642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24013,293,0.67 [0.39-1.14],0.1409521587408355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,20261,268,0.91 [0.80-1.03],0.1389317406093509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,24145,296,2.01 [1.40-2.88],0.0001719401687995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,24351,299,1.42 [1.01-2.00],0.0411948138106012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,20195,258,0.99 [0.85-1.15],0.897387588039517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,24311,299,1.31 [1.10-1.55],0.0019060939002706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,20324,257,1.35 [0.87-2.10],0.1861318469460767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,24166,299,0.93 [0.77-1.12],0.4544854510541156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,24349,299,1.12 [0.84-1.49],0.4416197019184447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VGF,Neurosecretory protein VGF,20901,269,0.64 [0.43-0.95],0.0277634994276636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIM,Vimentin,23674,285,1.04 [0.94-1.15],0.4164635310423714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,20347,252,1.10 [0.66-1.84],0.7039467274479145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,20929,268,2.28 [1.73-3.01],5.623315483213595e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,24013,293,1.21 [1.02-1.43],0.0255046223084604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,20949,268,1.39 [1.16-1.66],0.0002761469121037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,24013,293,1.80 [1.41-2.29],2.029578083406381e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,20535,263,0.88 [0.73-1.06],0.184278005727604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,24013,293,0.91 [0.79-1.04],0.1705192532380152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,20831,269,0.96 [0.85-1.09],0.556159094485042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,24013,293,0.95 [0.83-1.09],0.4639954433746809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,20831,269,1.02 [0.74-1.40],0.91645667302829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,20268,261,1.44 [1.04-2.00],0.0302689251232534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,20831,269,2.19 [1.85-2.60],3.444880030963336e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,24074,296,2.16 [1.69-2.76],5.879552642617234e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24078,294,1.06 [0.90-1.25],0.5024906027669465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,20872,268,1.89 [1.48-2.41],4.193249866482517e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,23557,291,1.37 [1.11-1.70],0.0034425832444558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,20535,263,1.01 [0.75-1.37],0.9373712341991596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,23674,285,1.13 [0.94-1.35],0.1923523738112245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,24351,299,1.03 [0.89-1.20],0.690267022802753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,23512,290,1.48 [1.07-2.07],0.0191785981303367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20437,253,1.01 [0.82-1.25],0.9055661743478408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,24307,301,2.10 [1.69-2.62],3.70837825630011e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,20195,258,1.01 [0.87-1.17],0.9079493569816957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,23881,296,1.12 [0.87-1.45],0.3688303518107574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,20901,269,0.85 [0.63-1.15],0.298403547443877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,24403,298,1.24 [1.07-1.42],0.0031449325235591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24103,297,1.53 [1.16-2.03],0.0028613840691876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,23650,292,0.98 [0.84-1.15],0.8388327217395628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,23674,285,0.90 [0.80-1.02],0.093056208889919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,23557,291,0.97 [0.86-1.10],0.6372267822798708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASHC3,WASH complex subunit 3,20872,268,0.94 [0.80-1.10],0.4491278782710615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,20324,257,0.98 [0.79-1.21],0.8652613237631972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,20831,269,1.13 [0.84-1.53],0.4199750013917167
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,20403,263,1.16 [0.93-1.45],0.1758362386767785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,24291,301,1.55 [1.34-1.79],4.7828542305168794e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,22879,282,2.61 [2.11-3.23],7.738094677124557e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",23893,295,0.41 [0.32-0.53],2.698708552642617e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24119,297,0.82 [0.60-1.11],0.1963700929209566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,24336,301,1.06 [0.79-1.42],0.6919368715757621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,23650,292,1.47 [1.05-2.06],0.02462396172434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,23969,296,0.92 [0.75-1.13],0.4310016123252354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,24336,301,1.13 [0.94-1.37],0.1844720774849193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,24274,296,0.55 [0.43-0.70],1.3247989166952572e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,20324,257,0.96 [0.78-1.19],0.7182245486955711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,24166,299,1.00 [0.90-1.11],0.9982038436595548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,23557,291,1.13 [0.85-1.49],0.4011411648636847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,20872,268,2.75 [1.86-4.06],3.6982433077268e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",20845,268,1.01 [0.93-1.10],0.7993679990142585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,24013,293,0.99 [0.90-1.09],0.8984843016037808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YJU2,Splicing factor YJU2,20831,269,1.01 [0.70-1.46],0.9458218215673728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,20268,261,1.22 [1.01-1.48],0.0399627203073864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,23650,292,1.00 [0.88-1.14],0.9832107917741664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YWHAQ,14-3-3 protein theta,20437,253,0.97 [0.82-1.15],0.7305206270507747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YY1,Transcriptional repressor protein YY1,20324,257,0.80 [0.51-1.25],0.3266172915385418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBP1,Z-DNA-binding protein 1,20324,257,0.96 [0.71-1.31],0.8109311993078632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,23512,290,0.93 [0.80-1.09],0.372410533037356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,23674,285,1.44 [1.17-1.78],0.0005142698268327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,20268,261,0.95 [0.77-1.17],0.6165549634625098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,20845,268,0.98 [0.86-1.12],0.8121101263407224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,20872,268,1.41 [1.09-1.84],0.0102424779366572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF174,Zinc finger protein 174,20324,257,0.69 [0.45-1.06],0.0901147649659493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF75D,Zinc finger protein 75D,20535,263,1.13 [0.94-1.34],0.1914774243819655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF830,Zinc finger protein 830,20831,269,0.93 [0.79-1.09],0.3564553029453599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,20845,268,1.02 [0.86-1.21],0.8231808042477888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,20831,269,0.86 [0.68-1.09],0.2060131980616996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,20347,252,1.01 [0.96-1.06],0.6222605919587779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,20195,258,0.74 [0.47-1.14],0.1730916268355117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZPR1,Zinc finger protein ZPR1,20261,268,1.05 [0.93-1.19],0.4493717811126213
